{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:51:02Z","timestamp":1794293462148,"version":"4.9.0"},"reference-count":485,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2022MC053"],"award-info":[{"award-number":["ZR2022MC053"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Qingdao City Science and Technology Plan Park Incubation Project","award":["24-1-5-yqpy-20-qy"],"award-info":[{"award-number":["24-1-5-yqpy-20-qy"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570683"],"award-info":[{"award-number":["82570683"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic reprogramming is a hallmark of cancer, including hepatocellular carcinoma (HCC). Cancer cells exhibit enhanced glucose and glutamine uptake, increased glycolysis, pentose phosphate pathway activity, de novo lipogenesis, and altered amino acid metabolism. However, the metabolic crosstalk underlying cancer progression and the strategic directions for drug development remain insufficiently synthesized. This review systematically summarizes the functional mechanisms of key signaling regulators involved in cancer metabolic reprogramming, including mammalian target of rapamycin complex 1 (mTORC1), myelocytomatosis viral oncogene homolog (c-Myc), hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1), activating transcription factor 4 (ATF4), nuclear factor erythroid 2\u2013related factor 2 (NRF2), and sterol regulatory element\u2013binding protein 1 (SREBP1). Notably, we highlight the interconnections among metabolic pathways in cancer cells and the signaling hubs that orchestrate metabolic crosstalk, which together constitute an integrated network of metabolic pathways and their regulatory signals. Metabolic targets and metabolism-directed therapeutic agents with substantial developmental potential are comprehensively summarized, providing up-to-date insights and concrete directions for metabolism-targeted cancer therapy. Encouragingly, agents such as the fatty acid synthase inhibitor TVB-2640 and the glutaminase inhibitor CB-839 have already entered clinical trials. We recognize that adverse effects on normal tissues and drug resistance driven by metabolic plasticity represent major challenges for metabolism-targeted therapies. Accordingly, we systematically summarize innovative strategies that offer new therapeutic possibilities, including targeting multiple metabolic pathways through combination therapy to enhance efficacy, combining metabolic inhibitors to overcome resistance to conventional anticancer agents, leveraging metabolic reprogramming for early cancer detection, and exploring emerging approaches such as immunometabolism and metabolomics.<\/jats:p>","DOI":"10.1186\/s43556-026-00427-2","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:07:23Z","timestamp":1773115643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities"],"prefix":"10.1186","volume":"7","author":[{"given":"Mingkang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1895-4983","authenticated-orcid":false,"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"issue":"1","key":"427_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"427_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115064","volume":"43","author":"Y Mao","year":"2024","unstructured":"Mao Y, Xia Z, Xia W, Jiang P. Metabolic reprogramming, sensing, and cancer therapy. Cell Rep. 2024;43(12):115064. https:\/\/doi.org\/10.1016\/j.celrep.2024.115064.","journal-title":"Cell Rep"},{"key":"427_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1426912","volume":"15","author":"LX Du","year":"2024","unstructured":"Du LX, Sheng GL, Shi AD, Li KS, Liu ZL, Tang YC, et al. Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC. Front Pharmacol. 2024;15:1426912. https:\/\/doi.org\/10.3389\/fphar.2024.1426912.","journal-title":"Front Pharmacol"},{"key":"427_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193400","author":"IA Kazi","year":"2024","unstructured":"Kazi IA, Jahagirdar V, Kabir BW, Syed AK, Kabir AW, Perisetti A. Role of imaging in screening for hepatocellular carcinoma. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16193400.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"427_CR5","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.4251\/wjgo.v16.i9.3851","volume":"16","author":"JJ Lu","year":"2024","unstructured":"Lu JJ, Yan S, Chen L, Ju LL, Cai WH, Wu JZ. Retrospective analysis of patients with hepatocellular carcinoma complicated with human immunodeficiency virus infection after hepatectomy. World J Gastrointest Oncol. 2024;16(9):3851\u201364. https:\/\/doi.org\/10.4251\/wjgo.v16.i9.3851.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"427_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12015-024-10797-1","volume":"21","author":"MA Elhinnawi","year":"2025","unstructured":"Elhinnawi MA, Boushra MI, Hussien DM, Hussein FH, Abdelmawgood IA. Mitochondria\u2019s role in the maintenance of cancer stem cells in hepatocellular carcinoma. Stem Cell Rev Rep. 2025;21(1):198\u2013210. https:\/\/doi.org\/10.1007\/s12015-024-10797-1.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"427_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100975","volume":"14","author":"N Attal","year":"2021","unstructured":"Attal N, Sullivan MT, Girardi CA, Thompson KJ, McKillop IH. Fatty acid binding protein-4 promotes alcohol-dependent hepatosteatosis and hepatocellular carcinoma progression. Transl Oncol. 2021;14(1):100975. https:\/\/doi.org\/10.1016\/j.tranon.2020.100975.","journal-title":"Transl Oncol"},{"issue":"9","key":"427_CR8","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.4251\/wjgo.v16.i9.3913","volume":"16","author":"HY Li","year":"2024","unstructured":"Li HY, Jing YM, Shen X, Tang MY, Shen HH, Li XW, et al. Protein tyrosine phosphatase non-receptor II: a possible biomarker of poor prognosis and mediator of immune evasion in hepatocellular carcinoma. World J Gastrointest Oncol. 2024;16(9):3913\u201331. https:\/\/doi.org\/10.4251\/wjgo.v16.i9.3913.","journal-title":"World J Gastrointest Oncol"},{"issue":"7","key":"427_CR9","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s13304-024-01889-1","volume":"76","author":"E Gringeri","year":"2024","unstructured":"Gringeri E, Furlanetto A, Billato I, Cescon M, De Carlis L, Mazzaferro V, et al. The Italian experience on liver transplantation for unresectable peri-hilar cholangiocarcinoma: a national survey and future perspectives. Updates Surg. 2024;76(7):2505\u201313. https:\/\/doi.org\/10.1007\/s13304-024-01889-1.","journal-title":"Updates Surg"},{"issue":"40","key":"427_CR10","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1038\/s41388-024-03142-w","volume":"43","author":"J Du","year":"2024","unstructured":"Du J, Bai D, Gu C, Zhao J, Zhou C, Wang Y, et al. Sorafenib-mediated cleavage of p62 initiates cellular senescence as a mechanism to evade its anti-hepatocellular carcinoma efficacy. Oncogene. 2024;43(40):3003\u201317. https:\/\/doi.org\/10.1038\/s41388-024-03142-w.","journal-title":"Oncogene"},{"issue":"3","key":"427_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s12276-025-01415-2","volume":"57","author":"S Park","year":"2025","unstructured":"Park S, Hall MN. Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications. Exp Mol Med. 2025;57(3):515\u201323. https:\/\/doi.org\/10.1038\/s12276-025-01415-2.","journal-title":"Exp Mol Med"},{"issue":"5","key":"427_CR12","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1097\/hep.0000000000000005","volume":"78","author":"F Yang","year":"2023","unstructured":"Yang F, Hilakivi-Clarke L, Shaha A, Wang Y, Wang X, Deng Y, et al. Metabolic reprogramming and its clinical implication for liver cancer. Hepatology. 2023;78(5):1602\u201324. https:\/\/doi.org\/10.1097\/hep.0000000000000005.","journal-title":"Hepatology"},{"key":"427_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.08.023","author":"H Wang","year":"2025","unstructured":"Wang H, Lun Y, Xu D, Jiang H, Yan Y, Yang X. Research progress and therapeutic strategies in hepatocellular carcinoma metabolic reprogramming. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.08.023.","journal-title":"J Adv Res"},{"key":"427_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1545086","volume":"15","author":"K Wang","year":"2025","unstructured":"Wang K, Li X, Guo S, Chen J, Lv Y, Guo Z, et al. Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma. Front Oncol. 2025;15:1545086. https:\/\/doi.org\/10.3389\/fonc.2025.1545086.","journal-title":"Front Oncol"},{"key":"427_CR15","doi-asserted-by":"publisher","unstructured":"Wong TL, Kong Y, Ma S. Lipid metabolism in cancer cells: Its role in hepatocellular carcinoma progression and therapeutic resistance. Hepatol Commun. 2025;9(11). https:\/\/doi.org\/10.1097\/hc9.0000000000000837.","DOI":"10.1097\/hc9.0000000000000837"},{"key":"427_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1242059","volume":"10","author":"Y Ye","year":"2023","unstructured":"Ye Y, Yu B, Wang H, Yi F. Glutamine metabolic reprogramming in hepatocellular carcinoma. Front Mol Biosci. 2023;10:1242059. https:\/\/doi.org\/10.3389\/fmolb.2023.1242059.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"427_CR17","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","volume":"14","author":"M Liao","year":"2024","unstructured":"Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang J, et al. Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer. Acta Pharm Sin B. 2024;14(3):953\u20131008. https:\/\/doi.org\/10.1016\/j.apsb.2023.12.003.","journal-title":"Acta Pharm Sin B"},{"key":"427_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1399065","volume":"12","author":"F Khan","year":"2024","unstructured":"Khan F, Elsori D, Verma M, Pandey S, Obaidur Rab S, Siddiqui S, et al. Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways. Front Cell Dev Biol. 2024;12:1399065. https:\/\/doi.org\/10.3389\/fcell.2024.1399065.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"427_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang CH, Li N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer. 2024;23(1):203. https:\/\/doi.org\/10.1186\/s12943-024-02119-3.","journal-title":"Mol Cancer"},{"issue":"2","key":"427_CR20","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.230056","volume":"6","author":"Q Dou","year":"2024","unstructured":"Dou Q, Grant AK, de Coutinto Souza P, Moussa M, Nasser I, Ahmed M, et al. Characterizing metabolic heterogeneity of hepatocellular carcinoma with hyperpolarized (13)C pyruvate MRI and mass spectrometry. Radiol Imaging Cancer. 2024;6(2):e230056. https:\/\/doi.org\/10.1148\/rycan.230056.","journal-title":"Radiol Imaging Cancer"},{"issue":"9","key":"427_CR21","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1111\/jgh.70015","volume":"40","author":"C Liu","year":"2025","unstructured":"Liu C, Chen G, Liao J, Wu D, Chen X, Wang N. M6A modification-mediated regulation of DCAF13 promotes glycolytic metabolism and drives hepatocellular carcinoma progression via interaction with G6PD. J Gastroenterol Hepatol. 2025;40(9):2311\u201323. https:\/\/doi.org\/10.1111\/jgh.70015.","journal-title":"J Gastroenterol Hepatol"},{"issue":"39","key":"427_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402115","volume":"11","author":"H Liu","year":"2024","unstructured":"Liu H, Li X, Zhang C, Hao X, Cao Y, Wang Y, et al. GJB2 promotes HCC progression by activating glycolysis through cytoplasmic translocation and generating a suppressive tumor microenvironment based on single cell RNA sequencing. Adv Sci Weinh. 2024;11(39):e2402115. https:\/\/doi.org\/10.1002\/advs.202402115.","journal-title":"Adv Sci Weinh"},{"issue":"4","key":"427_CR23","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/cas.15722","volume":"114","author":"R Nakahara","year":"2023","unstructured":"Nakahara R, Maeda K, Aki S, Osawa T. Metabolic adaptations of cancer in extreme tumor microenvironments. Cancer Sci. 2023;114(4):1200\u20137. https:\/\/doi.org\/10.1111\/cas.15722.","journal-title":"Cancer Sci"},{"key":"427_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122605","volume":"309","author":"T Fujimoto","year":"2024","unstructured":"Fujimoto T, Teraishi F, Kanehira N, Tajima T, Sakurai Y, Kondo N, et al. Bnct pancreatic cancer treatment strategy with glucose-conjugated boron drug. Biomaterials. 2024;309:122605. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122605.","journal-title":"Biomaterials"},{"issue":"12","key":"427_CR25","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1038\/s42255-024-01166-w","volume":"6","author":"M Nam","year":"2024","unstructured":"Nam M, Xia W, Mir AH, Jerrett A, Spinelli JB, Huang TT, et al. Glucose limitation protects cancer cells from apoptosis induced by pyrimidine restriction and replication inhibition. Nat Metab. 2024;6(12):2338\u201353. https:\/\/doi.org\/10.1038\/s42255-024-01166-w.","journal-title":"Nat Metab"},{"issue":"1","key":"427_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304791","volume":"11","author":"T Wang","year":"2024","unstructured":"Wang T, Zhang Y, Liu Y, Huang Y, Wang W. Amino acid-starved cancer cells utilize macropinocytosis and ubiquitin-proteasome system for nutrient acquisition. Adv Sci (Weinh). 2024;11(1):e2304791. https:\/\/doi.org\/10.1002\/advs.202304791.","journal-title":"Adv Sci (Weinh)"},{"key":"427_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217612","volume":"617","author":"C Jiang","year":"2025","unstructured":"Jiang C, Qian Y, Bai X, Li S, Zhang L, Xie Y, et al. SLC7A5\/E2F1\/PTBP1\/PKM2 axis mediates progression and therapy effect of triple-negative breast cancer through the crosstalk of amino acid metabolism and glycolysis pathway. Cancer Lett. 2025;617:217612. https:\/\/doi.org\/10.1016\/j.canlet.2025.217612.","journal-title":"Cancer Lett"},{"key":"427_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102760","volume":"63","author":"S Zhong","year":"2023","unstructured":"Zhong S, Chen W, Wang B, Gao C, Liu X, Song Y, et al. Energy stress modulation of AMPK\/FoxO3 signaling inhibits mitochondria-associated ferroptosis. Redox Biol. 2023;63:102760. https:\/\/doi.org\/10.1016\/j.redox.2023.102760.","journal-title":"Redox Biol"},{"key":"427_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007146","author":"N Liu","year":"2023","unstructured":"Liu N, Yan M, Tao Q, Wu J, Chen J, Chen X, et al. Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis. J Immunother Cancer. 2023. https:\/\/doi.org\/10.1136\/jitc-2023-007146.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"427_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50157-8","volume":"15","author":"T Lan","year":"2024","unstructured":"Lan T, Arastu S, Lam J, Kim H, Wang W, Wang S, et al. Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancer. Nat Commun. 2024;15(1):5857. https:\/\/doi.org\/10.1038\/s41467-024-50157-8.","journal-title":"Nat Commun"},{"issue":"1","key":"427_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02229-6","volume":"41","author":"S Dong","year":"2022","unstructured":"Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, et al. ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer. J Exp Clin Cancer Res. 2022;41(1):15. https:\/\/doi.org\/10.1186\/s13046-021-02229-6.","journal-title":"J Exp Clin Cancer Res"},{"issue":"46","key":"427_CR32","doi-asserted-by":"publisher","first-page":"31846","DOI":"10.1021\/acsnano.4c08083","volume":"18","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xu W, Jin H, Zhang M, Liu S, Liu Y, et al. Nutritional glutamine-modified iron-delivery system with enhanced endocytosis for ferroptosis therapy of pancreatic tumors. ACS Nano. 2024;18(46):31846\u201368. https:\/\/doi.org\/10.1021\/acsnano.4c08083.","journal-title":"ACS Nano"},{"issue":"7","key":"427_CR33","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","volume":"5","author":"KM Tharp","year":"2024","unstructured":"Tharp KM, Kersten K, Maller O, Timblin GA, Stashko C, Canale FP, et al. Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nat Cancer. 2024;5(7):1045\u201362. https:\/\/doi.org\/10.1038\/s43018-024-00775-4.","journal-title":"Nat Cancer"},{"issue":"1","key":"427_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55577-0","volume":"16","author":"T Lan","year":"2025","unstructured":"Lan T, Gao F, Cai Y, Lv Y, Zhu J, Liu H, et al. The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment. Nat Commun. 2025;16(1):333. https:\/\/doi.org\/10.1038\/s41467-024-55577-0.","journal-title":"Nat Commun"},{"issue":"7","key":"427_CR35","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41423-022-00872-3","volume":"19","author":"W Tang","year":"2022","unstructured":"Tang W, Zhou J, Yang W, Feng Y, Wu H, Mok MTS, et al. Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver. Cell Mol Immunol. 2022;19(7):834\u201347. https:\/\/doi.org\/10.1038\/s41423-022-00872-3.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"427_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06267-y","volume":"23","author":"P Liu","year":"2025","unstructured":"Liu P, Huang F, Lin P, Liu J, Zhou P, Wang J, et al. Histidine metabolism drives liver cancer progression via immune microenvironment modulation through metabolic reprogramming. J Transl Med. 2025;23(1):262. https:\/\/doi.org\/10.1186\/s12967-025-06267-y.","journal-title":"J Transl Med"},{"issue":"6","key":"427_CR37","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.7150\/thno.105947","volume":"15","author":"Z Ma","year":"2025","unstructured":"Ma Z, Yang J, Jia W, Li L, Li Y, Hu J, et al. Histone lactylation-driven B7-H3 expression promotes tumor immune evasion. Theranostics. 2025;15(6):2338\u201359. https:\/\/doi.org\/10.7150\/thno.105947.","journal-title":"Theranostics"},{"issue":"1","key":"427_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02815-w","volume":"42","author":"T Sun","year":"2023","unstructured":"Sun T, Liu B, Li Y, Wu J, Cao Y, Yang S, et al. Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation. J Exp Clin Cancer Res. 2023;42(1):253. https:\/\/doi.org\/10.1186\/s13046-023-02815-w.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"427_CR39","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","volume":"35","author":"L Wu","year":"2023","unstructured":"Wu L, Jin Y, Zhao X, Tang K, Zhao Y, Tong L, et al. Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T\u00a0cell-mediated bystander killing via TNF-\u03b1. Cell Metab. 2023;35(9):1580-96.e9. https:\/\/doi.org\/10.1016\/j.cmet.2023.07.001.","journal-title":"Cell Metab"},{"issue":"6","key":"427_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115774","volume":"44","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yan Q, Ruan S, Cui J, Li Z, Zhang Z, et al. GCLM lactylation mediated by ACAT2 promotes ferroptosis resistance in KRAS(G12D)-mutant cancer. Cell Rep. 2025;44(6):115774. https:\/\/doi.org\/10.1016\/j.celrep.2025.115774.","journal-title":"Cell Rep"},{"issue":"6","key":"427_CR41","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.ccell.2025.04.001","volume":"43","author":"S Gurung","year":"2025","unstructured":"Gurung S, Budden T, Mallela K, Jenkins B, von Kriegsheim A, Manrique E, et al. Stromal lipid species dictate melanoma metastasis and tropism. Cancer Cell. 2025;43(6):1108-24.e11. https:\/\/doi.org\/10.1016\/j.ccell.2025.04.001.","journal-title":"Cancer Cell"},{"issue":"2","key":"427_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70006","volume":"45","author":"F Dahboul","year":"2025","unstructured":"Dahboul F, Sun J, Buchard B, Abeywickrama-Samarakoon N, Pujos-Guillot E, Durand S, et al. Simultaneous activation of beta-oxidation and de novo lipogenesis in MASLD-HCC: a new paradigm. Liver Int. 2025;45(2):e70006. https:\/\/doi.org\/10.1111\/liv.70006.","journal-title":"Liver Int"},{"issue":"1","key":"427_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57583-2","volume":"16","author":"F Chen","year":"2025","unstructured":"Chen F, Tang H, Li C, Kang R, Tang D, Liu J. CYP51A1 drives resistance to pH-dependent cell death in pancreatic cancer. Nat Commun. 2025;16(1):2278. https:\/\/doi.org\/10.1038\/s41467-025-57583-2.","journal-title":"Nat Commun"},{"issue":"799","key":"427_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado7225","volume":"17","author":"H Teng","year":"2025","unstructured":"Teng H, Hang Q, Zheng C, Yan Y, Liu S, Zhao Y, et al. In vivo CRISPR activation screen identifies acyl-CoA-binding protein as a driver of bone metastasis. Sci Transl Med. 2025;17(799):eado7225. https:\/\/doi.org\/10.1126\/scitranslmed.ado7225.","journal-title":"Sci Transl Med"},{"key":"427_CR45","doi-asserted-by":"publisher","DOI":"10.1172\/jci178550","author":"Y Zeng","year":"2025","unstructured":"Zeng Y, Zhao L, Zeng K, Zhan Z, Zhan Z, Li S, et al. TRAF3 loss protects glioblastoma cells from lipid peroxidation and immune elimination via dysregulated lipid metabolism. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/jci178550.","journal-title":"J Clin Invest"},{"issue":"34","key":"427_CR46","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1038\/s41388-025-03474-1","volume":"44","author":"Y Luo","year":"2025","unstructured":"Luo Y, Zeng Y, Liu Y, Liu S, Dai Y, Pan W, et al. ACSL5 regulated acetyl-CoA to promote bladder cancer cellular senescence via 53BP1 acetylation. Oncogene. 2025;44(34):3096\u2013112. https:\/\/doi.org\/10.1038\/s41388-025-03474-1.","journal-title":"Oncogene"},{"issue":"1","key":"427_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55768-9","volume":"16","author":"Y Yi","year":"2025","unstructured":"Yi Y, Wang G, Zhang W, Yu S, Fei J, An T, et al. Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation. Nat Commun. 2025;16(1):212. https:\/\/doi.org\/10.1038\/s41467-024-55768-9.","journal-title":"Nat Commun"},{"key":"427_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030427","author":"L Avram","year":"2025","unstructured":"Avram L, Cri\u0219an D, Moldovan RC, Bogos LG, Iuga CA, Andra\u0219 D, et al. Metabolomic exploration of colorectal cancer through amino acids and acylcarnitines profiling of serum samples. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17030427.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"427_CR49","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1158\/0008-5472.Can-23-2266","volume":"84","author":"T Yamamoto","year":"2024","unstructured":"Yamamoto T, Hayashida T, Masugi Y, Oshikawa K, Hayakawa N, Itoh M, et al. PRMT1 sustains de novo fatty acid synthesis by methylating PHGDH to drive chemoresistance in triple-negative breast cancer. Cancer Res. 2024;84(7):1065\u201383. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-2266.","journal-title":"Cancer Res"},{"issue":"1","key":"427_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02295-w","volume":"24","author":"B Lu","year":"2025","unstructured":"Lu B, Chen S, Guan X, Chen X, Du Y, Yuan J, et al. Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer. Mol Cancer. 2025;24(1):83. https:\/\/doi.org\/10.1186\/s12943-025-02295-w.","journal-title":"Mol Cancer"},{"issue":"6","key":"427_CR51","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.7150\/ijbs.76704","volume":"19","author":"Z Wei","year":"2023","unstructured":"Wei Z, Xia J, Li J, Cai J, Shan J, Zhang C, et al. SIRT1 promotes glucolipid metabolic conversion to facilitate tumor development in colorectal carcinoma. Int J Biol Sci. 2023;19(6):1925\u201340. https:\/\/doi.org\/10.7150\/ijbs.76704.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"427_CR52","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/jcp.20166","volume":"202","author":"ML Macheda","year":"2005","unstructured":"Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol. 2005;202(3):654\u201362. https:\/\/doi.org\/10.1002\/jcp.20166.","journal-title":"J Cell Physiol"},{"issue":"8","key":"427_CR53","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.7150\/jca.108582","volume":"16","author":"J Ran","year":"2025","unstructured":"Ran J, Li F, Zhan L, Jin Y, Dong Q, Li X, et al. Hypoxia regulates glycolysis through the HIF-1\u03b1\/BMAL1\/ALDOC axis to reduce oxaliplatin sensitivity in colorectal cancer. J Cancer. 2025;16(8):2503\u201315. https:\/\/doi.org\/10.7150\/jca.108582.","journal-title":"J Cancer"},{"issue":"1","key":"427_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02480-w","volume":"23","author":"E Zamudio-Mart\u00ednez","year":"2025","unstructured":"Zamudio-Mart\u00ednez E, Delgado-Bellido D, Borrego-P\u00e9rez J, Garcia-Diaz A, Herrera-Campos AB, Rodr\u00edguez-Vargas JM, et al. Tankyrases modulate the hypoxia response through non-catalytic mechanisms affecting HIF-1\u03b1. Cell Commun Signal. 2025;23(1):477. https:\/\/doi.org\/10.1186\/s12964-025-02480-w.","journal-title":"Cell Commun Signal"},{"issue":"10","key":"427_CR55","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000033232","volume":"102","author":"Z Hao","year":"2023","unstructured":"Hao Z, Wang Y, Li J, Liu W, Zhao W, Wang J. Expression of HIF-1\u03b1\/PKM2 axis correlates to biological and clinical significance in papillary thyroid carcinoma. Medicine (Baltimore). 2023;102(10):e33232. https:\/\/doi.org\/10.1097\/md.0000000000033232.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"427_CR56","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.13990","volume":"26","author":"H Yi","year":"2023","unstructured":"Yi H, Han Y, Li Q, Lin R, Zhang J, Yang Y, et al. Prognostic impact of the combination of HIF\u20111\u03b1 and GLUT1 in patients with oesophageal squamous cell carcinoma. Oncol Lett. 2023;26(3):404. https:\/\/doi.org\/10.3892\/ol.2023.13990.","journal-title":"Oncol Lett"},{"key":"427_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111227","volume":"403","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Qin Y, Sun X, Bian Z, Liu L, Liu H, et al. Sodium butyrate blocks the growth of colorectal cancer by inhibiting the aerobic glycolysis mediated by SIRT4\/HIF-1\u03b1. Chem Biol Interact. 2024;403:111227. https:\/\/doi.org\/10.1016\/j.cbi.2024.111227.","journal-title":"Chem Biol Interact"},{"key":"427_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.796763","volume":"13","author":"X Yi","year":"2022","unstructured":"Yi X, Qi M, Huang M, Zhou S, Xiong J. Honokiol inhibits HIF-1\u03b1-mediated glycolysis to halt breast cancer growth. Front Pharmacol. 2022;13:796763. https:\/\/doi.org\/10.3389\/fphar.2022.796763.","journal-title":"Front Pharmacol"},{"issue":"1","key":"427_CR59","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41420-024-01898-4","volume":"10","author":"S Wei","year":"2024","unstructured":"Wei S, Zhang J, Zhao R, Shi R, An L, Yu Z, et al. Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K\/AKT\/HIF-1\u03b1 signal pathway in endometrial carcinoma. Cell Death Discov. 2024;10(1):121. https:\/\/doi.org\/10.1038\/s41420-024-01898-4.","journal-title":"Cell Death Discov"},{"issue":"15","key":"427_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35158","volume":"10","author":"P Thakor","year":"2024","unstructured":"Thakor P, Siddiqui MQ, Patel TR. Analysis of the interlink between glucose-6-phosphate dehydrogenase (G6PD) and lung cancer through multi-omics databases. Heliyon. 2024;10(15):e35158. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35158.","journal-title":"Heliyon"},{"issue":"2","key":"427_CR61","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/hep.32702","volume":"78","author":"I Pe\u00f1uelas-Haro","year":"2023","unstructured":"Pe\u00f1uelas-Haro I, Espinosa-Sotelo R, Crosas-Molist E, Herranz-It\u00farbide M, Caballero-D\u00edaz D, Alay A, et al. The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression. Hepatology. 2023;78(2):416\u201333. https:\/\/doi.org\/10.1002\/hep.32702.","journal-title":"Hepatology"},{"key":"427_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081630","author":"H Xie","year":"2017","unstructured":"Xie H, Tong G, Zhang Y, Liang S, Tang K, Yang Q. PGK1 drives hepatocellular carcinoma metastasis by enhancing metabolic process. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18081630.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"427_CR63","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/cac2.12403","volume":"43","author":"P Xia","year":"2023","unstructured":"Xia P, Zhang H, Lu H, Xu K, Jiang X, Jiang Y, et al. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression. Cancer Commun (Lond). 2023;43(3):338\u201364. https:\/\/doi.org\/10.1002\/cac2.12403.","journal-title":"Cancer Commun (Lond)"},{"issue":"11","key":"427_CR64","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.7150\/thno.53417","volume":"11","author":"YC Tang","year":"2021","unstructured":"Tang YC, Hsiao JR, Jiang SS, Chang JY, Chu PY, Liu KJ, et al. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation. Theranostics. 2021;11(11):5232\u201347. https:\/\/doi.org\/10.7150\/thno.53417.","journal-title":"Theranostics"},{"issue":"11","key":"427_CR65","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41422-023-00874-4","volume":"33","author":"YQ Wu","year":"2023","unstructured":"Wu YQ, Zhang CS, Xiong J, Cai DQ, Wang CZ, Wang Y, et al. Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate. Cell Res. 2023;33(11):835\u201350. https:\/\/doi.org\/10.1038\/s41422-023-00874-4.","journal-title":"Cell Res"},{"issue":"1","key":"427_CR66","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154042","volume":"24","author":"S Koyasu","year":"2023","unstructured":"Koyasu S, Horita S, Saito K, Kobayashi M, Ishikita H, Chow CC, et al. ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressiveness. EMBO Rep. 2023;24(1):e54042. https:\/\/doi.org\/10.15252\/embr.202154042.","journal-title":"EMBO Rep"},{"issue":"10","key":"427_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07137-z","volume":"15","author":"T Xia","year":"2024","unstructured":"Xia T, Meng L, Xu G, Sun H, Chen H. TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth. Cell Death Dis. 2024;15(10):740. https:\/\/doi.org\/10.1038\/s41419-024-07137-z.","journal-title":"Cell Death Dis"},{"issue":"9","key":"427_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18353","volume":"28","author":"R Ding","year":"2024","unstructured":"Ding R, Wang Y, Xu L, Sang S, Wu G, Yang W, et al. QiDongNing induces lung cancer cell apoptosis via triggering P53\/DRP1-mediated mitochondrial fission. J Cell Mol Med. 2024;28(9):e18353. https:\/\/doi.org\/10.1111\/jcmm.18353.","journal-title":"J Cell Mol Med"},{"key":"427_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2023.107059","volume":"128","author":"S Chen","year":"2023","unstructured":"Chen S, Tao Y, Wang Q, Ren J, Jing Y, Huang J, et al. Glucose induced-AKT\/mTOR activation accelerates glycolysis and promotes cell survival in acute myeloid leukemia. Leuk Res. 2023;128:107059. https:\/\/doi.org\/10.1016\/j.leukres.2023.107059.","journal-title":"Leuk Res"},{"key":"427_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144681","volume":"750","author":"J Huang","year":"2020","unstructured":"Huang J, Gao W, Liu H, Yin G, Duan H, Huang Z, et al. Up-regulated ANP32E promotes the thyroid carcinoma cell proliferation and migration via activating AKT\/mTOR\/HK2-mediated glycolysis. Gene. 2020;750:144681. https:\/\/doi.org\/10.1016\/j.gene.2020.144681.","journal-title":"Gene"},{"key":"427_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112690","author":"SY Park","year":"2022","unstructured":"Park SY, Chung YS, Park SY, Kim SH. Role of AMPK in regulation of oxaliplatin-resistant human colorectal cancer. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10112690.","journal-title":"Biomedicines"},{"issue":"4","key":"427_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114103","volume":"43","author":"AA Urrutia","year":"2024","unstructured":"Urrutia AA, Mesa-Ciller C, Guajardo-Grence A, Alkan HF, Soro-Arn\u00e1iz I, Vandekeere A, et al. HIF1\u03b1-dependent uncoupling of glycolysis suppresses tumor cell proliferation. Cell Rep. 2024;43(4):114103. https:\/\/doi.org\/10.1016\/j.celrep.2024.114103.","journal-title":"Cell Rep"},{"key":"427_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152554","author":"M Fujita","year":"2025","unstructured":"Fujita M, Orisaka M, Mizutani T, Fujita Y, Onuma T, Tsuyoshi H, et al. YAP\/TAZ promote GLUT1 expression and are associated with prognosis in endometrial cancer. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17152554.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"427_CR74","doi-asserted-by":"publisher","DOI":"10.1080\/19932820.2023.2283953","volume":"18","author":"M Hanbazazh","year":"2023","unstructured":"Hanbazazh M, Samman A, Samargandy S, Al-Maghrabi J. Prognostic value of glucose transporter proteins-1 (GLUT1) in breast carcinoma. Libyan J Med. 2023;18(1):2283953. https:\/\/doi.org\/10.1080\/19932820.2023.2283953.","journal-title":"Libyan J Med"},{"key":"427_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1094480","volume":"13","author":"TH Kim","year":"2023","unstructured":"Kim TH, Kwak Y, Song C, Lee HS, Kim DW, Oh HK, et al. GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer. Front Oncol. 2023;13:1094480. https:\/\/doi.org\/10.3389\/fonc.2023.1094480.","journal-title":"Front Oncol"},{"issue":"4","key":"427_CR76","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00210-022-02347-8","volume":"396","author":"H Huang","year":"2023","unstructured":"Huang H, Xue J, Xie T, Xie ML. Osthole increases the radiosensitivity of hepatoma cells by inhibiting GSK-3\u03b2\/AMPK\/mTOR pathway-controlled glycolysis. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(4):683\u201392. https:\/\/doi.org\/10.1007\/s00210-022-02347-8.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"427_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07418-1","volume":"16","author":"M Deng","year":"2025","unstructured":"Deng M, Liao S, Deng J, Li C, Liu L, Han Q, et al. S100A2 promotes clear cell renal cell carcinoma tumor metastasis through regulating GLUT2 expression. Cell Death Dis. 2025;16(1):135. https:\/\/doi.org\/10.1038\/s41419-025-07418-1.","journal-title":"Cell Death Dis"},{"issue":"1","key":"427_CR78","doi-asserted-by":"publisher","DOI":"10.3892\/br.2024.1794","volume":"21","author":"P Kokilakanit","year":"2024","unstructured":"Kokilakanit P, Koontongkaew S, Utispan K. Nitric oxide has diverse effects on head and neck cancer cell proliferation and glycolysis. Biomed Rep. 2024;21(1):106. https:\/\/doi.org\/10.3892\/br.2024.1794.","journal-title":"Biomed Rep"},{"issue":"45","key":"427_CR79","doi-asserted-by":"publisher","first-page":"17053","DOI":"10.1039\/d2nr04238j","volume":"14","author":"HJ Heo","year":"2022","unstructured":"Heo HJ, Park Y, Lee JH, Kim Y, Kim EK, Kim GH, et al. Clinical big-data-based design of GLUT2-targeted carbon nanodots for accurate diagnosis of hepatocellular carcinoma. Nanoscale. 2022;14(45):17053\u201364. https:\/\/doi.org\/10.1039\/d2nr04238j.","journal-title":"Nanoscale"},{"issue":"2","key":"427_CR80","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s12253-019-00708-y","volume":"26","author":"Y Lei","year":"2020","unstructured":"Lei Y, Hu Q, Gu J. Expressions of carbohydrate response element binding protein and glucose transporters in liver cancer and clinical significance. Pathol Oncol Res. 2020;26(2):1331\u201340. https:\/\/doi.org\/10.1007\/s12253-019-00708-y.","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"427_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0321020","volume":"20","author":"Y Kim","year":"2025","unstructured":"Kim Y, Yeuni Y, Heo HJ, Kim ES, Myung K, Baryawno N, et al. Solute carrier family 2 member 2 (glucose transporter 2): a common factor of hepatocyte and hepatocellular carcinoma differentiation. PLoS ONE. 2025;20(4):e0321020. https:\/\/doi.org\/10.1371\/journal.pone.0321020.","journal-title":"PLoS ONE"},{"issue":"8","key":"427_CR82","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1159\/000536060","volume":"102","author":"S Iwai","year":"2024","unstructured":"Iwai S, Motono N, Oyama T, Shioya A, Yamada S, Uramoto H. The clinical relevance of the expression of SGLT2 in lung adenocarcinoma. Oncology. 2024;102(8):710\u20139. https:\/\/doi.org\/10.1159\/000536060.","journal-title":"Oncology"},{"key":"427_CR83","doi-asserted-by":"publisher","DOI":"10.1172\/jci154754","author":"L Ding","year":"2023","unstructured":"Ding L, Chen X, Zhang W, Dai X, Guo H, Pan X, et al. Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/jci154754.","journal-title":"J Clin Invest"},{"key":"427_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110821","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhu J, Yu SJ, Ma HL, Chen J, Ding XF, et al. Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK\/mTOR pathway. Biomed Pharmacother. 2020. https:\/\/doi.org\/10.1016\/j.biopha.2020.110821.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"427_CR85","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/ijc.31193","volume":"142","author":"K Kaji","year":"2018","unstructured":"Kaji K, Nishimura N, Seki K, Sato S, Saikawa S, Nakanishi K, et al. Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake. Int J Cancer. 2018;142(8):1712\u201322. https:\/\/doi.org\/10.1002\/ijc.31193.","journal-title":"Int J Cancer"},{"issue":"12","key":"427_CR86","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1136\/gutjnl-2024-332481","volume":"73","author":"X Mao","year":"2024","unstructured":"Mao X, Zhang X, Kam L, Chien N, Lai R, Cheung KS, et al. Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease. Gut. 2024;73(12):2054\u201361. https:\/\/doi.org\/10.1136\/gutjnl-2024-332481.","journal-title":"Gut"},{"issue":"3","key":"427_CR87","doi-asserted-by":"publisher","DOI":"10.1093\/function\/zqae008","volume":"5","author":"S Nath","year":"2024","unstructured":"Nath S, Balling R. The Warburg effect reinterpreted 100 yr on: a first-principles stoichiometric analysis and interpretation from the perspective of ATP metabolism in cancer cells. Function. 2024;5(3):zqae008. https:\/\/doi.org\/10.1093\/function\/zqae008.","journal-title":"Function"},{"issue":"2","key":"427_CR88","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","volume":"2","author":"RJ DeBerardinis","year":"2020","unstructured":"DeBerardinis RJ, Chandel NS. We need to talk about the Warburg effect. Nat Metab. 2020;2(2):127\u20139. https:\/\/doi.org\/10.1038\/s42255-020-0172-2.","journal-title":"Nat Metab"},{"issue":"1","key":"427_CR89","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10960-y","volume":"52","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wu Y, Cheng A, Cui F, Yang Z, Guo J. The lactylation of glucose-6-phosphate dehydrogenase promotes malignant phenotypes in cancer cell lines. Mol Biol Rep. 2025;52(1):861. https:\/\/doi.org\/10.1007\/s11033-025-10960-y.","journal-title":"Mol Biol Rep"},{"key":"427_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ab.2018.10.026","volume":"566","author":"ML Sowers","year":"2019","unstructured":"Sowers ML, Herring J, Zhang W, Tang H, Ou Y, Gu W, et al. Analysis of glucose-derived amino acids involved in one-carbon and cancer metabolism by stable-isotope tracing gas chromatography mass spectrometry. Anal Biochem. 2019;566:1\u20139. https:\/\/doi.org\/10.1016\/j.ab.2018.10.026.","journal-title":"Anal Biochem"},{"issue":"6","key":"427_CR91","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s13402-024-01022-9","volume":"47","author":"J Yang","year":"2024","unstructured":"Yang J, Tong X, Wang W, Yu X, Xu J, Shi S. Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production. Cell Oncol (Dordr). 2024;47(6):2367\u201382. https:\/\/doi.org\/10.1007\/s13402-024-01022-9.","journal-title":"Cell Oncol (Dordr)"},{"key":"427_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154518","volume":"247","author":"J Steeghs","year":"2023","unstructured":"Steeghs J, Offermans K, Jenniskens JCA, Samarska I, Fazzi GE, van den Brandt PA, et al. Relationship between the Warburg effect in tumour cells and the tumour microenvironment in colorectal cancer patients: results from a large multicentre study. Pathol Res Pract. 2023;247:154518. https:\/\/doi.org\/10.1016\/j.prp.2023.154518.","journal-title":"Pathol Res Pract"},{"key":"427_CR93","doi-asserted-by":"publisher","DOI":"10.34133\/research.0184","volume":"6","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhai X, Liu Y, Xia Z, Xia T, Du G, et al. NOP2-mediated m5C modification of c-Myc in an EIF3A-dependent manner to reprogram glucose metabolism and promote hepatocellular carcinoma progression. Research Wash D C. 2023;6:0184. https:\/\/doi.org\/10.34133\/research.0184.","journal-title":"Research Wash D C"},{"issue":"7","key":"427_CR94","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.7150\/thno.72581","volume":"12","author":"H Zhang","year":"2022","unstructured":"Zhang H, Su X, Burley SK, Zheng XFS. mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma. Theranostics. 2022;12(7):3518\u201333. https:\/\/doi.org\/10.7150\/thno.72581.","journal-title":"Theranostics"},{"issue":"4","key":"427_CR95","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41419-021-03596-w","volume":"12","author":"X Luo","year":"2021","unstructured":"Luo X, Zheng E, Wei L, Zeng H, Qin H, Zhang X, et al. The fatty acid receptor CD36 promotes HCC progression through activating Src\/PI3K\/AKT axis-dependent aerobic glycolysis. Cell Death Dis. 2021;12(4):328. https:\/\/doi.org\/10.1038\/s41419-021-03596-w.","journal-title":"Cell Death Dis"},{"issue":"1","key":"427_CR96","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-023-02718-w","volume":"42","author":"C Bergamini","year":"2023","unstructured":"Bergamini C, Leoni I, Rizzardi N, Melli M, Galvani G, Coada CA, et al. MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma. J Exp Clin Cancer Res. 2023;42(1):145. https:\/\/doi.org\/10.1186\/s13046-023-02718-w.","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"427_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166823","volume":"1869","author":"Y Wu","year":"2023","unstructured":"Wu Y, Song L, Kong J, Wen Q, Jiao J, Wang X, et al. Scribble promotes fibrosis-dependent mechanisms of hepatocarcinogenesis by p53\/PUMA-mediated glycolysis. Biochim Biophys Acta Mol Basis Dis. 2023;1869(8):166823. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166823.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"427_CR98","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2023.07.036","volume":"208","author":"Y Wang","year":"2023","unstructured":"Wang Y, Mang X, Li D, Chen Y, Cai Z, Tan F. Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT\/mTOR\/HIF-1\u03b1 pathway. Free Radic Biol Med. 2023;208:134\u201352. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.07.036.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"427_CR99","first-page":"927","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang C, Zhao Q, Wei W, Dong Z, Shao L, et al. The miR-873\/NDFIP1 axis promotes hepatocellular carcinoma growth and metastasis through the AKT\/mTOR-mediated Warburg effect. Am J Cancer Res. 2019;9(5):927\u201344.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"427_CR100","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s12276-023-01142-6","volume":"56","author":"X Li","year":"2024","unstructured":"Li X, Zhang CC, Lin XT, Zhang J, Zhang YJ, Yu HQ, et al. Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma. Exp Mol Med. 2024;56(1):177\u201391. https:\/\/doi.org\/10.1038\/s12276-023-01142-6.","journal-title":"Exp Mol Med"},{"issue":"4","key":"427_CR101","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jhep.2014.04.035","volume":"61","author":"Q Huang","year":"2014","unstructured":"Huang Q, Li J, Xing J, Li W, Li H, Ke X, et al. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway. J Hepatol. 2014;61(4):859\u201366. https:\/\/doi.org\/10.1016\/j.jhep.2014.04.035.","journal-title":"J Hepatol"},{"key":"427_CR102","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2560650","volume":"2019","author":"G Yao","year":"2019","unstructured":"Yao G, Yin J, Wang Q, Dong R, Lu J. Glypican-3 enhances reprogramming of glucose metabolism in liver cancer cells. Biomed Res Int. 2019;2019:2560650. https:\/\/doi.org\/10.1155\/2019\/2560650.","journal-title":"Biomed Res Int"},{"issue":"4","key":"427_CR103","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3727\/096504018x15180451872087","volume":"27","author":"J Sun","year":"2019","unstructured":"Sun J, Li J, Guo Z, Sun L, Juan C, Zhou Y, et al. Overexpression of pyruvate dehydrogenase E1\u03b1 subunit inhibits Warburg effect and induces cell apoptosis through mitochondria-mediated pathway in hepatocellular carcinoma. Oncol Res. 2019;27(4):407\u201314. https:\/\/doi.org\/10.3727\/096504018x15180451872087.","journal-title":"Oncol Res"},{"issue":"6","key":"427_CR104","doi-asserted-by":"publisher","first-page":"E725","DOI":"10.1073\/pnas.1508779113","volume":"113","author":"IM Xu","year":"2016","unstructured":"Xu IM, Lai RK, Lin SH, Tse AP, Chiu DK, Koh HY, et al. Transketolase counteracts oxidative stress to drive cancer development. Proc Natl Acad Sci U S A. 2016;113(6):E725\u201334. https:\/\/doi.org\/10.1073\/pnas.1508779113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"39","key":"427_CR105","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1038\/s41388-023-02757-9","volume":"42","author":"J Hu","year":"2023","unstructured":"Hu J, Liu N, Song D, Steer CJ, Zheng G, Song G. A positive feedback between cholesterol synthesis and the pentose phosphate pathway rather than glycolysis promotes hepatocellular carcinoma. Oncogene. 2023;42(39):2892\u2013904. https:\/\/doi.org\/10.1038\/s41388-023-02757-9.","journal-title":"Oncogene"},{"issue":"3","key":"427_CR106","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41418-024-01406-2","volume":"32","author":"X Jin","year":"2025","unstructured":"Jin X, Lv Y, Bie F, Duan J, Ma C, Dai M, et al. METTL3 confers oxaliplatin resistance through the activation of G6PD-enhanced pentose phosphate pathway in hepatocellular carcinoma. Cell Death Differ. 2025;32(3):466\u201379. https:\/\/doi.org\/10.1038\/s41418-024-01406-2.","journal-title":"Cell Death Differ"},{"key":"427_CR107","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.biopha.2019.01.028","volume":"111","author":"H Chen","year":"2019","unstructured":"Chen H, Wu D, Bao L, Yin T, Lei D, Yu J, et al. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming. Biomed Pharmacother. 2019;111:1353\u20138. https:\/\/doi.org\/10.1016\/j.biopha.2019.01.028.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"427_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0637-7","volume":"36","author":"X Yin","year":"2017","unstructured":"Yin X, Tang B, Li JH, Wang Y, Zhang L, Xie XY, et al. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway. J Exp Clin Cancer Res. 2017;36(1):166. https:\/\/doi.org\/10.1186\/s13046-017-0637-7.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"427_CR109","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1111\/cas.15593","volume":"113","author":"C Yang","year":"2022","unstructured":"Yang C, Cui XW, Ding ZW, Jiang TY, Feng XF, Pan YF, et al. Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinoma. Cancer Sci. 2022;113(12):4151\u201364. https:\/\/doi.org\/10.1111\/cas.15593.","journal-title":"Cancer Sci"},{"issue":"1","key":"427_CR110","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000540180","volume":"14","author":"K Toshida","year":"2025","unstructured":"Toshida K, Itoh S, Iseda N, Tanaka S, Nakazono K, Tomiyama T, et al. The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis. Liver Cancer. 2025;14(1):36\u201357. https:\/\/doi.org\/10.1159\/000540180.","journal-title":"Liver Cancer"},{"issue":"3","key":"427_CR111","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1158\/0008-5472.Can-22-2370","volume":"83","author":"Y Li","year":"2023","unstructured":"Li Y, Chen H, Xie X, Yang B, Wang X, Zhang J, et al. PINK1-mediated mitophagy promotes oxidative phosphorylation and redox homeostasis to induce drug-tolerant persister cancer cells. Cancer Res. 2023;83(3):398\u2013413. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-2370.","journal-title":"Cancer Res"},{"issue":"6","key":"427_CR112","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205395","volume":"10","author":"YM Liu","year":"2023","unstructured":"Liu YM, Ge JY, Chen YF, Liu T, Chen L, Liu CC, et al. Combined single-cell and spatial transcriptomics reveal the metabolic evolvement of breast cancer during early dissemination. Adv Sci (Weinh). 2023;10(6):e2205395. https:\/\/doi.org\/10.1002\/advs.202205395.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"427_CR113","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.7150\/ijbs.110506","volume":"21","author":"Y Liu","year":"2025","unstructured":"Liu Y, Tian W, Ge C, Zhang C, Huang Z, Zhang C, et al. SNX17 mediates STAT3 activation to promote hepatocellular carcinoma progression via a retromer dependent mechanism. Int J Biol Sci. 2025;21(6):2762\u201379. https:\/\/doi.org\/10.7150\/ijbs.110506.","journal-title":"Int J Biol Sci"},{"key":"427_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155761","volume":"152","author":"X Ji","year":"2024","unstructured":"Ji X, Yang Z, Li C, Zhu S, Zhang Y, Xue F, et al. Mitochondrial ribosomal protein L12 potentiates hepatocellular carcinoma by regulating mitochondrial biogenesis and metabolic reprogramming. Metabolism. 2024;152:155761. https:\/\/doi.org\/10.1016\/j.metabol.2023.155761.","journal-title":"Metabolism"},{"key":"427_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155628","volume":"147","author":"T Yang","year":"2023","unstructured":"Yang T, Liang N, Zhang J, Bai Y, Li Y, Zhao Z, et al. OCTN2 enhances PGC-1\u03b1-mediated fatty acid oxidation and OXPHOS to support stemness in hepatocellular carcinoma. Metabolism. 2023;147:155628. https:\/\/doi.org\/10.1016\/j.metabol.2023.155628.","journal-title":"Metabolism"},{"issue":"1","key":"427_CR116","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hep.32621","volume":"78","author":"T Yuan","year":"2023","unstructured":"Yuan T, Zhou T, Qian M, Du J, Liu Y, Wang J, et al. SDHA\/B reduction promotes hepatocellular carcinoma by facilitating the deNEDDylation of cullin1 and stabilizing YAP\/TAZ. Hepatology. 2023;78(1):103\u201319. https:\/\/doi.org\/10.1002\/hep.32621.","journal-title":"Hepatology"},{"key":"427_CR117","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.canlet.2019.07.001","volume":"461","author":"J Li","year":"2019","unstructured":"Li J, Liang N, Long X, Zhao J, Yang J, Du X, et al. SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS\/NF\u03baB signaling. Cancer Lett. 2019;461:44\u201355. https:\/\/doi.org\/10.1016\/j.canlet.2019.07.001.","journal-title":"Cancer Lett"},{"issue":"1","key":"427_CR118","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1038\/s41598-018-21361-6","volume":"8","author":"PL Tseng","year":"2018","unstructured":"Tseng PL, Wu WH, Hu TH, Chen CW, Cheng HC, Li CF, et al. Decreased succinate dehydrogenase B in human hepatocellular carcinoma accelerates tumor malignancy by inducing the Warburg effect. Sci Rep. 2018;8(1):3081. https:\/\/doi.org\/10.1038\/s41598-018-21361-6.","journal-title":"Sci Rep"},{"key":"427_CR119","doi-asserted-by":"publisher","first-page":"1170223","DOI":"10.3389\/fimmu.2023.1170223","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Du Y, Jiang W, Dong S, Li W, Tang H, et al. Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cancer. Front Immunol. 2023;14:1170223. https:\/\/doi.org\/10.3389\/fimmu.2023.1170223.","journal-title":"Front Immunol"},{"key":"427_CR120","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2147\/jhc.S483664","volume":"11","author":"X Tang","year":"2024","unstructured":"Tang X, Xue J, Zhang J, Zhou J. A gluconeogenesis-related genes model for predicting prognosis, tumor microenvironment infiltration, and drug sensitivity in hepatocellular carcinoma. J Hepatocell Carcinoma. 2024;11:1907\u201326. https:\/\/doi.org\/10.2147\/jhc.S483664.","journal-title":"J Hepatocell Carcinoma"},{"issue":"12","key":"427_CR121","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41388-017-0070-6","volume":"37","author":"MX Liu","year":"2018","unstructured":"Liu MX, Jin L, Sun SJ, Liu P, Feng X, Cheng ZL, et al. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Oncogene. 2018;37(12):1637\u201353. https:\/\/doi.org\/10.1038\/s41388-017-0070-6.","journal-title":"Oncogene"},{"key":"427_CR122","doi-asserted-by":"publisher","DOI":"10.1172\/jci144703","author":"J Xiang","year":"2021","unstructured":"Xiang J, Chen C, Liu R, Gou D, Chang L, Deng H, et al. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/jci144703.","journal-title":"J Clin Invest"},{"issue":"10","key":"427_CR123","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70286","volume":"45","author":"K Tanaka","year":"2025","unstructured":"Tanaka K, Tsuji K, Hiraoka A, Tada T, Hirooka M, Kariyama K, et al. Clinical Utility of a Prognostic Scoring System Based on LDH and CRP in HCC Patients Receiving Atezolizumab Plus Bevacizumab. Liver Int. 2025;45(10):e70286. https:\/\/doi.org\/10.1111\/liv.70286.","journal-title":"Liver Int"},{"issue":"1","key":"427_CR124","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hep.32348","volume":"77","author":"Y Fang","year":"2023","unstructured":"Fang Y, Liu W, Tang Z, Ji X, Zhou Y, Song S, et al. Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack. Hepatology. 2023;77(1):109\u201323. https:\/\/doi.org\/10.1002\/hep.32348.","journal-title":"Hepatology"},{"issue":"1","key":"427_CR125","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","volume":"5","author":"Z Yang","year":"2023","unstructured":"Yang Z, Yan C, Ma J, Peng P, Ren X, Cai S, et al. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat Metab. 2023;5(1):61\u201379. https:\/\/doi.org\/10.1038\/s42255-022-00710-w.","journal-title":"Nat Metab"},{"issue":"10","key":"427_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108487","volume":"33","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Li M, Yao X, Fei Y, Lin Z, Li Z, et al. HCAR1\/MCT1 regulates tumor ferroptosis through the lactate-mediated AMPK-SCD1 activity and its therapeutic implications. Cell Rep. 2020;33(10):108487. https:\/\/doi.org\/10.1016\/j.celrep.2020.108487.","journal-title":"Cell Rep"},{"issue":"16","key":"427_CR127","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1016\/j.molcel.2023.07.017","volume":"83","author":"S Cho","year":"2023","unstructured":"Cho S, Chun Y, He L, Ramirez CB, Ganesh KS, Jeong K, et al. FAM120A couples SREBP-dependent transcription and splicing of lipogenesis enzymes downstream of mTORC1. Mol Cell. 2023;83(16):3010-26.e8. https:\/\/doi.org\/10.1016\/j.molcel.2023.07.017.","journal-title":"Mol Cell"},{"key":"427_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217006","volume":"595","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang F, Yan G, Tong Y, Guo W, Li S, et al. CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer. Cancer Lett. 2024;595:217006. https:\/\/doi.org\/10.1016\/j.canlet.2024.217006.","journal-title":"Cancer Lett"},{"issue":"12","key":"427_CR129","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.7150\/ijbs.101039","volume":"20","author":"B Li","year":"2024","unstructured":"Li B, Cheng B, Huang H, Huang S, Yu S, Li Z, et al. Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer. Int J Biol Sci. 2024;20(12):4635\u201353. https:\/\/doi.org\/10.7150\/ijbs.101039.","journal-title":"Int J Biol Sci"},{"key":"427_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155360","volume":"128","author":"M Chen","year":"2024","unstructured":"Chen M, Li H, Zheng S, Shen J, Chen Y, Li Y, et al. Nobiletin targets SREBP1\/ACLY to induce autophagy-dependent cell death of gastric cancer cells through PI3K\/Akt\/mTOR signaling pathway. Phytomedicine. 2024;128:155360. https:\/\/doi.org\/10.1016\/j.phymed.2024.155360.","journal-title":"Phytomedicine"},{"issue":"5","key":"427_CR131","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3724\/abbs.2024192","volume":"57","author":"C Liu","year":"2024","unstructured":"Liu C, Liu J, Liu G, Song Y, Yang X, Gao H, et al. Anthocyanins and flavonoids derived from Clitoria ternatea L. flower inhibit bladder cancer growth via suppressing fatty acid synthesis mediated by SREBP1 pathway. Acta Biochim Biophys Sin. 2024;57(5):770\u201381. https:\/\/doi.org\/10.3724\/abbs.2024192.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"10","key":"427_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100843","volume":"5","author":"S Wang","year":"2023","unstructured":"Wang S, Zhou Y, Yu R, Ling J, Li B, Yang C, et al. Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPAR\u03b3 and SREBP2. JHEP Rep. 2023;5(10):100843. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100843.","journal-title":"JHEP Rep"},{"issue":"21","key":"427_CR133","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70342","volume":"13","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Jiang W, Zhou J, Maldeney AR, Liang J, Yang J, et al. The combined inhibition of SREBP and mTORC1 signaling synergistically inhibits B-cell lymphoma. Cancer Med. 2024;13(21):e70342. https:\/\/doi.org\/10.1002\/cam4.70342.","journal-title":"Cancer Med"},{"key":"427_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216877","volume":"591","author":"JH Liang","year":"2024","unstructured":"Liang JH, Wang WT, Wang R, Gao R, Du KX, Duan ZW, et al. PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma. Cancer Lett. 2024;591:216877. https:\/\/doi.org\/10.1016\/j.canlet.2024.216877.","journal-title":"Cancer Lett"},{"issue":"10","key":"427_CR135","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1158\/1078-0432.Ccr-24-2000","volume":"31","author":"E Morelli","year":"2025","unstructured":"Morelli E, Ribeiro CF, Rodrigues SD, Gao C, Socciarelli F, Maisano D, et al. Targeting acetyl-CoA carboxylase suppresses de novo lipogenesis and tumor cell growth in multiple myeloma. Clin Cancer Res. 2025;31(10):1975\u201387. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-24-2000.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"427_CR136","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41388-020-01553-z","volume":"40","author":"KB Singh","year":"2021","unstructured":"Singh KB, Hahm ER, Kim SH, Wendell SG, Singh SV. A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer. Oncogene. 2021;40(3):592\u2013602. https:\/\/doi.org\/10.1038\/s41388-020-01553-z.","journal-title":"Oncogene"},{"key":"427_CR137","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2147\/idr.S397231","volume":"16","author":"K Zhu","year":"2023","unstructured":"Zhu K, Ma S, Chen H, Xie J, Huang D, Fu C, et al. Value of Laboratory Indicators in Predicting Pneumonia in Symptomatic COVID-19 Patients Infected with the SARS-CoV-2 Omicron Variant. Infect Drug Resist. 2023;16:1159\u201370. https:\/\/doi.org\/10.2147\/idr.S397231.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"427_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03346-2","volume":"44","author":"NI Lorenz","year":"2025","unstructured":"Lorenz NI, Sauer B, Urban H, Weinem JB, Parmar BS, Zeiner PS, et al. AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment. J Exp Clin Cancer Res. 2025;44(1):104. https:\/\/doi.org\/10.1186\/s13046-025-03346-2.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"427_CR139","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1007\/s11010-024-05198-4","volume":"480","author":"J Luo","year":"2025","unstructured":"Luo J, Pan S, Luo J, Wang L, Yin J, Zhao H, et al. GNA15 induces drug resistance in B cell acute lymphoblastic leukemia by promoting fatty acid oxidation via activation of the AMPK pathway. Mol Cell Biochem. 2025;480(6):3719\u201333. https:\/\/doi.org\/10.1007\/s11010-024-05198-4.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"427_CR140","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s11658-024-00675-6","volume":"29","author":"L Lu","year":"2024","unstructured":"Lu L, Hu X, Han Y, Wang H, Tian Z, Zhang Y, et al. ENPP2 promotes progression and lipid accumulation via AMPK\/SREBP1\/FAS pathway in chronic lymphocytic leukemia. Cell Mol Biol Lett. 2024;29(1):159. https:\/\/doi.org\/10.1186\/s11658-024-00675-6.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"427_CR141","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41419-025-07836-1","volume":"16","author":"F Yang","year":"2025","unstructured":"Yang F, Li Y, Shang X, Zhu Y, Hou W, Liu Y, et al. PLIN2 promotes colorectal cancer progression through CD36-mediated epithelial-mesenchymal transition. Cell Death Dis. 2025;16(1):510. https:\/\/doi.org\/10.1038\/s41419-025-07836-1.","journal-title":"Cell Death Dis"},{"key":"427_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155905","volume":"155","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu X, Yang D, Li L, Li S, Lu S, et al. Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression. Metabolism. 2024;155:155905. https:\/\/doi.org\/10.1016\/j.metabol.2024.155905.","journal-title":"Metabolism"},{"issue":"1","key":"427_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39752-3","volume":"14","author":"VS Peche","year":"2023","unstructured":"Peche VS, Pietka TA, Jacome-Sosa M, Samovski D, Palacios H, Chatterjee-Basu G, et al. Endothelial cell CD36 regulates membrane ceramide formation, exosome fatty acid transfer and circulating fatty acid levels. Nat Commun. 2023;14(1):4029. https:\/\/doi.org\/10.1038\/s41467-023-39752-3.","journal-title":"Nat Commun"},{"issue":"1","key":"427_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11274-x","volume":"10","author":"Y Tian","year":"2019","unstructured":"Tian Y, Yang B, Qiu W, Hao Y, Zhang Z, Yang B, et al. ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy. Nat Commun. 2019;10(1):3391. https:\/\/doi.org\/10.1038\/s41467-019-11274-x.","journal-title":"Nat Commun"},{"issue":"12","key":"427_CR145","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01808-7","volume":"39","author":"L Tao","year":"2022","unstructured":"Tao L, Ding X, Yan L, Xu G, Zhang P, Ji A, et al. CD36 accelerates the progression of hepatocellular carcinoma by promoting FAs absorption. Med Oncol. 2022;39(12):202. https:\/\/doi.org\/10.1007\/s12032-022-01808-7.","journal-title":"Med Oncol"},{"issue":"1","key":"427_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00388-8","volume":"27","author":"Q Xu","year":"2022","unstructured":"Xu Q, Liao Z, Gong Z, Liu X, Yang Y, Wang Z, et al. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration. Cell Mol Biol Lett. 2022;27(1):93. https:\/\/doi.org\/10.1186\/s11658-022-00388-8.","journal-title":"Cell Mol Biol Lett"},{"key":"427_CR147","doi-asserted-by":"publisher","DOI":"10.34133\/research.1001","volume":"8","author":"D Yang","year":"2025","unstructured":"Yang D, Li L, Zang K, Ma W, Yang Y, Sun Y, et al. EVA1A regulates hepatic lipid homeostasis by modulating CD36 expression and its palmitoylation. Research Wash D C. 2025;8:1001. https:\/\/doi.org\/10.34133\/research.1001.","journal-title":"Research Wash D C"},{"issue":"1","key":"427_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02915-9","volume":"23","author":"J Hong","year":"2023","unstructured":"Hong J, Liu J, Zhang Y, Ding L, Ye Q. MiR-3180 inhibits hepatocellular carcinoma growth and metastasis by targeting lipid synthesis and uptake. Cancer Cell Int. 2023;23(1):66. https:\/\/doi.org\/10.1186\/s12935-023-02915-9.","journal-title":"Cancer Cell Int"},{"issue":"13","key":"427_CR149","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/s41388-024-02960-2","volume":"43","author":"T Deng","year":"2024","unstructured":"Deng T, Zhao J, Tong Y, Chen Z, He B, Li J, et al. Crosstalk between endothelial progenitor cells and HCC through periostin\/CCL2\/CD36 supports formation of the pro-metastatic microenvironment in HCC. Oncogene. 2024;43(13):944\u201361. https:\/\/doi.org\/10.1038\/s41388-024-02960-2.","journal-title":"Oncogene"},{"issue":"10","key":"427_CR150","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.immuni.2024.08.016","volume":"57","author":"W Guo","year":"2024","unstructured":"Guo W, Li Z, Anagnostopoulos G, Kong WT, Zhang S, Chakarov S, et al. Notch signaling regulates macrophage-mediated inflammation in metabolic dysfunction-associated steatotic liver disease. Immunity. 2024;57(10):2310-27.e6. https:\/\/doi.org\/10.1016\/j.immuni.2024.08.016.","journal-title":"Immunity"},{"issue":"1","key":"427_CR151","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","volume":"9","author":"GQ Zhu","year":"2023","unstructured":"Zhu GQ, Tang Z, Huang R, Qu WF, Fang Y, Yang R, et al. CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discov. 2023;9(1):25. https:\/\/doi.org\/10.1038\/s41421-023-00529-z.","journal-title":"Cell Discov"},{"issue":"2","key":"427_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.113947","volume":"435","author":"H Wang","year":"2024","unstructured":"Wang H, Liu F, Wu X, Zhu G, Tang Z, Qu W, et al. Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogramming. Exp Cell Res. 2024;435(2):113947. https:\/\/doi.org\/10.1016\/j.yexcr.2024.113947.","journal-title":"Exp Cell Res"},{"key":"427_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050512","author":"N Berndt","year":"2019","unstructured":"Berndt N, Eckstein J, Heucke N, Gajowski R, Stockmann M, Meierhofer D, et al. Characterization of lipid and lipid droplet metabolism in human HCC. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8050512.","journal-title":"Cells"},{"issue":"41","key":"427_CR154","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404229","volume":"11","author":"L Li","year":"2024","unstructured":"Li L, Zhang X, Xu G, Xue R, Li S, Wu S, et al. Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells. Adv Sci (Weinh). 2024;11(41):e2404229. https:\/\/doi.org\/10.1002\/advs.202404229.","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"427_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2025.159634","volume":"1870","author":"GH Tamarindo","year":"2025","unstructured":"Tamarindo GH, Ribeiro CF, Rodrigues S, G\u00f3es RM, Loda M. DHA suppresses hormone-sensitive and castration-resistant prostate cancer growth by decreasing de novo lipogenesis. Biochim Biophys Acta Mol Cell Biol Lipids. 2025;1870(5):159634. https:\/\/doi.org\/10.1016\/j.bbalip.2025.159634.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"7","key":"427_CR156","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.ymthe.2022.03.015","volume":"30","author":"HH Liu","year":"2022","unstructured":"Liu HH, Xu Y, Li CJ, Hsu SJ, Lin XH, Zhang R, et al. An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming. Mol Ther. 2022;30(7):2554\u201367. https:\/\/doi.org\/10.1016\/j.ymthe.2022.03.015.","journal-title":"Mol Ther"},{"key":"427_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107128","volume":"202","author":"J Ni","year":"2024","unstructured":"Ni J, Zhang L, Feng G, Bao W, Wang Y, Huang Y, et al. Vanillic acid restores homeostasis of intestinal epithelium in colitis through inhibiting CA9\/STIM1-mediated ferroptosis. Pharmacol Res. 2024;202:107128. https:\/\/doi.org\/10.1016\/j.phrs.2024.107128.","journal-title":"Pharmacol Res"},{"key":"427_CR158","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jare.2024.09.027","volume":"74","author":"G Huang","year":"2025","unstructured":"Huang G, Cai Y, Ren M, Zhang X, Fu Y, Cheng R, et al. Salidroside sensitizes Triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy. J Adv Res. 2025;74:589\u2013607. https:\/\/doi.org\/10.1016\/j.jare.2024.09.027.","journal-title":"J Adv Res"},{"issue":"1","key":"427_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06704-y","volume":"23","author":"X Zhou","year":"2025","unstructured":"Zhou X, Cui G, Hu E, Wang X, Tang D, Zhang X, et al. The impact of de novo lipogenesis on predicting survival and clinical therapy: an exploration based on a multigene prognostic model in hepatocellular carcinoma. J Transl Med. 2025;23(1):679. https:\/\/doi.org\/10.1186\/s12967-025-06704-y.","journal-title":"J Transl Med"},{"issue":"1","key":"427_CR160","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41419-025-07707-9","volume":"16","author":"DY Tu","year":"2025","unstructured":"Tu DY, Peng R, Jin SJ, Su BB, Fan SS, Zhang JH, et al. MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesis. Cell Death Dis. 2025;16(1):391. https:\/\/doi.org\/10.1038\/s41419-025-07707-9.","journal-title":"Cell Death Dis"},{"key":"427_CR161","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canlet.2020.12.019","volume":"502","author":"J Chen","year":"2021","unstructured":"Chen J, Ding C, Chen Y, Hu W, Yu C, Peng C, et al. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc\/SREBP1 pathway. Cancer Lett. 2021;502:154\u201365. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.019.","journal-title":"Cancer Lett"},{"issue":"6","key":"427_CR162","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jhep.2015.07.039","volume":"63","author":"J Li","year":"2015","unstructured":"Li J, Huang Q, Long X, Zhang J, Huang X, Aa J, et al. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt\/mTOR\/SREBP1c and P38\/PPAR\u03b1 pathways. J Hepatol. 2015;63(6):1378\u201389. https:\/\/doi.org\/10.1016\/j.jhep.2015.07.039.","journal-title":"J Hepatol"},{"issue":"2","key":"427_CR163","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300070RRR","volume":"38","author":"XL He","year":"2024","unstructured":"He XL, Guo HJ, Lei YR, Li J, Li JY, Li MH, et al. NAMPT promotes the malignant progression of HBV-associated hepatocellular carcinoma through activation of SREBP1-mediated lipogenesis. FASEB J. 2024;38(2):e23444. https:\/\/doi.org\/10.1096\/fj.202300070RRR.","journal-title":"FASEB J"},{"issue":"3","key":"427_CR164","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41401-022-00981-9","volume":"44","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li XM, Shi XH, Ye K, Fu XL, Wang X, et al. Sorafenib triggers ferroptosis via inhibition of HBXIP\/SCD axis in hepatocellular carcinoma. Acta Pharmacol Sin. 2023;44(3):622\u201334. https:\/\/doi.org\/10.1038\/s41401-022-00981-9.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"427_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02656-7","volume":"42","author":"C Hu","year":"2023","unstructured":"Hu C, Xin Z, Sun X, Hu Y, Zhang C, Yan R, et al. Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress. J Exp Clin Cancer Res. 2023;42(1):108. https:\/\/doi.org\/10.1186\/s13046-023-02656-7.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"427_CR166","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.immuni.2025.03.002","volume":"58","author":"L Yu","year":"2025","unstructured":"Yu L, Liebenberg K, Shen Y, Liu F, Xu Z, Hao X, et al. Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer. Immunity. 2025;58(4):909-25.e7. https:\/\/doi.org\/10.1016\/j.immuni.2025.03.002.","journal-title":"Immunity"},{"issue":"1","key":"427_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44412-7","volume":"15","author":"H Lee","year":"2024","unstructured":"Lee H, Horbath A, Kondiparthi L, Meena JK, Lei G, Dasgupta S, et al. Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance. Nat Commun. 2024;15(1):79. https:\/\/doi.org\/10.1038\/s41467-023-44412-7.","journal-title":"Nat Commun"},{"issue":"18","key":"427_CR168","doi-asserted-by":"publisher","first-page":"7681","DOI":"10.7150\/thno.74974","volume":"12","author":"C Wu","year":"2022","unstructured":"Wu C, Dai C, Li X, Sun M, Chu H, Xuan Q, et al. AKR1C3-dependent lipid droplet formation confers hepatocellular carcinoma cell adaptability to targeted therapy. Theranostics. 2022;12(18):7681\u201398. https:\/\/doi.org\/10.7150\/thno.74974.","journal-title":"Theranostics"},{"issue":"4","key":"427_CR169","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/cbdd.14295","volume":"102","author":"S Li","year":"2023","unstructured":"Li S, Hao L, Deng J, Zhang J, Hu X. Coptidis rhizoma and evodiae fructus against lipid droplet deposition in nonalcoholic fatty liver disease-related liver cancer by AKT. Chem Biol Drug Des. 2023;102(4):828\u201342. https:\/\/doi.org\/10.1111\/cbdd.14295.","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"427_CR170","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-023-00328-w","volume":"11","author":"S Matsufuji","year":"2023","unstructured":"Matsufuji S, Kitajima Y, Higure K, Kimura N, Maeda S, Yamada K, et al. A HIF-1\u03b1 inhibitor combined with palmitic acid and L-carnitine treatment can prevent the fat metabolic reprogramming under hypoxia and induce apoptosis in hepatocellular carcinoma cells. Cancer Metab. 2023;11(1):25. https:\/\/doi.org\/10.1186\/s40170-023-00328-w.","journal-title":"Cancer Metab"},{"issue":"6","key":"427_CR171","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.celrep.2014.08.028","volume":"8","author":"D Huang","year":"2014","unstructured":"Huang D, Li T, Li X, Zhang L, Sun L, He X, et al. HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression. Cell Rep. 2014;8(6):1930\u201342. https:\/\/doi.org\/10.1016\/j.celrep.2014.08.028.","journal-title":"Cell Rep"},{"key":"427_CR172","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1615454","volume":"13","author":"D Liao","year":"2025","unstructured":"Liao D, Zeng S, Li C, Yao Y, Guo M, Cui Y, et al. FOXK2 regulates fatty acid metabolism and promotes cervical cancer progression by activating the mTOR\/DRP1 signaling axis. Front Cell Dev Biol. 2025;13:1615454. https:\/\/doi.org\/10.3389\/fcell.2025.1615454.","journal-title":"Front Cell Dev Biol"},{"key":"427_CR173","doi-asserted-by":"publisher","unstructured":"Feng X, Ji Z, Fan X, Kong Y, Yu Y, Shao Y, et al. ASS1 enhances anoikis resistance via AMPK\/CPT1A-mediated fatty acid metabolism in ovarian cancer. Cancer Lett. 2024:217082. https:\/\/doi.org\/10.1016\/j.canlet.2024.217082.","DOI":"10.1016\/j.canlet.2024.217082"},{"key":"427_CR174","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.ircmb.2024.07.003","volume":"389","author":"S Pandey","year":"2024","unstructured":"Pandey S, Anang V, Schumacher MM. Tumor microenvironment induced switch to mitochondrial metabolism promotes suppressive functions in immune cells. Int Rev Cell Mol Biol. 2024;389:67\u2013103. https:\/\/doi.org\/10.1016\/bs.ircmb.2024.07.003.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"2","key":"427_CR175","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/gutjnl-2017-315448","volume":"68","author":"N Senni","year":"2019","unstructured":"Senni N, Savall M, Cabrerizo Granados D, Alves-Guerra MC, Sartor C, Lagoutte I, et al. \u03b2-catenin-activated hepatocellular carcinomas are addicted to fatty acids. Gut. 2019;68(2):322\u201334. https:\/\/doi.org\/10.1136\/gutjnl-2017-315448.","journal-title":"Gut"},{"issue":"14","key":"427_CR176","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.7150\/thno.44025","volume":"10","author":"H Zhao","year":"2020","unstructured":"Zhao H, Yan G, Zheng L, Zhou Y, Sheng H, Wu L, et al. STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma. Theranostics. 2020;10(14):6483\u201399. https:\/\/doi.org\/10.7150\/thno.44025.","journal-title":"Theranostics"},{"key":"427_CR177","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20200219","author":"H Ndiaye","year":"2020","unstructured":"Ndiaye H, Liu JY, Hall A, Minogue S, Morgan MY, Waugh MG. Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases. 2020. Biosci Rep. https:\/\/doi.org\/10.1042\/bsr20200219."},{"issue":"5","key":"427_CR178","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41388-023-02902-4","volume":"43","author":"C Wang","year":"2024","unstructured":"Wang C, Chen Z, Yi Y, Ding Y, Xu F, Kang H, et al. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1\/ACSL4. Oncogene. 2024;43(5):328\u201340. https:\/\/doi.org\/10.1038\/s41388-023-02902-4.","journal-title":"Oncogene"},{"issue":"11","key":"427_CR179","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1158\/0008-5472.Can-20-2052","volume":"81","author":"F Gonz\u00e1lez-Romero","year":"2021","unstructured":"Gonz\u00e1lez-Romero F, Mestre D, Aurrekoetxea I, O\u2019Rourke CJ, Andersen JB, Woodhoo A, et al. E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment. Cancer Res. 2021;81(11):2874\u201387. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-2052.","journal-title":"Cancer Res"},{"issue":"8","key":"427_CR180","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1136\/gutjnl-2017-315193","volume":"67","author":"N Fujiwara","year":"2018","unstructured":"Fujiwara N, Nakagawa H, Enooku K, Kudo Y, Hayata Y, Nakatsuka T, et al. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. Gut. 2018;67(8):1493\u2013504. https:\/\/doi.org\/10.1136\/gutjnl-2017-315193.","journal-title":"Gut"},{"issue":"12","key":"427_CR181","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41417-022-00510-0","volume":"29","author":"J Liu","year":"2022","unstructured":"Liu J, Sun B, Guo K, Yang Z, Zhao Y, Gao M, et al. Lipid-related FABP5 activation of tumor-associated monocytes fosters immune privilege via PD-L1 expression on Treg cells in hepatocellular carcinoma. Cancer Gene Ther. 2022;29(12):1951\u201360. https:\/\/doi.org\/10.1038\/s41417-022-00510-0.","journal-title":"Cancer Gene Ther"},{"issue":"5","key":"427_CR182","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1158\/2326-6066.Cir-19-0261","volume":"8","author":"L Wu","year":"2020","unstructured":"Wu L, Zhang X, Zheng L, Zhao H, Yan G, Zhang Q, et al. RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis. Cancer Immunol Res. 2020;8(5):710\u201321. https:\/\/doi.org\/10.1158\/2326-6066.Cir-19-0261.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"427_CR183","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","volume":"69","author":"L Che","year":"2020","unstructured":"Che L, Chi W, Qiao Y, Zhang J, Song X, Liu Y, et al. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. Gut. 2020;69(1):177\u201386. https:\/\/doi.org\/10.1136\/gutjnl-2018-317581.","journal-title":"Gut"},{"issue":"4","key":"427_CR184","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/neuonc\/noad233","volume":"26","author":"J Zhang","year":"2024","unstructured":"Zhang J, Liu B, Xu C, Ji C, Yin A, Liu Y, et al. Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR. Neuro Oncol. 2024;26(4):684\u2013700. https:\/\/doi.org\/10.1093\/neuonc\/noad233.","journal-title":"Neuro Oncol"},{"key":"427_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107539","volume":"150","author":"MY Xiao","year":"2024","unstructured":"Xiao MY, Pei WJ, Li S, Li FF, Xie P, Luo HT, et al. Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response. Bioorg Chem. 2024;150:107539. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107539.","journal-title":"Bioorg Chem"},{"issue":"1","key":"427_CR186","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.1038\/s41467-021-26718-6","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang J, Li X, Xiong X, Wang J, Zhou Z, et al. N(1)-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism. Nat Commun. 2021;12(1):6314. https:\/\/doi.org\/10.1038\/s41467-021-26718-6.","journal-title":"Nat Commun"},{"issue":"11","key":"427_CR187","doi-asserted-by":"publisher","first-page":"10300","DOI":"10.18632\/aging.103254","volume":"12","author":"J Jiang","year":"2020","unstructured":"Jiang J, Zheng Q, Zhu W, Chen X, Lu H, Chen D, et al. Alterations in glycolytic\/cholesterogenic gene expression in hepatocellular carcinoma. Aging (Albany NY). 2020;12(11):10300\u201316. https:\/\/doi.org\/10.18632\/aging.103254.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"427_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110712","volume":"39","author":"WQ Shao","year":"2022","unstructured":"Shao WQ, Zhu WW, Luo MJ, Fan MH, Li Q, Wang SH, et al. Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma. Cell Rep. 2022;39(3):110712. https:\/\/doi.org\/10.1016\/j.celrep.2022.110712.","journal-title":"Cell Rep"},{"issue":"17","key":"427_CR189","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1158\/0008-5472.Can-21-2934","volume":"82","author":"EHK Mok","year":"2022","unstructured":"Mok EHK, Leung CON, Zhou L, Lei MML, Leung HW, Tong M, et al. Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma. Cancer Res. 2022;82(17):3102\u201315. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-2934.","journal-title":"Cancer Res"},{"issue":"10","key":"427_CR190","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1158\/2326-6066.Cir-22-0907","volume":"11","author":"Z Li","year":"2023","unstructured":"Li Z, Wang Y, Xing R, Zeng H, Yu XJ, Zhang YJ, et al. Cholesterol efflux drives the generation of immunosuppressive macrophages to promote the progression of human hepatocellular carcinoma. Cancer Immunol Res. 2023;11(10):1400\u201313. https:\/\/doi.org\/10.1158\/2326-6066.Cir-22-0907.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"427_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-023-01877-1","volume":"22","author":"J Cao","year":"2023","unstructured":"Cao J, Wang Z, Zhu M, Huang Y, Jin Z, Xiong Z. Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis. Lipids Health Dis. 2023;22(1):110. https:\/\/doi.org\/10.1186\/s12944-023-01877-1.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"427_CR192","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/hep.32518","volume":"77","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Gu L, Lin X, Zhou X, Lu B, Liu C, et al. P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis. Hepatology. 2023;77(5):1499\u2013511. https:\/\/doi.org\/10.1002\/hep.32518.","journal-title":"Hepatology"},{"issue":"6","key":"427_CR193","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.jhep.2021.01.028","volume":"74","author":"L de la Conde Rosa","year":"2021","unstructured":"de la Conde Rosa L, Garcia-Ruiz C, Vallejo C, Baulies A, Nu\u00f1ez S, Monte MJ, et al. STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway. J Hepatol. 2021;74(6):1429\u201341. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.028.","journal-title":"J Hepatol"},{"issue":"1","key":"427_CR194","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13046-023-02865-0","volume":"42","author":"J Huang","year":"2023","unstructured":"Huang J, Pan H, Sun J, Wu J, Xuan Q, Wang J, et al. TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages. J Exp Clin Cancer Res. 2023;42(1):286. https:\/\/doi.org\/10.1186\/s13046-023-02865-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"427_CR195","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10565-021-09607-y","volume":"38","author":"M Jin","year":"2022","unstructured":"Jin M, Yang Y, Dai Y, Cai R, Wu L, Jiao Y, et al. 27-Hydroxycholesterol is a specific factor in the neoplastic microenvironment of HCC that causes MDR via GRP75 regulation of the redox balance and metabolic reprogramming. Cell Biol Toxicol. 2022;38(2):311\u201324. https:\/\/doi.org\/10.1007\/s10565-021-09607-y.","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"427_CR196","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13046-024-03047-2","volume":"43","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Xu J, Jiang Q, Yang C, Wang N, Liu X, et al. Ficolin 3 promotes ferroptosis in HCC by downregulating IR\/SREBP axis-mediated MUFA synthesis. J Exp Clin Cancer Res. 2024;43(1):133. https:\/\/doi.org\/10.1186\/s13046-024-03047-2.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"427_CR197","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1158\/0008-5472.Can-23-2491","volume":"84","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Wang X, Sun Y, Jin T, Tang R, Zhou X, et al. ACSL4-mediated membrane phospholipid remodeling induces integrin \u03b21 activation to facilitate triple-negative breast cancer metastasis. Cancer Res. 2024;84(11):1856\u201371. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-2491.","journal-title":"Cancer Res"},{"issue":"4","key":"427_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2025.159608","volume":"1870","author":"CM Holdaway","year":"2025","unstructured":"Holdaway CM, Leonard KA, Nelson R, van der Veen J, Das C, Watts R, et al. Alterations in phosphatidylethanolamine metabolism impacts hepatocellular lipid storage, energy homeostasis, and proliferation. Biochim Biophys Acta Mol Cell Biol Lipids. 2025;1870(4):159608. https:\/\/doi.org\/10.1016\/j.bbalip.2025.159608.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"427_CR199","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jare.2023.10.010","volume":"63","author":"X Chen","year":"2024","unstructured":"Chen X, Lu T, Ding M, Cai Y, Yu Z, Zhou X, et al. Targeting YTHDF2 inhibits tumorigenesis of diffuse large B-cell lymphoma through ACER2-mediated ceramide catabolism. J Adv Res. 2024;63:17\u201333. https:\/\/doi.org\/10.1016\/j.jare.2023.10.010.","journal-title":"J Adv Res"},{"issue":"1","key":"427_CR200","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13046-022-02589-7","volume":"42","author":"X Wang","year":"2023","unstructured":"Wang X, Guo W, Shi X, Chen Y, Yu Y, Du B, et al. S1PR1\/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma. J Exp Clin Cancer Res. 2023;42(1):3. https:\/\/doi.org\/10.1186\/s13046-022-02589-7.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"427_CR201","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cmet.2025.01.016","volume":"37","author":"J Jiang","year":"2025","unstructured":"Jiang J, Gao Y, Wang J, Huang Y, Yang R, Zhang Y, et al. Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism. Cell Metab. 2025;37(5):1119-36.e13. https:\/\/doi.org\/10.1016\/j.cmet.2025.01.016.","journal-title":"Cell Metab"},{"issue":"2","key":"427_CR202","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jhep.2023.03.041","volume":"79","author":"D Povero","year":"2023","unstructured":"Povero D, Chen Y, Johnson SM, McMahon CE, Pan M, Bao H, et al. HILPDA promotes NASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia. J Hepatol. 2023;79(2):378\u201393. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.041.","journal-title":"J Hepatol"},{"issue":"16","key":"427_CR203","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413439","volume":"12","author":"M Yu","year":"2025","unstructured":"Yu M, Su M, Tian Z, Pan L, Li Z, Huang E, et al. Extracellular Vesicle-Packaged Linc-ZNF25-1 from Pancreatic Cancer Cell Promotes Pancreatic Stellate Cell Uptake of Asparagine to Advance Chemoresistance. Adv Sci (Weinh). 2025;12(16):e2413439. https:\/\/doi.org\/10.1002\/advs.202413439.","journal-title":"Adv Sci (Weinh)"},{"issue":"19","key":"427_CR204","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1158\/0008-5472.Can-24-0254","volume":"84","author":"J Yang","year":"2024","unstructured":"Yang J, Chen F, Lang L, Yang F, Fu Z, Martinez J, et al. Therapeutic targeting of the GLS1-c-Myc positive feedback loop suppresses glutaminolysis and inhibits progression of head and neck cancer. Cancer Res. 2024;84(19):3223\u201334. https:\/\/doi.org\/10.1158\/0008-5472.Can-24-0254.","journal-title":"Cancer Res"},{"issue":"16","key":"427_CR205","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1158\/0008-5472.Can-23-3748","volume":"85","author":"T Qu","year":"2025","unstructured":"Qu T, Song L, Xu J, Lu X, Yin D, Dai J, et al. MYLK-AS1 enhances glutamine metabolism to promote EGFR inhibitor resistance in non-small cell lung cancer. Cancer Res. 2025;85(16):3052\u201371. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-3748.","journal-title":"Cancer Res"},{"issue":"1","key":"427_CR206","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/neuonc\/noae179","volume":"27","author":"M Adiamah","year":"2025","unstructured":"Adiamah M, Poole B, Lindsey JC, Kohe S, Morcavallo A, Burt\u00e9 F, et al. MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma. Neuro Oncol. 2025;27(1):237\u201353. https:\/\/doi.org\/10.1093\/neuonc\/noae179.","journal-title":"Neuro Oncol"},{"issue":"9","key":"427_CR207","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2809196","volume":"28","author":"Y Situ","year":"2023","unstructured":"Situ Y, Zhang J, Liao W, Liang Q, Lu L, Xu Q, et al. SHMT as a potential therapeutic target for renal cell carcinoma. Front Biosci (Landmark Ed). 2023;28(9):196. https:\/\/doi.org\/10.31083\/j.fbl2809196.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"427_CR208","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02623-2","volume":"42","author":"K Fang","year":"2023","unstructured":"Fang K, Sun M, Leng Z, Chu Y, Zhao Z, Li Z, et al. Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia. J Exp Clin Cancer Res. 2023;42(1):73. https:\/\/doi.org\/10.1186\/s13046-023-02623-2.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"427_CR209","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1038\/s41417-023-00653-8","volume":"30","author":"M Wang","year":"2023","unstructured":"Wang M, Li J, Yang X, Yan Q, Wang H, Xu X, et al. Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR\/ASNS axis. Cancer Gene Ther. 2023;30(11):1485\u201397. https:\/\/doi.org\/10.1038\/s41417-023-00653-8.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"427_CR210","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03279-4","volume":"24","author":"J Li","year":"2024","unstructured":"Li J, Fang Z, Dal E, Zhang H, Yu K, Ma M, et al. Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression. Cancer Cell Int. 2024;24(1):95. https:\/\/doi.org\/10.1186\/s12935-024-03279-4.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"427_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101073","volume":"4","author":"A Amleh","year":"2023","unstructured":"Amleh A, Chen HP, Watad L, Abramovich I, Agranovich B, Gottlieb E, et al. Arginine depletion attenuates renal cystogenesis in tuberous sclerosis complex model. Cell Rep Med. 2023;4(6):101073. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101073.","journal-title":"Cell Rep Med"},{"issue":"5","key":"427_CR212","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s10565-021-09681-2","volume":"39","author":"Y Bian","year":"2023","unstructured":"Bian Y, Yin G, Wang G, Liu T, Liang L, Yang X, et al. Degradation of HIF-1\u03b1 induced by curcumol blocks glutaminolysis and inhibits epithelial-mesenchymal transition and invasion in colorectal cancer cells. Cell Biol Toxicol. 2023;39(5):1957\u201378. https:\/\/doi.org\/10.1007\/s10565-021-09681-2.","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"427_CR213","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13046-023-02927-3","volume":"42","author":"HJ Yun","year":"2023","unstructured":"Yun HJ, Li M, Guo D, Jeon SM, Park SH, Lim JS, et al. AMPK-HIF-1\u03b1 signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth. J Exp Clin Cancer Res. 2023;42(1):340. https:\/\/doi.org\/10.1186\/s13046-023-02927-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"427_CR214","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07445-y","volume":"16","author":"SQ Wang","year":"2025","unstructured":"Wang SQ, Liu N, Zhang Q, Li BQ, Zhao FY, Li C, et al. TFE3 and HIF1\u03b1 regulates the expression of SHMT2 isoforms via alternative promoter utilization in ovarian cancer cells. Cell Death Dis. 2025;16(1):178. https:\/\/doi.org\/10.1038\/s41419-025-07445-y.","journal-title":"Cell Death Dis"},{"issue":"9","key":"427_CR215","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/mc.23437","volume":"61","author":"JC van der Mijn","year":"2022","unstructured":"van der Mijn JC, Chen Q, Laursen KB, Khani F, Wang X, Dorsaint P, et al. Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR). Mol Carcinog. 2022;61(9):851\u201364. https:\/\/doi.org\/10.1002\/mc.23437.","journal-title":"Mol Carcinog"},{"issue":"11","key":"427_CR216","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1038\/s41401-023-01108-4","volume":"44","author":"ZJ Zhang","year":"2023","unstructured":"Zhang ZJ, Wu QF, Ren AQ, Chen Q, Shi JZ, Li JP, et al. ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming. Acta Pharmacol Sin. 2023;44(11):2282\u201395. https:\/\/doi.org\/10.1038\/s41401-023-01108-4.","journal-title":"Acta Pharmacol Sin"},{"key":"427_CR217","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.10.030","author":"Z Tian","year":"2025","unstructured":"Tian Z, Su M, Yu M, Huang E, Hu B, Chen Y. KRAS\/ACTN4\/p65-NR2A axis mediates glutamine-glutamate metabolic coupling between schwann cells and pancreatic cancer promoting perineural invasion. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.10.030.","journal-title":"J Adv Res"},{"issue":"10","key":"427_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101753","volume":"5","author":"S Guo","year":"2024","unstructured":"Guo S, Xing S, Wu Z, Chen F, Pan X, Li Q, et al. Leucine restriction ameliorates Fusobacterium nucleatum-driven malignant progression and radioresistance in nasopharyngeal carcinoma. Cell Rep Med. 2024;5(10):101753. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101753.","journal-title":"Cell Rep Med"},{"issue":"1","key":"427_CR219","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41421-023-00567-7","volume":"9","author":"J He","year":"2023","unstructured":"He J, Lin M, Zhang X, Zhang R, Tian T, Zhou Y, et al. TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential. Cell Discov. 2023;9(1):84. https:\/\/doi.org\/10.1038\/s41421-023-00567-7.","journal-title":"Cell Discov"},{"issue":"17","key":"427_CR220","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1038\/s44318-025-00505-1","volume":"44","author":"G Figlia","year":"2025","unstructured":"Figlia G, M\u00fcller S, Garcia-Cortizo F, Neff M, Klinke G, Poschet G, et al. mTORC1 senses glutamine and other\u00a0amino acids through GCN2. EMBO J. 2025;44(17):4825\u201366. https:\/\/doi.org\/10.1038\/s44318-025-00505-1.","journal-title":"EMBO J"},{"issue":"17","key":"427_CR221","doi-asserted-by":"publisher","first-page":"15879","DOI":"10.1007\/s00432-023-05360-3","volume":"149","author":"HG Feng","year":"2023","unstructured":"Feng HG, Wu CX, Zhong GC, Gong JP, Miao CM, Xiong B. Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K\/AKT\/mTOR signaling via glutamine mediated energy metabolism. J Cancer Res Clin Oncol. 2023;149(17):15879\u201398. https:\/\/doi.org\/10.1007\/s00432-023-05360-3.","journal-title":"J Cancer Res Clin Oncol"},{"key":"427_CR222","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-981-13-7647-4_3","volume":"1141","author":"X Liu","year":"2019","unstructured":"Liu X. SLC family transporters. Adv Exp Med Biol. 2019;1141:101\u2013202. https:\/\/doi.org\/10.1007\/978-981-13-7647-4_3.","journal-title":"Adv Exp Med Biol"},{"key":"427_CR223","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147558","author":"V Tambay","year":"2024","unstructured":"Tambay V, Raymond VA, Voisin L, Meloche S, Bilodeau M. Reprogramming of glutamine amino acid transporters expression and prognostic significance in hepatocellular carcinoma. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25147558.","journal-title":"Int J Mol Sci"},{"issue":"23","key":"427_CR224","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70245","volume":"28","author":"B Chai","year":"2024","unstructured":"Chai B, Zhang A, Liu Y, Zhang X, Kong P, Zhang Z, et al. KLF7 promotes hepatocellular carcinoma progression through regulating SLC1A5-mediated tryptophan metabolism. J Cell Mol Med. 2024;28(23):e70245. https:\/\/doi.org\/10.1111\/jcmm.70245.","journal-title":"J Cell Mol Med"},{"key":"427_CR225","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01323-4","author":"X Shi","year":"2024","unstructured":"Shi X, Zhang Y, Wang Y, Wang J, Gao Y, Wang R, et al. The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine. Cell Death Differ. 2024. https:\/\/doi.org\/10.1038\/s41418-024-01323-4.","journal-title":"Cell Death Differ"},{"issue":"5","key":"427_CR226","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.852","volume":"12","author":"T Zhang","year":"2022","unstructured":"Zhang T, Cui Y, Wu Y, Meng J, Han L, Zhang J, et al. Mitochondrial GCN5L1 regulates glutaminase acetylation and hepatocellular carcinoma. Clin Transl Med. 2022;12(5):e852. https:\/\/doi.org\/10.1002\/ctm2.852.","journal-title":"Clin Transl Med"},{"key":"427_CR227","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ebiom.2018.11.063","volume":"39","author":"B Li","year":"2019","unstructured":"Li B, Cao Y, Meng G, Qian L, Xu T, Yan C, et al. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt\/beta-catenin pathway. EBioMedicine. 2019;39:239\u201354. https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.063.","journal-title":"EBioMedicine"},{"issue":"7","key":"427_CR228","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1080\/15548627.2019.1580105","volume":"15","author":"X Huang","year":"2019","unstructured":"Huang X, Gan G, Wang X, Xu T, Xie W. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance. Autophagy. 2019;15(7):1258\u201379. https:\/\/doi.org\/10.1080\/15548627.2019.1580105.","journal-title":"Autophagy"},{"issue":"1","key":"427_CR229","doi-asserted-by":"publisher","DOI":"10.1515\/med-2023-0756","volume":"18","author":"R Tian","year":"2023","unstructured":"Tian R, Li Y, Shen X, Li Y. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase. Open Med (Wars). 2023;18(1):20230756. https:\/\/doi.org\/10.1515\/med-2023-0756.","journal-title":"Open Med (Wars)"},{"issue":"7","key":"427_CR230","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1039\/d1fo03728e","volume":"13","author":"H Lu","year":"2022","unstructured":"Lu H, Yin H, Qu L, Ma X, Fu R, Fan D. Ginsenoside Rk1 regulates glutamine metabolism in hepatocellular carcinoma through inhibition of the ERK\/c-Myc pathway. Food Funct. 2022;13(7):3793\u2013811. https:\/\/doi.org\/10.1039\/d1fo03728e.","journal-title":"Food Funct"},{"key":"427_CR231","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010025","author":"K Xu","year":"2022","unstructured":"Xu K, Ding J, Zhou L, Li D, Luo J, Wang W, et al. SMYD2 promotes hepatocellular carcinoma progression by reprogramming glutamine metabolism via c-Myc\/GLS1 axis. Cells. 2022. https:\/\/doi.org\/10.3390\/cells12010025.","journal-title":"Cells"},{"key":"427_CR232","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.freeradbiomed.2023.09.006","volume":"208","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Jiang H, Zhang X, Xu J, Wu X, Xu Q, et al. Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation. Free Radic Biol Med. 2023;208:571\u201386. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.09.006.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"427_CR233","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07498-z","volume":"16","author":"J Deng","year":"2025","unstructured":"Deng J, Li Y, Yin L, Liu S, Li Y, Liao W, et al. Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis. 2025;16(1):193. https:\/\/doi.org\/10.1038\/s41419-025-07498-z.","journal-title":"Cell Death Dis"},{"issue":"17","key":"427_CR234","doi-asserted-by":"publisher","first-page":"16432","DOI":"10.1021\/acsnano.2c12857","volume":"17","author":"X Liu","year":"2023","unstructured":"Liu X, Cao Z, Wang W, Zou C, Wang Y, Pan L, et al. Engineered extracellular vesicle-delivered CRISPR\/Cas9 for radiotherapy sensitization of glioblastoma. ACS Nano. 2023;17(17):16432\u201347. https:\/\/doi.org\/10.1021\/acsnano.2c12857.","journal-title":"ACS Nano"},{"issue":"18","key":"427_CR235","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/0008-5472.Can-21-3914","volume":"82","author":"S Suzuki","year":"2022","unstructured":"Suzuki S, Venkatesh D, Kanda H, Nakayama A, Hosokawa H, Lee E, et al. GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma. Cancer Res. 2022;82(18):3209\u201322. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-3914.","journal-title":"Cancer Res"},{"issue":"2","key":"427_CR236","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1158\/2159-8290.Cd-21-0218","volume":"13","author":"D Thomas","year":"2023","unstructured":"Thomas D, Wu M, Nakauchi Y, Zheng M, Thompson-Peach CAL, Lim K, et al. Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability. Cancer Discov. 2023;13(2):496\u2013515. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0218.","journal-title":"Cancer Discov"},{"issue":"6","key":"427_CR237","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1158\/2159-8290.Cd-22-0825","volume":"13","author":"K Gunn","year":"2023","unstructured":"Gunn K, Myllykoski M, Cao JZ, Ahmed M, Huang B, Rouaisnel B, et al. (R)-2-hydroxyglutarate inhibits KDM5 histone lysine demethylases to drive transformation in IDH-mutant cancers. Cancer Discov. 2023;13(6):1478\u201397. https:\/\/doi.org\/10.1158\/2159-8290.Cd-22-0825.","journal-title":"Cancer Discov"},{"issue":"3","key":"427_CR238","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.molcel.2014.09.025","volume":"56","author":"C Yang","year":"2014","unstructured":"Yang C, Ko B, Hensley CT, Jiang L, Wasti AT, Kim J, et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol Cell. 2014;56(3):414\u201324. https:\/\/doi.org\/10.1016\/j.molcel.2014.09.025.","journal-title":"Mol Cell"},{"issue":"12","key":"427_CR239","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1021\/acs.molpharmaceut.3c00772","volume":"20","author":"A Ghosh","year":"2023","unstructured":"Ghosh A, Ghosh AK, Zaman A, Das PK. Metformin-loaded hyaluronic acid-derived carbon dots for targeted therapy against hepatocellular carcinoma by glutamine metabolic reprogramming. Mol Pharm. 2023;20(12):6391\u2013406. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00772.","journal-title":"Mol Pharm"},{"key":"427_CR240","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107415","volume":"165","author":"B Wang","year":"2023","unstructured":"Wang B, Pei J, Xu S, Liu J, Yu J. System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma. Comput Biol Med. 2023;165:107415. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107415.","journal-title":"Comput Biol Med"},{"issue":"5","key":"427_CR241","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000530845","volume":"16","author":"MR Li","year":"2023","unstructured":"Li MR, Li JZ, Li JY, Wang CC, Yuan RK, Ye LH, et al. Clinical features of non-alcoholic fatty liver disease in the non-lean population. Obes Facts. 2023;16(5):427\u201334. https:\/\/doi.org\/10.1159\/000530845.","journal-title":"Obes Facts"},{"issue":"10","key":"427_CR242","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1158\/0008-5472.Can-23-0673","volume":"84","author":"Y Wang","year":"2024","unstructured":"Wang Y, Cheng C, Lu Y, Lian Z, Liu Q, Xu Y, et al. \u03b2-Catenin activation reprograms ammonia metabolism to promote senescence resistance in hepatocellular carcinoma. Cancer Res. 2024;84(10):1643\u201358. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-0673.","journal-title":"Cancer Res"},{"key":"427_CR243","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjae014","author":"HJ You","year":"2024","unstructured":"You HJ, Li Q, Ma LH, Wang X, Zhang HY, Wang YX, et al. Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis. J Mol Cell Biol. 2024. https:\/\/doi.org\/10.1093\/jmcb\/mjae014.","journal-title":"J Mol Cell Biol"},{"issue":"3","key":"427_CR244","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.7150\/jca.64195","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Yu H, Cheng S, Chen Y, He L, Ren J, et al. Glutamate dehydrogenase 1 mediated glutaminolysis sustains HCC cells survival under glucose deprivation. J Cancer. 2022;13(3):1061\u201372. https:\/\/doi.org\/10.7150\/jca.64195.","journal-title":"J Cancer"},{"issue":"1","key":"427_CR245","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00801-2","volume":"6","author":"Y Wei","year":"2021","unstructured":"Wei Y, Tang X, Ren Y, Yang Y, Song F, Fu J, et al. An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity. Signal Transduct Target Ther. 2021;6(1):421. https:\/\/doi.org\/10.1038\/s41392-021-00801-2.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"427_CR246","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/hepr.13433","volume":"50","author":"P Liu","year":"2020","unstructured":"Liu P, Lu D, Al-Ameri A, Wei X, Ling S, Li J, et al. Glutamine synthetase promotes tumor invasion in hepatocellular carcinoma through mediating epithelial-mesenchymal transition. Hepatol Res. 2020;50(2):246\u201357. https:\/\/doi.org\/10.1111\/hepr.13433.","journal-title":"Hepatol Res"},{"issue":"10","key":"427_CR247","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/hepr.13933","volume":"53","author":"Y Kurebayashi","year":"2023","unstructured":"Kurebayashi Y, Tsujikawa H, Sugimoto K, Yunaiyama D, Araki Y, Saito K, et al. Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy. Hepatol Res. 2023;53(10):1008\u201320. https:\/\/doi.org\/10.1111\/hepr.13933.","journal-title":"Hepatol Res"},{"issue":"17","key":"427_CR248","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1097\/cm9.0000000000002380","volume":"136","author":"M Shao","year":"2023","unstructured":"Shao M, Tao Q, Xu Y, Xu Q, Shu Y, Chen Y, et al. Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy. Chin Med J (Engl). 2023;136(17):2066\u201376. https:\/\/doi.org\/10.1097\/cm9.0000000000002380.","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"427_CR249","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2023.102248","volume":"47","author":"J Jiang","year":"2023","unstructured":"Jiang J, Hu Y, Fang D, Luo J. Glutamine synthetase and hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2023;47(10):102248. https:\/\/doi.org\/10.1016\/j.clinre.2023.102248.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"24","key":"427_CR250","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1158\/1078-0432.Ccr-23-0060","volume":"29","author":"M He","year":"2023","unstructured":"He M, Huang Y, Du Z, Lai Z, Ouyang H, Shen J, et al. Lenvatinib, Toripalimab plus FOLFOX Chemotherapy in Hepatocellular Carcinoma Patients with Extrahepatic Metastasis: A Biomolecular Exploratory, Phase II Trial (LTSC). Clin Cancer Res. 2023;29(24):5104\u201315. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-0060.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"427_CR251","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1182\/blood.2024025245","volume":"145","author":"SE Millman","year":"2025","unstructured":"Millman SE, Chaves-Perez A, Janaki-Raman S, Ho YJ, Morris JPt, Narendra V, et al. \u03b1-ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia. Blood. 2025;145(13):1422\u201336. https:\/\/doi.org\/10.1182\/blood.2024025245.","journal-title":"Blood"},{"issue":"7","key":"427_CR252","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/s42255-024-01060-5","volume":"6","author":"LQJ Lim","year":"2024","unstructured":"Lim LQJ, Adler L, Hajaj E, Soria LR, Perry RB, Darzi N, et al. ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response. Nat Metab. 2024;6(7):1294\u2013309. https:\/\/doi.org\/10.1038\/s42255-024-01060-5.","journal-title":"Nat Metab"},{"issue":"1","key":"427_CR253","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-022-01380-z","volume":"15","author":"J Bai","year":"2022","unstructured":"Bai J, Tang R, Zhou K, Chang J, Wang H, Zhang Q, et al. An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma. BMC Med Genomics. 2022;15(1):222. https:\/\/doi.org\/10.1186\/s12920-022-01380-z.","journal-title":"BMC Med Genomics"},{"key":"427_CR254","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-024-01311-y","author":"Y Liu","year":"2024","unstructured":"Liu Y, Miao Z, Yang Q. AGC1-mediated Metabolic Reprogramming and Autophagy Sustain Survival of Hepatocellular Carcinoma Cells under Glutamine Deprivation. Cell Biochem Biophys. 2024. https:\/\/doi.org\/10.1007\/s12013-024-01311-y.","journal-title":"Cell Biochem Biophys"},{"key":"427_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2022.106146","volume":"199","author":"F \u00d6zdemir","year":"2022","unstructured":"\u00d6zdemir F, Didem Orhan M, Atasavum ZT, T\u00fclek A. Biochemical characterization and detection of antitumor activity of l-asparaginase from thermophilic Geobacillus kaustophilus DSM 7263(T). Protein Expr Purif. 2022;199:106146. https:\/\/doi.org\/10.1016\/j.pep.2022.106146.","journal-title":"Protein Expr Purif"},{"key":"427_CR256","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.758549","volume":"11","author":"K Okuda","year":"2021","unstructured":"Okuda K, Umemura A, Kataoka S, Yano K, Takahashi A, Okishio S, et al. Enhanced Antitumor Effect in Liver Cancer by Amino Acid Depletion-Induced Oxidative Stress. Front Oncol. 2021;11:758549. https:\/\/doi.org\/10.3389\/fonc.2021.758549.","journal-title":"Front Oncol"},{"issue":"8","key":"427_CR257","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0307448","volume":"19","author":"A Riaz","year":"2024","unstructured":"Riaz A, Kaleem A, Abdullah R, Iqtedar M, Hoessli DC, Aftab M. In silico approaches to study the human asparagine synthetase: an insight of the interaction between the enzyme active sites and its substrates. PLoS ONE. 2024;19(8):e0307448. https:\/\/doi.org\/10.1371\/journal.pone.0307448.","journal-title":"PLoS ONE"},{"issue":"1","key":"427_CR258","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/bjc.2013.293","volume":"109","author":"B Zhang","year":"2013","unstructured":"Zhang B, Dong LW, Tan YX, Zhang J, Pan YF, Yang C, et al. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma. Br J Cancer. 2013;109(1):14\u201323. https:\/\/doi.org\/10.1038\/bjc.2013.293.","journal-title":"Br J Cancer"},{"issue":"14","key":"427_CR259","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1158\/0008-5472.Can-22-3561","volume":"83","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Li L, Sha F, Lei Y, Tian X, Chen L, et al. PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression. Cancer Res. 2023;83(14):2372\u201386. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-3561.","journal-title":"Cancer Res"},{"issue":"1","key":"427_CR260","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-017-0635-4","volume":"17","author":"W Li","year":"2017","unstructured":"Li W, Dong C. Polymorphism in asparagine synthetase is associated with overall survival of hepatocellular carcinoma patients. BMC Gastroenterol. 2017;17(1):79. https:\/\/doi.org\/10.1186\/s12876-017-0635-4.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"427_CR261","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36708-5","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Luo L, Fu S, Wang M, Wang Z, Dong L, et al. PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma. Nat Commun. 2023;14(1):1011. https:\/\/doi.org\/10.1038\/s41467-023-36708-5.","journal-title":"Nat Commun"},{"issue":"94","key":"427_CR262","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg8817","volume":"9","author":"S Ma","year":"2024","unstructured":"Ma S, Sandhoff R, Luo X, Shang F, Shi Q, Li Z, et al. Serine enrichment in tumors promotes regulatory T cell accumulation through sphinganine-mediated regulation of c-Fos. Sci Immunol. 2024;9(94):eadg8817. https:\/\/doi.org\/10.1126\/sciimmunol.adg8817.","journal-title":"Sci Immunol"},{"issue":"46","key":"427_CR263","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401399","volume":"11","author":"Y Lu","year":"2024","unstructured":"Lu Y, Zhu J, Zhang Y, Li W, Xiong Y, Fan Y, et al. Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC. Adv Sci Weinh. 2024;11(46):e2401399. https:\/\/doi.org\/10.1002\/advs.202401399.","journal-title":"Adv Sci Weinh"},{"issue":"1","key":"427_CR264","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03361-3","volume":"44","author":"X Liu","year":"2025","unstructured":"Liu X, Liu B, Wang J, Liu H, Wu J, Qi Y, et al. PHGDH activation fuels glioblastoma progression and radioresistance via serine synthesis pathway. J Exp Clin Cancer Res. 2025;44(1):99. https:\/\/doi.org\/10.1186\/s13046-025-03361-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"427_CR265","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1016\/j.apsb.2024.06.001","volume":"14","author":"Z Huang","year":"2024","unstructured":"Huang Z, Zhang K, Jiang Y, Wang M, Li M, Guo Y, et al. Molecular glue triggers degradation of PHGDH by enhancing the interaction between DDB1 and PHGDH. Acta Pharm Sin B. 2024;14(9):4001\u201313. https:\/\/doi.org\/10.1016\/j.apsb.2024.06.001.","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"427_CR266","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/molpharm.124.000912","volume":"106","author":"C O'Connor","year":"2024","unstructured":"O\u2019Connor C, Schneider M, Katinas JM, Nayeen MJ, Shah K, Magdum T, et al. Role of mitochondrial and cytosolic folylpolyglutamate synthetase in one-carbon metabolism and antitumor efficacy of mitochondrial-targeted antifolates. Mol Pharmacol. 2024;106(4):173\u201387. https:\/\/doi.org\/10.1124\/molpharm.124.000912.","journal-title":"Mol Pharmacol"},{"issue":"4","key":"427_CR267","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s42255-023-00771-5","volume":"5","author":"AC Green","year":"2023","unstructured":"Green AC, Marttila P, Kiweler N, Chalkiadaki C, Wiita E, Cookson V, et al. Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells. Nat Metab. 2023;5(4):642\u201359. https:\/\/doi.org\/10.1038\/s42255-023-00771-5.","journal-title":"Nat Metab"},{"key":"427_CR268","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100985","volume":"70","author":"J Wang","year":"2023","unstructured":"Wang J, Zeng L, Wu N, Liang Y, Jin J, Fan M, et al. Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells. Drug Resist Updat. 2023;70:100985. https:\/\/doi.org\/10.1016\/j.drup.2023.100985.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"427_CR269","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00926-5","volume":"9","author":"H Deng","year":"2025","unstructured":"Deng H, Wang Y, Xiao L, Feng M, Dou W, Pan Y. SHMT inhibitor synergizes with 5-Fu to suppress gastric cancer via cell cycle arrest and chemoresistance alleviation. NPJ Precis Oncol. 2025;9(1):135. https:\/\/doi.org\/10.1038\/s41698-025-00926-5.","journal-title":"NPJ Precis Oncol"},{"issue":"10","key":"427_CR270","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1158\/0008-5472.Can-22-1999","volume":"83","author":"Q Hu","year":"2023","unstructured":"Hu Q, Dai J, Zhang Z, Yu H, Zhang J, Zhu X, et al. ASS1-mediated reductive carboxylation of cytosolic glutamine confers ferroptosis resistance in cancer cells. Cancer Res. 2023;83(10):1646\u201365. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-1999.","journal-title":"Cancer Res"},{"issue":"10","key":"427_CR271","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.molcel.2024.04.012","volume":"84","author":"C Yang","year":"2024","unstructured":"Yang C, Pataskar A, Feng X, Montenegro Navarro J, Paniagua I, Jacobs JJL, et al. Arginine deprivation enriches lung cancer proteomes with cysteine by inducing arginine-to-cysteine substitutants. Mol Cell. 2024;84(10):1904-16.e7. https:\/\/doi.org\/10.1016\/j.molcel.2024.04.012.","journal-title":"Mol Cell"},{"issue":"7","key":"427_CR272","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2174\/0929866530666230529143121","volume":"30","author":"K Bibi","year":"2023","unstructured":"Bibi K, Fatima T, Sohrab S, Haider G, Zarina S, Ilyas A. Polymorphic variants of ASS1 gene related to arginine metabolism and the risk of HCC. Protein Pept Lett. 2023;30(7):587\u201396. https:\/\/doi.org\/10.2174\/0929866530666230529143121.","journal-title":"Protein Pept Lett"},{"issue":"5","key":"427_CR273","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06672-z","volume":"15","author":"W Luo","year":"2024","unstructured":"Luo W, Zou Z, Nie Y, Luo J, Ming Z, Hu X, et al. ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis. Cell Death Dis. 2024;15(5):319. https:\/\/doi.org\/10.1038\/s41419-024-06672-z.","journal-title":"Cell Death Dis"},{"issue":"23","key":"427_CR274","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","volume":"186","author":"D Mossmann","year":"2023","unstructured":"Mossmann D, M\u00fcller C, Park S, Ryback B, Colombi M, Ritter N, et al. Arginine reprograms metabolism in liver cancer via RBM39. Cell. 2023;186(23):5068-83.e23. https:\/\/doi.org\/10.1016\/j.cell.2023.09.011.","journal-title":"Cell"},{"issue":"10","key":"427_CR275","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110677","volume":"301","author":"M Zhao","year":"2025","unstructured":"Zhao M, Yuan D, Wei M, Zhang J, Yang W, Qin S, et al. FOXO1-mediated argininosuccinate lyase transcription inhibits ammonia metabolism and breast cancer cell metastasis. J Biol Chem. 2025;301(10):110677. https:\/\/doi.org\/10.1016\/j.jbc.2025.110677.","journal-title":"J Biol Chem"},{"issue":"31","key":"427_CR276","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1038\/s41388-025-03456-3","volume":"44","author":"X Geng","year":"2025","unstructured":"Geng X, Li M, Zhang L, Cai Y, Chen X, Mu X, et al. P5CS deacetylation mediated by SIRT2 facilitates tumor growth by enhancing mitochondrial respiration in hepatocellular carcinoma. Oncogene. 2025;44(31):2746\u201361. https:\/\/doi.org\/10.1038\/s41388-025-03456-3.","journal-title":"Oncogene"},{"issue":"4","key":"427_CR277","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jhep.2019.10.026","volume":"72","author":"Z Ding","year":"2020","unstructured":"Ding Z, Ericksen RE, Escande-Beillard N, Lee QY, Loh A, Denil S, et al. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis. J Hepatol. 2020;72(4):725\u201335. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.026.","journal-title":"J Hepatol"},{"key":"427_CR278","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.gene.2018.09.036","volume":"681","author":"W Qiao","year":"2019","unstructured":"Qiao W, Wang H, Zhang X, Luo K. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through \u03b2-catenin signaling. Gene. 2019;681:7\u201314. https:\/\/doi.org\/10.1016\/j.gene.2018.09.036.","journal-title":"Gene"},{"issue":"2","key":"427_CR279","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1158\/1078-0432.Ccr-17-1707","volume":"24","author":"L Tang","year":"2018","unstructured":"Tang L, Zeng J, Geng P, Fang C, Wang Y, Sun M, et al. Global metabolic profiling identifies a pivotal role of proline and hydroxyproline metabolism in supporting hypoxic response in hepatocellular carcinoma. Clin Cancer Res. 2018;24(2):474\u201385. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-1707.","journal-title":"Clin Cancer Res"},{"key":"427_CR280","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1118675","volume":"12","author":"JM Phang","year":"2022","unstructured":"Phang JM. The regulatory mechanisms of proline and hydroxyproline metabolism: recent advances in perspective. Front Oncol. 2022;12:1118675. https:\/\/doi.org\/10.3389\/fonc.2022.1118675.","journal-title":"Front Oncol"},{"issue":"1","key":"427_CR281","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03399-3","volume":"44","author":"Z Li","year":"2025","unstructured":"Li Z, Liu Z, Lin M, Pan H, Liu Y, Liu Y, et al. Acetylation-induced degradation of ECHS1 enhances BCAA accumulation and proliferation in KRAS-mutant colorectal cancer. J Exp Clin Cancer Res. 2025;44(1):164. https:\/\/doi.org\/10.1186\/s13046-025-03399-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"427_CR282","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.cmet.2025.02.008","volume":"37","author":"N Wang","year":"2025","unstructured":"Wang N, Lu S, Cao Z, Li H, Xu J, Zhou Q, et al. Pyruvate metabolism enzyme DLAT promotes tumorigenesis by suppressing leucine catabolism. Cell Metab. 2025;37(6):1381-99.e9. https:\/\/doi.org\/10.1016\/j.cmet.2025.02.008.","journal-title":"Cell Metab"},{"issue":"20","key":"427_CR283","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2306776121","volume":"121","author":"J Chen","year":"2024","unstructured":"Chen J, Liu X, Zou Y, Gong J, Ge Z, Lin X, et al. A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation. Proc Natl Acad Sci U S A. 2024;121(20):e2306776121. https:\/\/doi.org\/10.1073\/pnas.2306776121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"427_CR284","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1002\/cam4.3908","volume":"10","author":"A Hiraoka","year":"2021","unstructured":"Hiraoka A, Kato M, Marui K, Murakami T, Onishi K, Adachi T, et al. Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker. Cancer Med. 2021;10(11):3584\u201392. https:\/\/doi.org\/10.1002\/cam4.3908.","journal-title":"Cancer Med"},{"key":"427_CR285","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed7120437","author":"SE Ghanem","year":"2022","unstructured":"Ghanem SE, Abdel-Samiee M, El-Said H, Youssef MI, ElZohry HA, Abdelsameea E, et al. Evaluation of amino acids profile as non-invasive biomarkers of hepatocellular carcinoma in Egyptians. Trop Med Infect Dis. 2022. https:\/\/doi.org\/10.3390\/tropicalmed7120437.","journal-title":"Trop Med Infect Dis"},{"issue":"7","key":"427_CR286","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s42255-023-00818-7","volume":"5","author":"L Qian","year":"2023","unstructured":"Qian L, Li N, Lu XC, Xu M, Liu Y, Li K, et al. Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression. Nat Metab. 2023;5(7):1159\u201373. https:\/\/doi.org\/10.1038\/s42255-023-00818-7.","journal-title":"Nat Metab"},{"issue":"5","key":"427_CR287","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41416-022-02095-9","volume":"128","author":"SL Ibrahim","year":"2023","unstructured":"Ibrahim SL, Abed MN, Mohamed G, Price JC, Abdullah MI, Richardson A. Inhibition of branched-chain alpha-keto acid dehydrogenase kinase augments the sensitivity of ovarian and breast cancer cells to paclitaxel. Br J Cancer. 2023;128(5):896\u2013906. https:\/\/doi.org\/10.1038\/s41416-022-02095-9.","journal-title":"Br J Cancer"},{"key":"427_CR288","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151154","volume":"742","author":"T Bo","year":"2025","unstructured":"Bo T, Osaki T, Fujii J. Dephosphorylation of branched-chain \u03b1-keto acid dehydrogenase E1\u03b1 (BCKDHA) promotes branched-chain amino acid catabolism and renders cancer cells resistant to X-rays by mitigating DNA damage. Biochem Biophys Res Commun. 2025;742:151154. https:\/\/doi.org\/10.1016\/j.bbrc.2024.151154.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"427_CR289","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cmet.2024.10.017","volume":"37","author":"K Lin","year":"2025","unstructured":"Lin K, Wei L, Wang R, Li L, Song S, Wang F, et al. Disrupted methionine cycle triggers muscle atrophy in cancer cachexia through epigenetic regulation of REDD1. Cell Metab. 2025;37(2):460-76.e8. https:\/\/doi.org\/10.1016\/j.cmet.2024.10.017.","journal-title":"Cell Metab"},{"issue":"4","key":"427_CR290","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41556-025-01610-3","volume":"27","author":"Y Fan","year":"2025","unstructured":"Fan Y, Wang Y, Dan W, Zhang Y, Nie L, Ma Z, et al. PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer. Nat Cell Biol. 2025;27(4):641\u201353. https:\/\/doi.org\/10.1038\/s41556-025-01610-3.","journal-title":"Nat Cell Biol"},{"issue":"18","key":"427_CR291","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307834","volume":"11","author":"T Han","year":"2024","unstructured":"Han T, Wang Y, Cheng M, Hu Q, Wan X, Huang M, et al. Phosphorylated SHMT2 regulates oncogenesis through m(6)A modification in lung adenocarcinoma. Adv Sci (Weinh). 2024;11(18):e2307834. https:\/\/doi.org\/10.1002\/advs.202307834.","journal-title":"Adv Sci (Weinh)"},{"key":"427_CR292","doi-asserted-by":"publisher","DOI":"10.1172\/jci161713","author":"D Gou","year":"2023","unstructured":"Gou D, Liu R, Shan X, Deng H, Chen C, Xiang J, et al. Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/jci161713.","journal-title":"J Clin Invest"},{"issue":"10","key":"427_CR293","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07113-7","volume":"15","author":"S Shen","year":"2024","unstructured":"Shen S, Liu R, Huang J, Sun Y, Tan Q, Luo Q. MAT1A activation of glycolysis to promote NSCLC progression depends on stabilizing CCND1. Cell Death Dis. 2024;15(10):768. https:\/\/doi.org\/10.1038\/s41419-024-07113-7.","journal-title":"Cell Death Dis"},{"issue":"1","key":"427_CR294","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s43018-023-00671-3","volume":"5","author":"F Li","year":"2024","unstructured":"Li F, Liu P, Mi W, Li L, Anderson NM, Lesner NP, et al. Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer. Nat Cancer. 2024;5(1):131\u201346. https:\/\/doi.org\/10.1038\/s43018-023-00671-3.","journal-title":"Nat Cancer"},{"issue":"6","key":"427_CR295","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41375-024-02222-w","volume":"38","author":"J Guo","year":"2024","unstructured":"Guo J, Buettner R, Du L, Li Z, Liu W, Su R, et al. 8-Cl-Ado and 8-NH(2)-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia. Leukemia. 2024;38(6):1236\u201345. https:\/\/doi.org\/10.1038\/s41375-024-02222-w.","journal-title":"Leukemia"},{"issue":"7","key":"427_CR296","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1158\/0008-5472.Can-24-2097","volume":"85","author":"R Chen","year":"2025","unstructured":"Chen R, Ma C, Qian H, Xie X, Zhang Y, Lu D, et al. Mutant KRAS and CK2 cooperatively stimulate SLC16A3 activity to drive intrahepatic cholangiocarcinoma progression. Cancer Res. 2025;85(7):1253\u201369. https:\/\/doi.org\/10.1158\/0008-5472.Can-24-2097.","journal-title":"Cancer Res"},{"key":"427_CR297","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.174538","volume":"947","author":"Z Fu","year":"2024","unstructured":"Fu Z, Deng M, Zhou Q, Li S, Liu W, Cao S, et al. Arsenic activated GLUT1-mTORC1\/HIF-1\u03b1-PKM2 positive feedback networks promote proliferation and migration of bladder epithelial cells. Sci Total Environ. 2024;947:174538. https:\/\/doi.org\/10.1016\/j.scitotenv.2024.174538.","journal-title":"Sci Total Environ"},{"issue":"1","key":"427_CR298","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31478","volume":"240","author":"ST Chen","year":"2025","unstructured":"Chen ST, Chang KS, Lin YH, Hou CP, Lin WY, Hsu SY, et al. Glucose Upregulates ChREBP via Phosphorylation of AKT and AMPK to Modulate MALT1 and WISP1 Expression. J Cell Physiol. 2025;240(1):e31478. https:\/\/doi.org\/10.1002\/jcp.31478.","journal-title":"J Cell Physiol"},{"key":"427_CR299","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146932","author":"M Engeler","year":"2025","unstructured":"Engeler M, Karim M, Gischke M, Willer F, Leiner H, Prey J, et al. Carbohydrate-responsive element-binding protein-associated metabolic changes in chemically induced hepatocarcinogenesis mouse model. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26146932.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"427_CR300","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41420-025-02527-4","volume":"11","author":"F Zhang","year":"2025","unstructured":"Zhang F, Wu Z, Xiang Y, He Q, Li W, Yang K, et al. SOX4 reprograms fatty acid metabolism through the CHREBP to inhibit ferroptosis in hepatocellular carcinoma. Cell Death Discov. 2025;11(1):246. https:\/\/doi.org\/10.1038\/s41420-025-02527-4.","journal-title":"Cell Death Discov"},{"key":"427_CR301","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052246","author":"M Karim","year":"2025","unstructured":"Karim M, Prey J, Willer F, Leiner H, Yasser M, Dombrowski F, et al. Hepatic deletion of carbohydrate response element binding protein impairs hepatocarcinogenesis in a high-fat diet-induced mouse model. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26052246.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"427_CR302","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s42255-024-01047-2","volume":"6","author":"Y Meng","year":"2024","unstructured":"Meng Y, Guo D, Lin L, Zhao H, Xu W, Luo S, et al. Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet-mitochondria tethering to enhance \u03b2-oxidation and tumor cell proliferation. Nat Metab. 2024;6(6):1092\u2013107. https:\/\/doi.org\/10.1038\/s42255-024-01047-2.","journal-title":"Nat Metab"},{"issue":"16","key":"427_CR303","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.7150\/jca.50502","volume":"12","author":"YJ Chen","year":"2021","unstructured":"Chen YJ, Liao WX, Huang SZ, Yu YF, Wen JY, Chen J, et al. Prognostic and immunological role of CD36: a pan-cancer analysis. J Cancer. 2021;12(16):4762\u201373. https:\/\/doi.org\/10.7150\/jca.50502.","journal-title":"J Cancer"},{"issue":"7","key":"427_CR304","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1080\/15384101.2018.1460023","volume":"17","author":"S Cassim","year":"2018","unstructured":"Cassim S, Raymond VA, Dehbidi-Assadzadeh L, Lapierre P, Bilodeau M. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment. Cell Cycle. 2018;17(7):903\u201316. https:\/\/doi.org\/10.1080\/15384101.2018.1460023.","journal-title":"Cell Cycle"},{"key":"427_CR305","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673304759240722064518","author":"A Zeb","year":"2024","unstructured":"Zeb A, Khan W, Ul Islam W, Khan F, Khan A, Khan H, et al. Exploring the Anticancer Potential of Astragalin in Triple Negative Breast Cancer Cells by Attenuating Glycolytic Pathway through AMPK\/mTOR. Curr Med Chem. 2024. https:\/\/doi.org\/10.2174\/0109298673304759240722064518.","journal-title":"Curr Med Chem"},{"issue":"4","key":"427_CR306","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/hep.28415","volume":"63","author":"MD Wang","year":"2016","unstructured":"Wang MD, Wu H, Fu GB, Zhang HL, Zhou X, Tang L, et al. Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients. Hepatology. 2016;63(4):1272\u201386. https:\/\/doi.org\/10.1002\/hep.28415.","journal-title":"Hepatology"},{"key":"427_CR307","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150709","volume":"733","author":"J Shen","year":"2024","unstructured":"Shen J, Wu Z, Zhou Y, Yang D, Wang X, Yu B, et al. Knockdown of SLC16A3 decreases extracellular lactate concentration in hepatocellular carcinoma, alleviates hypoxia and induces ferroptosis. Biochem Biophys Res Commun. 2024;733:150709. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150709.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"427_CR308","doi-asserted-by":"publisher","first-page":"E496","DOI":"10.1152\/ajpendo.00061.2018","volume":"315","author":"T Wang","year":"2018","unstructured":"Wang T, Yao W, Li J, He Q, Shao Y, Huang F. Acetyl-CoA from inflammation-induced fatty acids oxidation promotes hepatic malate-aspartate shuttle activity and glycolysis. Am J Physiol Endocrinol Metab. 2018;315(4):E496-e510. https:\/\/doi.org\/10.1152\/ajpendo.00061.2018.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"427_CR309","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/hep.32177","volume":"75","author":"Y Fang","year":"2022","unstructured":"Fang Y, Zhan Y, Xie Y, Du S, Chen Y, Zeng Z, et al. Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC. Hepatology. 2022;75(6):1386\u2013401. https:\/\/doi.org\/10.1002\/hep.32177.","journal-title":"Hepatology"},{"issue":"1","key":"427_CR310","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45548-w","volume":"15","author":"E Benichou","year":"2024","unstructured":"Benichou E, Seffou B, Top\u00e7u S, Renoult O, Lenoir V, Planchais J, et al. The transcription factor ChREBP orchestrates liver carcinogenesis by coordinating the PI3K\/AKT signaling and cancer metabolism. Nat Commun. 2024;15(1):1879. https:\/\/doi.org\/10.1038\/s41467-024-45548-w.","journal-title":"Nat Commun"},{"issue":"42","key":"427_CR311","doi-asserted-by":"publisher","first-page":"15656","DOI":"10.1021\/acs.jafc.3c05566","volume":"71","author":"X Zhou","year":"2023","unstructured":"Zhou X, Zhang J, Sun Y, Shen J, Sun B, Ma Q. Glutamine ameliorates liver steatosis via regulation of glycolipid metabolism and gut microbiota in high-fat diet-induced obese mice. J Agric Food Chem. 2023;71(42):15656\u201367. https:\/\/doi.org\/10.1021\/acs.jafc.3c05566.","journal-title":"J Agric Food Chem"},{"issue":"11","key":"427_CR312","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.cmet.2023.09.009","volume":"35","author":"P Zhou","year":"2023","unstructured":"Zhou P, Chang WY, Gong DA, Xia J, Chen W, Huang LY, et al. High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate. Cell Metab. 2023;35(11):1961-75.e6. https:\/\/doi.org\/10.1016\/j.cmet.2023.09.009.","journal-title":"Cell Metab"},{"issue":"2","key":"427_CR313","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jhep.2023.10.024","volume":"80","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Wei T, Jin W, Yan L, Shi L, Zhu S, et al. Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism. J Hepatol. 2024;80(2):293\u2013308. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.024.","journal-title":"J Hepatol"},{"issue":"9","key":"427_CR314","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1158\/1541-7786.Mcr-17-0061","volume":"15","author":"MJ Kim","year":"2017","unstructured":"Kim MJ, Choi YK, Park SY, Jang SY, Lee JY, Ham HJ, et al. PPAR\u03b4 reprograms glutamine metabolism in Sorafenib-resistant HCC. Mol Cancer Res. 2017;15(9):1230\u201342. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-17-0061.","journal-title":"Mol Cancer Res"},{"key":"427_CR315","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102732","volume":"63","author":"Y Kong","year":"2023","unstructured":"Kong Y, Wu M, Wan X, Sun M, Zhang Y, Wu Z, et al. Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation. Redox Biol. 2023;63:102732. https:\/\/doi.org\/10.1016\/j.redox.2023.102732.","journal-title":"Redox Biol"},{"issue":"8","key":"427_CR316","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/s41418-023-01186-1","volume":"30","author":"X Jiang","year":"2023","unstructured":"Jiang X, Peng J, Xie Y, Xu Y, Liu Q, Cheng C, et al. Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function. Cell Death Differ. 2023;30(8):1931\u201342. https:\/\/doi.org\/10.1038\/s41418-023-01186-1.","journal-title":"Cell Death Differ"},{"issue":"5","key":"427_CR317","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jhep.2019.12.015","volume":"72","author":"W Dai","year":"2020","unstructured":"Dai W, Xu L, Yu X, Zhang G, Guo H, Liu H, et al. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism. J Hepatol. 2020;72(5):909\u201323. https:\/\/doi.org\/10.1016\/j.jhep.2019.12.015.","journal-title":"J Hepatol"},{"key":"427_CR318","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1124678","volume":"10","author":"F Lengauer","year":"2023","unstructured":"Lengauer F, Geisslinger F, Gabriel A, von Schwarzenberg K, Vollmar AM, Bartel K. A metabolic shift toward glycolysis enables cancer cells to maintain survival upon concomitant glutamine deprivation and V-ATPase inhibition. Front Nutr. 2023;10:1124678. https:\/\/doi.org\/10.3389\/fnut.2023.1124678.","journal-title":"Front Nutr"},{"issue":"3","key":"427_CR319","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113868","volume":"43","author":"M Benzarti","year":"2024","unstructured":"Benzarti M, Neises L, Oudin A, Kr\u00f6tz C, Viry E, Gargiulo E, et al. PKM2 diverts glycolytic flux in dependence on mitochondrial one-carbon cycle. Cell Rep. 2024;43(3):113868. https:\/\/doi.org\/10.1016\/j.celrep.2024.113868.","journal-title":"Cell Rep"},{"issue":"1","key":"427_CR320","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03805-y","volume":"25","author":"C Mancini","year":"2025","unstructured":"Mancini C, Menegazzi G, Peppicelli S, Versienti G, Guasti D, Pieraccini G, et al. BCR::ABL1 expression in chronic myeloid leukemia cells in low oxygen is regulated by glutamine via CD36-mediated fatty acid uptake. Cancer Cell Int. 2025;25(1):176. https:\/\/doi.org\/10.1186\/s12935-025-03805-y.","journal-title":"Cancer Cell Int"},{"issue":"19","key":"427_CR321","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41388-025-03320-4","volume":"44","author":"Z Li","year":"2025","unstructured":"Li Z, Guan Y, Gao J, Zhu L, Zeng Z, Jing Q, et al. PPDPF-mediated regulation of BCAA metabolism enhances mTORC1 activity and drives cholangiocarcinoma progression. Oncogene. 2025;44(19):1415\u201333. https:\/\/doi.org\/10.1038\/s41388-025-03320-4.","journal-title":"Oncogene"},{"issue":"7","key":"427_CR322","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3724\/abbs.2024226","volume":"57","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Ye S, Chen J, Dai F, Chen L, Ye R, et al. ATF4 promotes glutaminolysis and glycolysis in colorectal cancer by transcriptionally inducing SLC1A5. Acta Biochim Biophys Sin (Shanghai). 2024;57(7):1093\u2013105. https:\/\/doi.org\/10.3724\/abbs.2024226.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"17","key":"427_CR323","doi-asserted-by":"publisher","first-page":"9091","DOI":"10.7150\/thno.115661","volume":"15","author":"R Liu","year":"2025","unstructured":"Liu R, Li X, Xu J, Yan L, Hu K, Shi M, et al. The contrasting regulatory effects of valproic acid on ferroptosis and disulfidptosis in hepatocellular carcinoma. Theranostics. 2025;15(17):9091\u2013113. https:\/\/doi.org\/10.7150\/thno.115661.","journal-title":"Theranostics"},{"key":"427_CR324","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110626","volume":"105","author":"X Chu","year":"2023","unstructured":"Chu X, Zhong L, Dan W, Wang X, Zhang Z, Liu Z, et al. DNMT3A R882H mutation promotes acute leukemic cell survival by regulating glycolysis through the NRF2\/NQO1 axis. Cell Signal. 2023;105:110626. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110626.","journal-title":"Cell Signal"},{"issue":"1","key":"427_CR325","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01411-3","volume":"9","author":"M Li","year":"2023","unstructured":"Li M, Thorne RF, Wang R, Cao L, Cheng F, Sun X, et al. Sestrin2-mediated disassembly of stress granules dampens aerobic glycolysis to overcome glucose starvation. Cell Death Discov. 2023;9(1):127. https:\/\/doi.org\/10.1038\/s41420-023-01411-3.","journal-title":"Cell Death Discov"},{"issue":"7424","key":"427_CR326","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nature11540","volume":"491","author":"B Chaneton","year":"2012","unstructured":"Chaneton B, Hillmann P, Zheng L, Martin ACL, Maddocks ODK, Chokkathukalam A, et al. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature. 2012;491(7424):458\u201362. https:\/\/doi.org\/10.1038\/nature11540.","journal-title":"Nature"},{"issue":"18","key":"427_CR327","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1073\/pnas.1204176109","volume":"109","author":"J Ye","year":"2012","unstructured":"Ye J, Mancuso A, Tong X, Ward PS, Fan J, Rabinowitz JD, et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci U S A. 2012;109(18):6904\u20139. https:\/\/doi.org\/10.1073\/pnas.1204176109.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"427_CR328","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19102907","author":"M Kurihara-Shimomura","year":"2018","unstructured":"Kurihara-Shimomura M, Sasahira T, Nakashima C, Kuniyasu H, Shimomura H, Kirita T. The multifarious functions of pyruvate kinase M2 in oral cancer cells. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19102907.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"427_CR329","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112971","volume":"42","author":"W Dai","year":"2023","unstructured":"Dai W, Wang Z, Wang G, Wang QA, DeBerardinis R, Jiang L. FASN deficiency induces a cytosol-to-mitochondria citrate flux to mitigate detachment-induced oxidative stress. Cell Rep. 2023;42(8):112971. https:\/\/doi.org\/10.1016\/j.celrep.2023.112971.","journal-title":"Cell Rep"},{"issue":"1","key":"427_CR330","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1186\/s12967-025-06853-0","volume":"23","author":"J Chen","year":"2025","unstructured":"Chen J, Zhao L, Li W, Wang S, Li J, Lv Z, et al. Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer. J Transl Med. 2025;23(1):803. https:\/\/doi.org\/10.1186\/s12967-025-06853-0.","journal-title":"J Transl Med"},{"key":"427_CR331","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/bs.ircmb.2024.03.005","volume":"389","author":"S Chatterjee","year":"2024","unstructured":"Chatterjee S, Prashanth P, Rawat V, Ghosh Roy S. Regulation of lipid and serine metabolism by the oncogene c-Myc. Int Rev Cell Mol Biol. 2024;389:236\u201356. https:\/\/doi.org\/10.1016\/bs.ircmb.2024.03.005.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"1","key":"427_CR332","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-02039-0","volume":"27","author":"X Ma","year":"2025","unstructured":"Ma X, Zhang B, Yin X, Yang S, Lin Z, Yang Y, et al. CPT1A\/HIF-1\u03b1 positive feedback loop induced fatty acid oxidation metabolic pathway contributes to the L-ascorbic acid-driven angiogenesis in breast cancer. Breast Cancer Res. 2025;27(1):74. https:\/\/doi.org\/10.1186\/s13058-025-02039-0.","journal-title":"Breast Cancer Res"},{"issue":"13","key":"427_CR333","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1158\/0008-5472.Can-24-2745","volume":"85","author":"U Sen","year":"2025","unstructured":"Sen U, Coleman C, Gandhi N, Jethalia V, Demircioglu D, Elliott A, et al. SCD1 inhibition blocks the AKT-NRF2-SLC7A11 pathway to induce lipid metabolism remodeling and ferroptosis priming in lung adenocarcinoma. Cancer Res. 2025;85(13):2485\u2013503. https:\/\/doi.org\/10.1158\/0008-5472.Can-24-2745.","journal-title":"Cancer Res"},{"key":"427_CR334","doi-asserted-by":"publisher","DOI":"10.3390\/cells12202509","author":"MJ Kim","year":"2023","unstructured":"Kim MJ, Kim HS, Kang HW, Lee DE, Hong WC, Kim JH, et al. SLC38A5 modulates ferroptosis to overcome gemcitabine resistance in pancreatic cancer. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12202509.","journal-title":"Cells"},{"issue":"1","key":"427_CR335","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40170-024-00335-5","volume":"12","author":"K Gotvaldov\u00e1","year":"2024","unstructured":"Gotvaldov\u00e1 K, \u0160pa\u010dkov\u00e1 J, Novotn\u00fd J, Baslarov\u00e1 K, Je\u017eek P, Rossmeislov\u00e1 L, et al. BCAA metabolism in pancreatic cancer affects lipid balance by regulating fatty acid import into mitochondria. Cancer Metab. 2024;12(1):10. https:\/\/doi.org\/10.1186\/s40170-024-00335-5.","journal-title":"Cancer Metab"},{"key":"427_CR336","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101742","volume":"37","author":"Y Yan","year":"2020","unstructured":"Yan Y, Wu X, Wang P, Zhang S, Sun L, Zhao Y, et al. Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1\u03b1-ERO1\u03b1-dependent oxidative stress manner. Redox Biol. 2020;37:101742. https:\/\/doi.org\/10.1016\/j.redox.2020.101742.","journal-title":"Redox Biol"},{"issue":"1","key":"427_CR337","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.clnu.2015.01.021","volume":"35","author":"P Jegatheesan","year":"2016","unstructured":"Jegatheesan P, Beutheu S, Ventura G, Sarfati G, Nubret E, Kapel N, et al. Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease. Clin Nutr. 2016;35(1):175\u201382. https:\/\/doi.org\/10.1016\/j.clnu.2015.01.021.","journal-title":"Clin Nutr"},{"issue":"4","key":"427_CR338","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1080\/15548627.2021.1961072","volume":"18","author":"K Liu","year":"2022","unstructured":"Liu K, Qiu D, Liang X, Huang Y, Wang Y, Jia X, et al. Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy. Autophagy. 2022;18(4):860\u201376. https:\/\/doi.org\/10.1080\/15548627.2021.1961072.","journal-title":"Autophagy"},{"issue":"3","key":"427_CR339","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","volume":"31","author":"J Simon","year":"2020","unstructured":"Simon J, Nu\u00f1ez-Garc\u00eda M, Fern\u00e1ndez-Tussy P, Barbier-Torres L, Fern\u00e1ndez-Ramos D, G\u00f3mez-Santos B, et al. Targeting hepatic glutaminase 1 ameliorates non-alcoholic steatohepatitis by restoring very-low-density lipoprotein triglyceride assembly. Cell Metab. 2020;31(3):605-22.e10. https:\/\/doi.org\/10.1016\/j.cmet.2020.01.013.","journal-title":"Cell Metab"},{"key":"427_CR340","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010210","author":"EA Ahmed","year":"2022","unstructured":"Ahmed EA, El-Derany MO, Anwar AM, Saied EM, Magdeldin S. Metabolomics and lipidomics screening reveal reprogrammed signaling pathways toward cancer development in non-alcoholic steatohepatitis. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms24010210.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"427_CR341","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2023.05.029","volume":"165","author":"XM Yang","year":"2023","unstructured":"Yang XM, Wang XQ, Hu LP, Feng MX, Zhou YQ, Li DX, et al. Nucleolar HEAT repeat containing 1 up-regulated by the mechanistic target of rapamycin complex 1 signaling promotes hepatocellular carcinoma growth by dominating ribosome biogenesis and proteome homeostasis. Gastroenterology. 2023;165(3):629\u201346. https:\/\/doi.org\/10.1053\/j.gastro.2023.05.029.","journal-title":"Gastroenterology"},{"issue":"1","key":"427_CR342","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09211-1","volume":"22","author":"M Sadria","year":"2022","unstructured":"Sadria M, Seo D, Layton AT. The mixed blessing of AMPK signaling in cancer treatments. BMC Cancer. 2022;22(1):105. https:\/\/doi.org\/10.1186\/s12885-022-09211-1.","journal-title":"BMC Cancer"},{"issue":"2","key":"427_CR343","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s42255-022-00732-4","volume":"5","author":"X Dai","year":"2023","unstructured":"Dai X, Jiang C, Jiang Q, Fang L, Yu H, Guo J, et al. AMPK-dependent phosphorylation of the GATOR2 component WDR24 suppresses glucose-mediated mTORC1 activation. Nat Metab. 2023;5(2):265\u201376. https:\/\/doi.org\/10.1038\/s42255-022-00732-4.","journal-title":"Nat Metab"},{"key":"427_CR344","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jare.2022.09.007","volume":"49","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Wang A, Zhang S, Kim J, Xia J, Zhang F, et al. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells. J Adv Res. 2023;49:159\u201373. https:\/\/doi.org\/10.1016\/j.jare.2022.09.007.","journal-title":"J Adv Res"},{"key":"427_CR345","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097771","author":"MA Franczak","year":"2023","unstructured":"Franczak MA, Krol O, Harasim G, Jedrzejewska A, Zaffaroni N, Granchi C, et al. Metabolic effects of new glucose transporter (GLUT-1) and lactate dehydrogenase-A (LDH-A) inhibitors against chemoresistant malignant mesothelioma. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24097771.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"427_CR346","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14141-9","volume":"25","author":"M Hayashi","year":"2025","unstructured":"Hayashi M, Nakamura K, Harada S, Tanaka M, Kobayashi A, Saito H, et al. GLUT1 inhibition by BAY-876 induces metabolic changes and cell death in human colorectal cancer cells. BMC Cancer. 2025;25(1):716. https:\/\/doi.org\/10.1186\/s12885-025-14141-9.","journal-title":"BMC Cancer"},{"issue":"1","key":"427_CR347","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13186-6","volume":"24","author":"TJ Schumacher","year":"2024","unstructured":"Schumacher TJ, Iyer AV, Rumbley J, Ronayne CT, Mereddy VR. Exploring the impact of mitochondrial-targeting anthelmintic agents with GLUT1 inhibitor BAY-876 on breast cancer cell metabolism. BMC Cancer. 2024;24(1):1415. https:\/\/doi.org\/10.1186\/s12885-024-13186-6.","journal-title":"BMC Cancer"},{"issue":"1","key":"427_CR348","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02106-z","volume":"10","author":"ZA Miller","year":"2024","unstructured":"Miller ZA, Muthuswami S, Mueller A, Ma RZ, Sywanycz SM, Naik A, et al. GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cells. Cell Death Discov. 2024;10(1):339. https:\/\/doi.org\/10.1038\/s41420-024-02106-z.","journal-title":"Cell Death Discov"},{"issue":"1","key":"427_CR349","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-025-02044-y","volume":"23","author":"M Komza","year":"2025","unstructured":"Komza M, Khatun J, Gelles JD, Trotta AP, Abraham-Enachescu I, Henao J, et al. Metabolic adaptations to acute glucose uptake inhibition converge upon mitochondrial respiration for leukemia cell survival. Cell Commun Signal. 2025;23(1):47. https:\/\/doi.org\/10.1186\/s12964-025-02044-y.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"427_CR350","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1007\/s00210-024-03021-x","volume":"397","author":"P Mohite","year":"2024","unstructured":"Mohite P, Lokwani DK, Sakle NS. Exploring the therapeutic potential of SGLT2 inhibitors in cancer treatment: integrating in silico and in vitro investigations. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(8):6107\u201319. https:\/\/doi.org\/10.1007\/s00210-024-03021-x.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"427_CR351","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40170-023-00306-2","volume":"11","author":"LK Park","year":"2023","unstructured":"Park LK, Lim KH, Volkman J, Abdiannia M, Johnston H, Nigogosyan Z, et al. Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study. Cancer Metab. 2023;11(1):6. https:\/\/doi.org\/10.1186\/s40170-023-00306-2.","journal-title":"Cancer Metab"},{"issue":"2","key":"427_CR352","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1158\/1078-0432.Ccr-18-1854","volume":"25","author":"S Agnihotri","year":"2019","unstructured":"Agnihotri S, Mansouri S, Burrell K, Li M, Mamatjan Y, Liu J, et al. Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells. Clin Cancer Res. 2019;25(2):844\u201355. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-1854.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"427_CR353","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1158\/0008-5472.Can-18-2799","volume":"79","author":"S Xu","year":"2019","unstructured":"Xu S, Zhou T, Doh HM, Trinh KR, Catapang A, Lee JT, et al. An HK2 antisense oligonucleotide induces synthetic lethality in HK1(-)HK2(+) multiple myeloma. Cancer Res. 2019;79(10):2748\u201360. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-2799.","journal-title":"Cancer Res"},{"issue":"1","key":"427_CR354","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.4103\/0973-1482.55141","volume":"5","author":"VK Prasanna","year":"2009","unstructured":"Prasanna VK, Venkataramana NK, Dwarakanath BS, Santhosh V. Differential responses of tumors and normal brain to the combined treatment of 2-DG and radiation in glioablastoma. J Cancer Res Ther. 2009;5(1):S44\u20137. https:\/\/doi.org\/10.4103\/0973-1482.55141.","journal-title":"J Cancer Res Ther"},{"issue":"5","key":"427_CR355","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.chest.2023.01.007","volume":"163","author":"N Gupta","year":"2023","unstructured":"Gupta N, Zhang B, Zhou Y, McCormack FX, Ingledue R, Robbins N, et al. Safety and Efficacy of Combined Resveratrol and Sirolimus in Lymphangioleiomyomatosis. Chest. 2023;163(5):1144\u201355. https:\/\/doi.org\/10.1016\/j.chest.2023.01.007.","journal-title":"Chest"},{"key":"427_CR356","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156337","volume":"136","author":"YC Peng","year":"2025","unstructured":"Peng YC, He ZJ, Yin LC, Pi HF, Jiang Y, Li KY, et al. Sanguinarine suppresses oral squamous cell carcinoma progression by targeting the PKM2\/TFEB aix to inhibit autophagic flux. Phytomedicine. 2025;136:156337. https:\/\/doi.org\/10.1016\/j.phymed.2024.156337.","journal-title":"Phytomedicine"},{"issue":"1","key":"427_CR357","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1186\/s12967-025-06905-5","volume":"23","author":"L Yan","year":"2025","unstructured":"Yan L, Sun Y, Shi SS, Li Y, Zhang YF, Qu LZ, et al. Triclabendazole inhibits PKM2 nuclear localization and glycolysis by enhancing HDAC6-mediated deacetylation in lung cancer. J Transl Med. 2025;23(1):1001. https:\/\/doi.org\/10.1186\/s12967-025-06905-5.","journal-title":"J Transl Med"},{"issue":"1","key":"427_CR358","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-024-02009-8","volume":"23","author":"J Zhang","year":"2024","unstructured":"Zhang J, Ouyang F, Gao A, Zeng T, Li M, Li H, et al. Esm1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment. Mol Cancer. 2024;23(1):94. https:\/\/doi.org\/10.1186\/s12943-024-02009-8.","journal-title":"Mol Cancer"},{"issue":"1","key":"427_CR359","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-025-02302-0","volume":"24","author":"B Wang","year":"2025","unstructured":"Wang B, Wang Z, Zhou Z, Liu G, Jiang Z, Zheng M, et al. Inhibition of 6-phosphogluconate dehydrogenase suppresses esophageal squamous cell carcinoma growth and enhances the anti-tumor effects of metformin via the AMPK\/mTOR pathway. Mol Cancer. 2025;24(1):97. https:\/\/doi.org\/10.1186\/s12943-025-02302-0.","journal-title":"Mol Cancer"},{"key":"427_CR360","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62592","author":"JL Gillis","year":"2021","unstructured":"Gillis JL, Hinneh JA, Ryan NK, Irani S, Moldovan M, Quek LE, et al. A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth. Elife. 2021. https:\/\/doi.org\/10.7554\/eLife.62592.","journal-title":"Elife"},{"key":"427_CR361","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101239","volume":"70","author":"X Lin","year":"2025","unstructured":"Lin X, Xu Y, Bai E, Deng Y, Zhang W, Xue R, et al. 6-aminonicotinamide, a G6PD inhibitor, mitigates CAPS1 reduction mediated HCC metastasis via ERK and GSK3\u03b2 signals. Neoplasia. 2025;70:101239. https:\/\/doi.org\/10.1016\/j.neo.2025.101239.","journal-title":"Neoplasia"},{"key":"427_CR362","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf325","author":"Q Liu","year":"2025","unstructured":"Liu Q, Shen J, Chen Y, Zhou J, Luo H, Deng J, et al. Phase II trial of radiotherapy plus Huachansu in elderly or chemotherapy-ineligible patients with locally advanced esophageal squamous cell carcinoma. Oncologist. 2025. https:\/\/doi.org\/10.1093\/oncolo\/oyaf325.","journal-title":"Oncologist"},{"issue":"7","key":"427_CR363","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3324\/haematol.2016.163030","volume":"102","author":"RA Noble","year":"2017","unstructured":"Noble RA, Bell N, Blair H, Sikka A, Thomas H, Phillips N, et al. Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma. Haematologica. 2017;102(7):1247\u201357. https:\/\/doi.org\/10.3324\/haematol.2016.163030.","journal-title":"Haematologica"},{"issue":"1","key":"427_CR364","doi-asserted-by":"publisher","DOI":"10.1080\/19336950.2023.2273008","volume":"17","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P, Bhowmik D, Roy SS. A systemic analysis of monocarboxylate transporters in ovarian cancer and possible therapeutic interventions. Channels (Austin). 2023;17(1):2273008. https:\/\/doi.org\/10.1080\/19336950.2023.2273008.","journal-title":"Channels (Austin)"},{"key":"427_CR365","doi-asserted-by":"publisher","unstructured":"Khajah MA, Khushaish S, Luqmani YA. The effect of lactate dehydrogenase inhibitors on proliferation, motility and invasion of breast cancer cells in\u00a0vitro highlights a new role for lactate. Mol Med Rep. 2024;29(1). https:\/\/doi.org\/10.3892\/mmr.2023.13135.","DOI":"10.3892\/mmr.2023.13135"},{"key":"427_CR366","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114605","volume":"240","author":"L Di Magno","year":"2022","unstructured":"Di Magno L, Coluccia A, Bufano M, Ripa S, La Regina G, Nalli M, et al. Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment. Eur J Med Chem. 2022;240:114605. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114605.","journal-title":"Eur J Med Chem"},{"key":"427_CR367","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125710","author":"T Hashimoto","year":"2025","unstructured":"Hashimoto T, Ushikubo G, Arao N, Hatabi K, Tsubota K, Hosoi Y. Oxamate, an LDHA inhibitor, inhibits stemness, including EMT and high DNA repair ability, induces senescence, and exhibits radiosensitizing effects in glioblastoma cells. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26125710.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"427_CR368","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s10637-013-0047-4","volume":"32","author":"EM Dunbar","year":"2014","unstructured":"Dunbar EM, Coats BS, Shroads AL, Langaee T, Lew A, Forder JR, et al. Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors. Invest New Drugs. 2014;32(3):452\u201364. https:\/\/doi.org\/10.1007\/s10637-013-0047-4.","journal-title":"Invest New Drugs"},{"issue":"7","key":"427_CR369","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMoa2304194","volume":"389","author":"IK Mellinghoff","year":"2023","unstructured":"Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J, et al. Vorasidenib in IDH1- or IDH2-mutant low-grade glioma. N Engl J Med. 2023;389(7):589\u2013601. https:\/\/doi.org\/10.1056\/NEJMoa2304194.","journal-title":"N Engl J Med"},{"key":"427_CR370","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-25-0174","author":"JJ Harding","year":"2025","unstructured":"Harding JJ, Oh DY, Mercade TM, Goyal L, Varkaris A, Palmieri LJ, et al. Final results from a first-in-human phase 1 study of the dual isocitrate dehydrogenase (IDH) 1\/2 inhibitor, LY3410738, in advanced solid tumors harboring IDH1 or IDH2 mutations. Clin Cancer Res. 2025. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-25-0174.","journal-title":"Clin Cancer Res"},{"key":"427_CR371","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaf258","author":"Y Arakawa","year":"2025","unstructured":"Arakawa Y, Saito R, Kanemura Y, Mishima K, Koriyama S, Narita Y, et al. Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-na\u00efve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas. Neuro Oncol. 2025. https:\/\/doi.org\/10.1093\/neuonc\/noaf258.","journal-title":"Neuro Oncol"},{"issue":"3","key":"427_CR372","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00432-022-03983-6","volume":"149","author":"CD DiNardo","year":"2023","unstructured":"DiNardo CD, Hochhaus A, Frattini MG, Yee K, Zander T, Kr\u00e4mer A, et al. A phase 1 study of IDH305 in patients with IDH1(R132)-mutant acute myeloid leukemia or myelodysplastic syndrome. J Cancer Res Clin Oncol. 2023;149(3):1145\u201358. https:\/\/doi.org\/10.1007\/s00432-022-03983-6.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"427_CR373","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1158\/1078-0432.Ccr-23-2234","volume":"30","author":"A Woods","year":"2024","unstructured":"Woods A, Norsworthy KJ, Wang X, Vallejo J, Chiu Yuen Chow E, Li RJ, et al. FDA approval summary: ivosidenib in combination with azacitidine for treatment of patients with newly diagnosed acute myeloid leukemia with an IDH1 mutation. Clin Cancer Res. 2024;30(7):1226\u201331. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-2234.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"427_CR374","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00433-x","volume":"4","author":"D Mahalingam","year":"2024","unstructured":"Mahalingam D, Harb W, Patnaik A, Bullock A, Watnick RS, Vincent MY, et al. First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors. Commun Med (Lond). 2024;4(1):10. https:\/\/doi.org\/10.1038\/s43856-024-00433-x.","journal-title":"Commun Med (Lond)"},{"issue":"8","key":"427_CR375","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412244","volume":"12","author":"J Chen","year":"2025","unstructured":"Chen J, Yu X, Yang G, Chen X, Gong C, Han L, et al. Combined blockade of lipid uptake and synthesis by CD36 inhibitor and SCD1 siRNA is beneficial for the treatment of refractory prostate cancer. Adv Sci. 2025;12(8):e2412244. https:\/\/doi.org\/10.1002\/advs.202412244.","journal-title":"Adv Sci"},{"key":"427_CR376","doi-asserted-by":"publisher","unstructured":"Velez BC, Petrella CP, DiSalvo KH, Cheng K, Kravtsov R, Krasniqi D, et al. Combined inhibition of ACLY and CDK4\/6 reduces cancer cell growth and invasion. Oncol Rep. 2023;49(2). https:\/\/doi.org\/10.3892\/or.2022.8469.","DOI":"10.3892\/or.2022.8469"},{"key":"427_CR377","doi-asserted-by":"publisher","first-page":"11235","DOI":"10.2147\/ijn.S478308","volume":"19","author":"R Li","year":"2024","unstructured":"Li R, Li Y, Song Z, Gu Y, Jiao X, Wan C, et al. A Graphene-Based Lipid Modulation Nanoplatform for Synergetic Lipid Starvation\/Chemo\/Photothermal Therapy of Oral Squamous Cell Carcinoma. Int J Nanomedicine. 2024;19:11235\u201355. https:\/\/doi.org\/10.2147\/ijn.S478308.","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"427_CR378","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18129","volume":"28","author":"X Zhang","year":"2024","unstructured":"Zhang X, Xu Y, Li S, Qin Y, Zhu G, Zhang Q, et al. SIRT2-mediated deacetylation of ACLY promotes the progression of oesophageal squamous cell carcinoma. J Cell Mol Med. 2024;28(6):e18129. https:\/\/doi.org\/10.1111\/jcmm.18129.","journal-title":"J Cell Mol Med"},{"key":"427_CR379","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810170","author":"S Saisomboon","year":"2024","unstructured":"Saisomboon S, Kariya R, Mahalapbutr P, Insawang T, Sawanyawisuth K, Cha\u2019on U, et al. Augmented global protein acetylation diminishes cell growth and migration of cholangiocarcinoma cells. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms251810170.","journal-title":"Int J Mol Sci"},{"key":"427_CR380","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.02.003","author":"M Jiang","year":"2025","unstructured":"Jiang M, Xu L, Lin W, Liu W, Zhang Y, Wang H, et al. LncRNA CRCMSL interferes in phospholipid unsaturation to suppress colorectal cancer progression via reducing membrane fluidity. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.02.003.","journal-title":"J Adv Res"},{"key":"427_CR381","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2025.107092","volume":"209","author":"M Feng","year":"2025","unstructured":"Feng M, Gong W, Zhu X, Zhu J, Hu J, Xu W, et al. Covalent binding of 5-tetradecyloxy-2-furoic acid (TOFA) and c(RGDfK) and its co-delivery with Lipusu, a novel synergistic strategy to inhibit the proliferation of nasopharyngeal cancer. Eur J Pharm Sci. 2025;209:107092. https:\/\/doi.org\/10.1016\/j.ejps.2025.107092.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"427_CR382","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/1878-0261.13582","volume":"18","author":"JA Menendez","year":"2024","unstructured":"Menendez JA, Cuy\u00e0s E, Encinar JA, Vander Steen T, Verdura S, Llop-Hern\u00e1ndez \u00c0, et al. Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology. Mol Oncol. 2024;18(3):479\u2013516. https:\/\/doi.org\/10.1002\/1878-0261.13582.","journal-title":"Mol Oncol"},{"issue":"2","key":"427_CR383","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/odi.14017","volume":"29","author":"LY Almeida","year":"2023","unstructured":"Almeida LY, Moreira FDS, Santos G, Cuadra Zelaya FJM, Ortiz CA, Agostini M, et al. FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1. Oral Dis. 2023;29(2):649\u201360. https:\/\/doi.org\/10.1111\/odi.14017.","journal-title":"Oral Dis"},{"issue":"21","key":"427_CR384","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1158\/1078-0432.Ccr-21-0493","volume":"27","author":"SD Sardesai","year":"2021","unstructured":"Sardesai SD, Thomas A, Gallagher C, Lynce F, Ottaviano YL, Ballinger TJ, et al. Inhibiting fatty acid synthase with omeprazole to improve efficacy of neoadjuvant chemotherapy in patients with operable TNBC. Clin Cancer Res. 2021;27(21):5810\u20137. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-0493.","journal-title":"Clin Cancer Res"},{"key":"427_CR385","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/lctt.S512936","volume":"16","author":"E Polonio-Alcal\u00e1","year":"2025","unstructured":"Polonio-Alcal\u00e1 E, Ausell\u00e9-Bosch S, Riesco-Llach G, Novales P, Feliu L, Planas M, et al. Elucidating the Role of FASN in Lung Cancer Stem Cells in Sensitive and Resistant EGFR-Mutated Non-Small Cell Lung Cancer Cells. Lung Cancer (Auckl). 2025;16:57\u201372. https:\/\/doi.org\/10.2147\/lctt.S512936.","journal-title":"Lung Cancer (Auckl)"},{"key":"427_CR386","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101143","volume":"62","author":"TV Steen","year":"2025","unstructured":"Steen TV, Espinoza I, Duran C, Casadevall G, Serrano-Herv\u00e1s E, Cuy\u00e0s E, et al. Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer. Neoplasia. 2025;62:101143. https:\/\/doi.org\/10.1016\/j.neo.2025.101143.","journal-title":"Neoplasia"},{"issue":"1","key":"427_CR387","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12964-024-01951-w","volume":"22","author":"D Bandyopadhyay","year":"2024","unstructured":"Bandyopadhyay D, Tran ET, Patel RA, Luetzen MA, Cho K, Shriver LP, et al. Momordicine-I suppresses head and neck cancer growth by modulating key metabolic pathways. Cell Commun Signal. 2024;22(1):597. https:\/\/doi.org\/10.1186\/s12964-024-01951-w.","journal-title":"Cell Commun Signal"},{"issue":"11","key":"427_CR388","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41375-024-02390-9","volume":"38","author":"V Dembitz","year":"2024","unstructured":"Dembitz V, Lawson H, Burt R, Natani S, Philippe C, James SC, et al. Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation. Leukemia. 2024;38(11):2395\u2013409. https:\/\/doi.org\/10.1038\/s41375-024-02390-9.","journal-title":"Leukemia"},{"key":"427_CR389","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119364","volume":"342","author":"Y Peng","year":"2025","unstructured":"Peng Y, Wu S, Xu Y, Ye X, Huang X, Gao L, et al. Huangqi-Danshen decoction alleviates renal fibrosis through targeting SCD1 to modulate cGAS\/STING signaling. J Ethnopharmacol. 2025;342:119364. https:\/\/doi.org\/10.1016\/j.jep.2025.119364.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"427_CR390","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05738-8","volume":"14","author":"J Cai","year":"2023","unstructured":"Cai J, Ye Z, Hu Y, Ye L, Gao L, Wang Y, et al. Fatostatin induces ferroptosis through inhibition of the AKT\/mTORC1\/GPX4 signaling pathway in glioblastoma. Cell Death Dis. 2023;14(3):211. https:\/\/doi.org\/10.1038\/s41419-023-05738-8.","journal-title":"Cell Death Dis"},{"issue":"1","key":"427_CR391","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02354-7","volume":"11","author":"G Wei","year":"2025","unstructured":"Wei G, Huang Y, Li W, Xie Y, Zhang D, Niu Y, et al. SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance. Cell Death Discov. 2025;11(1):75. https:\/\/doi.org\/10.1038\/s41420-025-02354-7.","journal-title":"Cell Death Discov"},{"key":"427_CR392","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101925","volume":"44","author":"G Wei","year":"2024","unstructured":"Wei G, Zhu H, Zhou Y, Pan Y, Yi B, Bai Y. Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer. Transl Oncol. 2024;44:101925. https:\/\/doi.org\/10.1016\/j.tranon.2024.101925.","journal-title":"Transl Oncol"},{"issue":"4","key":"427_CR393","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1158\/1541-7786.Mcr-24-0508","volume":"23","author":"SD Varney","year":"2025","unstructured":"Varney SD, Erkes DA, Mersky GL, Mustafa MU, Chua V, Chervoneva I, et al. Metabolic Inhibition Induces Pyroptosis in Uveal Melanoma. Mol Cancer Res. 2025;23(4):350\u201362. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-24-0508.","journal-title":"Mol Cancer Res"},{"issue":"6","key":"427_CR394","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s10120-024-01552-z","volume":"27","author":"K Kawabata","year":"2024","unstructured":"Kawabata K, Takahashi T, Tanaka K, Kurokawa Y, Yamamoto K, Saito T, et al. Lipolysis-stimulated lipoprotein receptor promote lipid uptake and fatty acid oxidation in gastric cancer. Gastric Cancer. 2024;27(6):1258\u201372. https:\/\/doi.org\/10.1007\/s10120-024-01552-z.","journal-title":"Gastric Cancer"},{"key":"427_CR395","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102959","volume":"68","author":"A Hu","year":"2023","unstructured":"Hu A, Wang H, Xu Q, Pan Y, Jiang Z, Li S, et al. A novel CPT1A covalent inhibitor modulates fatty acid oxidation and CPT1A-VDAC1 axis with therapeutic potential for colorectal cancer. Redox Biol. 2023;68:102959. https:\/\/doi.org\/10.1016\/j.redox.2023.102959.","journal-title":"Redox Biol"},{"issue":"1","key":"427_CR396","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11271-9","volume":"15","author":"S Shinoda","year":"2025","unstructured":"Shinoda S, Nakamura N, Inoko K, Sato-Dahlman M, Carmella S, Hecht S, et al. Inhibition of fatty acid binding protein suppresses pancreatic cancer progression and metastasis. Sci Rep. 2025;15(1):26084. https:\/\/doi.org\/10.1038\/s41598-025-11271-9.","journal-title":"Sci Rep"},{"issue":"5","key":"427_CR397","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.104536","volume":"10","author":"MA Gouda","year":"2025","unstructured":"Gouda MA, Voss MH, Tawbi H, Gordon M, Tykodi SS, Lam ET, et al. A phase I\/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer. ESMO Open. 2025;10(5):104536. https:\/\/doi.org\/10.1016\/j.esmoop.2025.104536.","journal-title":"ESMO Open"},{"issue":"2","key":"427_CR398","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/1871520622666220513163341","volume":"23","author":"H Guo","year":"2023","unstructured":"Guo H, Li W, Pan G, Wang C, Li D, Liu N, et al. The Glutaminase Inhibitor Compound 968 Exhibits Potent In vitro and In vivo Anti-tumor Effects in Endometrial Cancer. Anticancer Agents Med Chem. 2023;23(2):210\u201321. https:\/\/doi.org\/10.2174\/1871520622666220513163341.","journal-title":"Anticancer Agents Med Chem"},{"issue":"3","key":"427_CR399","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/10715762.2024.2332343","volume":"58","author":"S Tanaka","year":"2024","unstructured":"Tanaka S, Hayashi S, Otsuka T, Kamiya T, Ishikawa K, Hara H. Inhibition of glutamine metabolism increases sensitivity to plasma-activated medium-induced cytotoxicity. Free Radic Res. 2024;58(3):170\u20139. https:\/\/doi.org\/10.1080\/10715762.2024.2332343.","journal-title":"Free Radic Res"},{"key":"427_CR400","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114595","volume":"154","author":"Y Lu","year":"2025","unstructured":"Lu Y, Zhou C, Li J, Liu L, Liu X, Shen L, et al. Radiation induces M2 polarization of glioma-associated macrophages via upregulation of glutamine synthetases. Int Immunopharmacol. 2025;154:114595. https:\/\/doi.org\/10.1016\/j.intimp.2025.114595.","journal-title":"Int Immunopharmacol"},{"key":"427_CR401","doi-asserted-by":"publisher","unstructured":"Tatarskiy V, Chan W-K, Tan L, Khamidullina A, Mahmud I, Kumar SV, et al. The ASNS inhibitor ASX-173 potentiates L-asparaginase anticancer activity. 2025:2025.07.03.662851. https:\/\/doi.org\/10.1101\/2025.07.03.662851 %J bioRxiv.","DOI":"10.1101\/2025.07.03.662851"},{"key":"427_CR402","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176156","volume":"960","author":"Y Pan","year":"2023","unstructured":"Pan Y, Suzuki T, Sakai K, Hirano Y, Ikeda H, Hattori A, et al. Bisabosqual A: a novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549\u00a0cells. Eur J Pharmacol. 2023;960:176156. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176156.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"427_CR403","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1001\/jamaoncol.2023.6789","volume":"10","author":"PW Szlosarek","year":"2024","unstructured":"Szlosarek PW, Creelan BC, Sarkodie T, Nolan L, Taylor P, Olevsky O, et al. Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial. JAMA Oncol. 2024;10(4):475\u201383. https:\/\/doi.org\/10.1001\/jamaoncol.2023.6789.","journal-title":"JAMA Oncol"},{"key":"427_CR404","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80721","author":"RE Menjivar","year":"2023","unstructured":"Menjivar RE, Nwosu ZC, Du W, Donahue KL, Hong HS, Espinoza C, et al. Arginase 1 is a key driver of immune suppression in pancreatic cancer. Elife. 2023. https:\/\/doi.org\/10.7554\/eLife.80721.","journal-title":"Elife"},{"key":"427_CR405","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109028","volume":"165","author":"HMB Akram","year":"2025","unstructured":"Akram HMB, Liu Y, Dong J, Zhao X, Wang L, Zhao W, et al. Discovery of W478, a novel SHMT2 inhibitor for the treatment of esophageal carcinoma. Bioorg Chem. 2025;165:109028. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109028.","journal-title":"Bioorg Chem"},{"issue":"4","key":"427_CR406","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1182\/blood.2021012081","volume":"139","author":"AC Wilke","year":"2022","unstructured":"Wilke AC, Doebele C, Zindel A, Lee KS, Rieke SA, Ceribelli M, et al. SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Blood. 2022;139(4):538\u201353. https:\/\/doi.org\/10.1182\/blood.2021012081.","journal-title":"Blood"},{"issue":"5","key":"427_CR407","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202406942","volume":"21","author":"Q Ma","year":"2025","unstructured":"Ma Q, Gao S, Li C, Yao J, Xie Y, Jiang C, et al. Cuproptosis and serine metabolism blockade triggered by copper-based Prussian blue nanomedicine for enhanced tumor therapy. Small. 2025;21(5):e2406942. https:\/\/doi.org\/10.1002\/smll.202406942.","journal-title":"Small"},{"issue":"1","key":"427_CR408","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01013-0","volume":"15","author":"K Gong","year":"2024","unstructured":"Gong K, Huang Y, Zheng Y, Zhu Y, Hao W, Shi K. Preclinical efficacy of CBR-5884 against epithelial ovarian cancer cells by targeting the serine synthesis pathway. Discov Oncol. 2024;15(1):154. https:\/\/doi.org\/10.1007\/s12672-024-01013-0.","journal-title":"Discov Oncol"},{"key":"427_CR409","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102458","volume":"56","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Yin Y, Yu M, Gao D, Sun J, Yang Z, et al. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biol. 2022;56:102458. https:\/\/doi.org\/10.1016\/j.redox.2022.102458.","journal-title":"Redox Biol"},{"key":"427_CR410","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24101993","author":"H Wu","year":"2019","unstructured":"Wu H, Pan L, Gao C, Xu H, Li Y, Zhang L, et al. Quercetin inhibits the proliferation of glycolysis-addicted HCC cells by reducing hexokinase 2 and Akt-mTOR pathway. Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24101993.","journal-title":"Molecules"},{"issue":"29","key":"427_CR411","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1021\/acs.jafc.7b02120","volume":"65","author":"W Li","year":"2017","unstructured":"Li W, Hao J, Zhang L, Cheng Z, Deng X, Shu G. Astragalin reduces hexokinase 2 through increasing miR-125b to inhibit the proliferation of hepatocellular carcinoma cells in vitro and in vivo. J Agric Food Chem. 2017;65(29):5961\u201372. https:\/\/doi.org\/10.1021\/acs.jafc.7b02120.","journal-title":"J Agric Food Chem"},{"issue":"5","key":"427_CR412","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1111\/jcmm.14971","volume":"24","author":"M Li","year":"2020","unstructured":"Li M, Shao J, Guo Z, Jin C, Wang L, Wang F, et al. Novel mitochondrion-targeting copper(II) complex induces HK2 malfunction and inhibits glycolysis via Drp1-mediating mitophagy in HCC. J Cell Mol Med. 2020;24(5):3091\u2013107. https:\/\/doi.org\/10.1111\/jcmm.14971.","journal-title":"J Cell Mol Med"},{"key":"427_CR413","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114115","volume":"158","author":"M Li","year":"2023","unstructured":"Li M, Zhang A, Qi X, Yu R, Li J. A novel inhibitor of PGK1 suppresses the aerobic glycolysis and proliferation of hepatocellular carcinoma. Biomed Pharmacother. 2023;158:114115. https:\/\/doi.org\/10.1016\/j.biopha.2022.114115.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"427_CR414","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.apsb.2021.05.009","volume":"11","author":"R Huang","year":"2021","unstructured":"Huang R, Zhang L, Jin J, Zhou Y, Zhang H, Lv C, et al. Bruceine D inhibits HIF-1\u03b1-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT\/\u03b2-catenin interaction. Acta Pharm Sin B. 2021;11(11):3481\u201392. https:\/\/doi.org\/10.1016\/j.apsb.2021.05.009.","journal-title":"Acta Pharm Sin B"},{"issue":"7","key":"427_CR415","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1158\/2159-8290.Cd-21-1022","volume":"12","author":"B Hu","year":"2022","unstructured":"Hu B, Yu M, Ma X, Sun J, Liu C, Wang C, et al. IFN\u03b1 potentiates anti-PD-1 efficacy by remodeling glucose metabolism in the hepatocellular carcinoma microenvironment. Cancer Discov. 2022;12(7):1718\u201341. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1022.","journal-title":"Cancer Discov"},{"issue":"3","key":"427_CR416","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3892\/or.2015.4092","volume":"34","author":"CC Hsu","year":"2015","unstructured":"Hsu CC, Wu LC, Hsia CY, Yin PH, Chi CW, Yeh TS, et al. Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs. Oncol Rep. 2015;34(3):1620\u20138. https:\/\/doi.org\/10.3892\/or.2015.4092.","journal-title":"Oncol Rep"},{"issue":"3","key":"427_CR417","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.bbrc.2017.03.139","volume":"486","author":"G Yang","year":"2017","unstructured":"Yang G, Wang Y, Feng J, Liu Y, Wang T, Zhao M, et al. Aspirin suppresses the abnormal lipid metabolism in liver cancer cells via disrupting an NF\u03baB-ACSL1 signaling. Biochem Biophys Res Commun. 2017;486(3):827\u201332. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"427_CR418","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1038\/s41467-023-41852-z","volume":"14","author":"Z Ding","year":"2023","unstructured":"Ding Z, Pan Y, Shang T, Jiang T, Lin Y, Yang C, et al. URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. Nat Commun. 2023;14(1):6269. https:\/\/doi.org\/10.1038\/s41467-023-41852-z.","journal-title":"Nat Commun"},{"issue":"5","key":"427_CR419","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s42255-020-0203-z","volume":"2","author":"Y Wei","year":"2020","unstructured":"Wei Y, Tian C, Zhao Y, Liu X, Liu F, Li S, et al. MRG15 orchestrates rhythmic epigenomic remodelling and controls hepatic lipid metabolism. Nat Metab. 2020;2(5):447\u201360. https:\/\/doi.org\/10.1038\/s42255-020-0203-z.","journal-title":"Nat Metab"},{"issue":"1","key":"427_CR420","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.1038\/s41467-022-34299-1","volume":"13","author":"W Su","year":"2022","unstructured":"Su W, Wu S, Yang Y, Guo Y, Zhang H, Su J, et al. Phosphorylation of 17\u03b2-hydroxysteroid dehydrogenase 13 at serine 33 attenuates nonalcoholic fatty liver disease in mice. Nat Commun. 2022;13(1):6577. https:\/\/doi.org\/10.1038\/s41467-022-34299-1.","journal-title":"Nat Commun"},{"issue":"42","key":"427_CR421","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1038\/s41388-023-02795-3","volume":"42","author":"D Du","year":"2023","unstructured":"Du D, Qin M, Shi L, Liu C, Jiang J, Liao Z, et al. RNA binding motif protein 45-mediated phosphorylation enhances protein stability of ASCT2 to promote hepatocellular carcinoma progression. Oncogene. 2023;42(42):3127\u201341. https:\/\/doi.org\/10.1038\/s41388-023-02795-3.","journal-title":"Oncogene"},{"issue":"6","key":"427_CR422","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/bjc.2014.425","volume":"111","author":"M Chiu","year":"2014","unstructured":"Chiu M, Tardito S, Pillozzi S, Arcangeli A, Armento A, Uggeri J, et al. Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts. Br J Cancer. 2014;111(6):1159\u201367. https:\/\/doi.org\/10.1038\/bjc.2014.425.","journal-title":"Br J Cancer"},{"issue":"6","key":"427_CR423","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1158\/1535-7163.Mct-22-0490","volume":"22","author":"D Wei","year":"2023","unstructured":"Wei D, Chen D, Mou H, Chakraborty S, Wei B, Tan L, et al. Targeting glutamine metabolism with a novel Na+\/K+-ATPase inhibitor RX108 in hepatocellular carcinoma. Mol Cancer Ther. 2023;22(6):693\u2013705. https:\/\/doi.org\/10.1158\/1535-7163.Mct-22-0490.","journal-title":"Mol Cancer Ther"},{"issue":"13","key":"427_CR424","doi-asserted-by":"publisher","first-page":"19367","DOI":"10.1021\/acsami.4c21998","volume":"17","author":"H Hu","year":"2025","unstructured":"Hu H, Ning S, Liu F, Zhang Z, Zeng W, Liu Y, et al. Hafnium Metal-Organic Framework-Based Glutamine Metabolism Disruptor For Potentiating Radio-Immunotherapy in MYC-Amplified Hepatocellular Carcinoma. ACS Appl Mater Interfaces. 2025;17(13):19367\u201381. https:\/\/doi.org\/10.1021\/acsami.4c21998.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"34","key":"427_CR425","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202104","volume":"9","author":"C Yang","year":"2022","unstructured":"Yang C, Lee D, Zhang MS, Tse AP, Wei L, Bao MH, et al. Genome-wide CRISPR\/Cas9 library screening revealed dietary restriction of glutamine in combination with inhibition of pyruvate metabolism as effective liver cancer treatment. Adv Sci (Weinh). 2022;9(34):e2202104. https:\/\/doi.org\/10.1002\/advs.202202104.","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"427_CR426","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cmet.2022.06.010","volume":"34","author":"R Missiaen","year":"2022","unstructured":"Missiaen R, Anderson NM, Kim LC, Nance B, Burrows M, Skuli N, et al. GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment. Cell Metab. 2022;34(8):1151-67.e7. https:\/\/doi.org\/10.1016\/j.cmet.2022.06.010.","journal-title":"Cell Metab"},{"issue":"10","key":"427_CR427","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1016\/j.ymthe.2024.08.028","volume":"32","author":"I Ajmal","year":"2024","unstructured":"Ajmal I, Farooq MA, Duan Y, Yao J, Gao Y, Hui X, et al. Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer. Mol Ther. 2024;32(10):3539\u201357. https:\/\/doi.org\/10.1016\/j.ymthe.2024.08.028.","journal-title":"Mol Ther"},{"key":"427_CR428","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042079","author":"G Pucci","year":"2024","unstructured":"Pucci G, Minafra L, Bravat\u00e0 V, Calvaruso M, Turturici G, Cammarata FP, et al. Glut-3 gene knockdown as a potential strategy to overcome glioblastoma radioresistance. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25042079.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"427_CR429","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01771-5","volume":"22","author":"T Li","year":"2023","unstructured":"Li T, Gu Y, Xu B, Kuca K, Zhang J, Wu W. CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure. Mol Cancer. 2023;22(1):77. https:\/\/doi.org\/10.1186\/s12943-023-01771-5.","journal-title":"Mol Cancer"},{"issue":"3","key":"427_CR430","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10549-024-07462-z","volume":"208","author":"V Gunasekharan","year":"2024","unstructured":"Gunasekharan V, Lin HK, Marczyk M, Rios-Hoyo A, Campos GE, Shan NL, et al. Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancer. Breast Cancer Res Treat. 2024;208(3):657\u201371. https:\/\/doi.org\/10.1007\/s10549-024-07462-z.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"427_CR431","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-04002-7","volume":"25","author":"L Silva","year":"2025","unstructured":"Silva L, Skiados N, Murugavel N, Cover K, Luna N, Gupta MK, et al. Efficient identification of new small molecules targeting succinate dehydrogenase in non-small cell lung cancer. Cancer Cell Int. 2025;25(1):362. https:\/\/doi.org\/10.1186\/s12935-025-04002-7.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"427_CR432","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49087-2","volume":"15","author":"L Luo","year":"2024","unstructured":"Luo L, Wu X, Fan J, Dong L, Wang M, Zeng Y, et al. FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma. Nat Commun. 2024;15(1):4790. https:\/\/doi.org\/10.1038\/s41467-024-49087-2.","journal-title":"Nat Commun"},{"issue":"2","key":"427_CR433","doi-asserted-by":"publisher","first-page":"772","DOI":"10.7150\/ijbs.104458","volume":"21","author":"TTM Pham","year":"2025","unstructured":"Pham TTM, Kim M, Nguyen TQN, Park JH, Kim JI, Seo JH, et al. Glycine decarboxylase regulates renal carcinoma progression via interferon stimulated gene factor 3-mediated pathway. Int J Biol Sci. 2025;21(2):772\u201388. https:\/\/doi.org\/10.7150\/ijbs.104458.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"427_CR434","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401343RRR","volume":"39","author":"X Hu","year":"2025","unstructured":"Hu X, Chen W, Yang K, Zhu C, Li Z, Zheng D, et al. TCF19\/CDKN2A regulates glycolysis and macrophage M2 polarization for osteosarcoma progression. FASEB J. 2025;39(7):e70519. https:\/\/doi.org\/10.1096\/fj.202401343RRR.","journal-title":"FASEB J"},{"key":"427_CR435","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1606125","volume":"16","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang C, Zhao S, Gu C. Unraveling the role of GPCR signaling in metabolic reprogramming and immune microenvironment of lung adenocarcinoma: a multi-omics study with experimental validation. Front Immunol. 2025;16:1606125. https:\/\/doi.org\/10.3389\/fimmu.2025.1606125.","journal-title":"Front Immunol"},{"key":"427_CR436","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115398","author":"D Baiskhanova","year":"2025","unstructured":"Baiskhanova D, Menzel M, Geismann C, R\u00f6cken C, Beitz E, Sebens S, et al. Transmembrane protease serine 11B modulates lactate transport through SLC16A1 in pancreatic ductal adenocarcinoma-a functional link to phenotype heterogeneity. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26115398.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"427_CR437","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41588-020-00753-3","volume":"53","author":"AK Najumudeen","year":"2021","unstructured":"Najumudeen AK, Ceteci F, Fey SK, Hamm G, Steven RT, Hall H, et al. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nat Genet. 2021;53(1):16\u201326. https:\/\/doi.org\/10.1038\/s41588-020-00753-3.","journal-title":"Nat Genet"},{"issue":"8","key":"427_CR438","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1007\/s11033-023-08495-1","volume":"50","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Wang Y, Miao Z, Liu Y, Yang Q. c-Myc protects hepatocellular carcinoma cell from ferroptosis induced by glutamine deprivation via upregulating GOT1 and Nrf2. Mol Biol Rep. 2023;50(8):6627\u201341. https:\/\/doi.org\/10.1007\/s11033-023-08495-1.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"427_CR439","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-024-00668-x","volume":"10","author":"Y Huang","year":"2024","unstructured":"Huang Y, Meng F, Zeng T, Thorne RF, He L, Zha Q, et al. IFRD1 promotes tumor cells \u201clow-cost\u201d survival under glutamine starvation via inhibiting histone H1.0 nucleophagy. Cell Discov. 2024;10(1):57. https:\/\/doi.org\/10.1038\/s41421-024-00668-x.","journal-title":"Cell Discov"},{"issue":"2","key":"427_CR440","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s11060-025-05183-x","volume":"175","author":"CR Garcia","year":"2025","unstructured":"Garcia CR, Highsmith K, Knight S, Andrade IP, Leung CH, Puduvalli V, et al. Single center experience of IDH inhibitors in recurrent high-grade gliomas. J Neurooncol. 2025;175(2):837\u201344. https:\/\/doi.org\/10.1007\/s11060-025-05183-x.","journal-title":"J Neurooncol"},{"issue":"1","key":"427_CR441","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60798-y","volume":"16","author":"Y Shen","year":"2025","unstructured":"Shen Y, Wang H, Guo D, Liu J, Sun J, Chen N, et al. Dual asparagine-depriving nanoparticles against solid tumors. Nat Commun. 2025;16(1):5675. https:\/\/doi.org\/10.1038\/s41467-025-60798-y.","journal-title":"Nat Commun"},{"key":"427_CR442","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16173028","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang Q, Fu H, Han Y, Li X, Zou Q, et al. ASCT2 regulates fatty acid metabolism to trigger glutamine addiction in basal-like breast cancer. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16173028.","journal-title":"Cancers (Basel)"},{"issue":"19","key":"427_CR443","doi-asserted-by":"publisher","first-page":"21836","DOI":"10.1021\/acsami.2c00111","volume":"14","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yu Z, Fu H, Guo Y, Hu P, Shi J. Dual inhibitions on glucose\/glutamine metabolisms for nontoxic pancreatic cancer therapy. ACS Appl Mater Interfaces. 2022;14(19):21836\u201347. https:\/\/doi.org\/10.1021\/acsami.2c00111.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"15","key":"427_CR444","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1158\/1078-0432.Ccr-22-0061","volume":"28","author":"CH Lee","year":"2022","unstructured":"Lee CH, Motzer R, Emamekhoo H, Matrana M, Percent I, Hsieh JJ, et al. Telaglenastat plus Everolimus in advanced renal cell carcinoma: a randomized, double-blinded, placebo-controlled, phase II ENTRATA trial. Clin Cancer Res. 2022;28(15):3248\u201355. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-0061.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"427_CR445","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1158\/1078-0432.Ccr-21-2972","volume":"28","author":"F Meric-Bernstam","year":"2022","unstructured":"Meric-Bernstam F, Tannir NM, Iliopoulos O, Lee RJ, Telli ML, Fan AC, et al. Telaglenastat plus Cabozantinib or Everolimus for advanced or metastatic renal cell carcinoma: an open-label phase I trial. Clin Cancer Res. 2022;28(8):1540\u20138. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-2972.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"427_CR446","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41416-025-02948-z","volume":"132","author":"X Lin","year":"2025","unstructured":"Lin X, Liu Z, Zhou K, Li Y, Huang G, Zhang H, et al. Intratumoral and peritumoral PET\/CT-based radiomics for non-invasively and dynamically predicting immunotherapy response in NSCLC. Br J Cancer. 2025;132(6):558\u201368. https:\/\/doi.org\/10.1038\/s41416-025-02948-z.","journal-title":"Br J Cancer"},{"issue":"6","key":"427_CR447","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.7150\/thno.104310","volume":"15","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li M, Chen C, Xu L, Fu Y, Xu J, et al. Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesis. Theranostics. 2025;15(6):2428\u201350. https:\/\/doi.org\/10.7150\/thno.104310.","journal-title":"Theranostics"},{"issue":"3","key":"427_CR448","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00259-024-06976-4","volume":"52","author":"H Yuan","year":"2025","unstructured":"Yuan H, Chen X, Zhao X, Dai M, Liu Y, Han J, et al. A head-to-head comparison of [(68)Ga]Ga-DOTA-FGFR1 and [(18)F]FDG PET\/CT in the diagnosis of lung cancer. Eur J Nucl Med Mol Imaging. 2025;52(3):979\u201392. https:\/\/doi.org\/10.1007\/s00259-024-06976-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"427_CR449","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00259-025-07108-2","volume":"52","author":"W Guo","year":"2025","unstructured":"Guo W, Xu W, Meng T, Fan C, Fu H, Pang Y, et al. FAP-targeted PET\/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic management. Eur J Nucl Med Mol Imaging. 2025;52(7):2317\u201334. https:\/\/doi.org\/10.1007\/s00259-025-07108-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"427_CR450","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/cbr.2022.0090","volume":"38","author":"S Huang","year":"2023","unstructured":"Huang S, Ren L, Beck JA, Phelps TE, Olkowski C, Ton A, et al. Exploration of imaging biomarkers for metabolically-targeted osteosarcoma therapy in a murine xenograft model. Cancer Biother Radiopharm. 2023;38(7):475\u201385. https:\/\/doi.org\/10.1089\/cbr.2022.0090.","journal-title":"Cancer Biother Radiopharm"},{"issue":"4","key":"427_CR451","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1158\/1541-7786.Mcr-22-0736","volume":"21","author":"CM Storey","year":"2023","unstructured":"Storey CM, Altai M, Bicak M, Veach DR, L\u00fcckerath K, Adrian G, et al. Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response. Mol Cancer Res. 2023;21(4):307\u201315. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-22-0736.","journal-title":"Mol Cancer Res"},{"issue":"6","key":"427_CR452","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s11307-018-1194-y","volume":"20","author":"C Beinat","year":"2018","unstructured":"Beinat C, Haywood T, Chen YS, Patel CB, Alam IS, Murty S, et al. The utility of [(18)F]DASA-23 for molecular imaging of prostate cancer with positron emission tomography. Mol Imaging Biol. 2018;20(6):1015\u201324. https:\/\/doi.org\/10.1007\/s11307-018-1194-y.","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"427_CR453","doi-asserted-by":"publisher","first-page":"47","DOI":"10.14670\/HH-18-490","volume":"38","author":"S Nakayama","year":"2023","unstructured":"Nakayama S, Nishio J, Aoki M, Koga K, Nabeshima K, Yamamoto T. GLUT-1 expression is helpful to distinguish myxofibrosarcoma from nodular fasciitis. Histol Histopathol. 2023;38(1):47\u201351. https:\/\/doi.org\/10.14670\/HH-18-490.","journal-title":"Histol Histopathol"},{"issue":"1","key":"427_CR454","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41389-023-00464-4","volume":"12","author":"Y Tang","year":"2023","unstructured":"Tang Y, Li W, Qiu L, Zhang X, Zhang L, Miyagishi M, et al. The p52-ZER6\/G6PD axis alters aerobic glycolysis and promotes tumor progression by activating the pentose phosphate pathway. Oncogenesis. 2023;12(1):17. https:\/\/doi.org\/10.1038\/s41389-023-00464-4.","journal-title":"Oncogenesis"},{"issue":"1","key":"427_CR455","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10020-025-01125-5","volume":"31","author":"Q Yin","year":"2025","unstructured":"Yin Q, Yao Y, Ni J, Zhang Y, Wu J, Zeng H, et al. DLAT activates EMT to promote HCC metastasis by regulating GLUT1-mediated aerobic glycolysis. Mol Med. 2025;31(1):71. https:\/\/doi.org\/10.1186\/s10020-025-01125-5.","journal-title":"Mol Med"},{"issue":"2","key":"427_CR456","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2242247","volume":"55","author":"W Wang","year":"2023","unstructured":"Wang W, Tian X, Yan L, Guan X, Dong B, Zhao M, et al. Identification of the \u03b3-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer. Ann Med. 2023;55(2):2242247. https:\/\/doi.org\/10.1080\/07853890.2023.2242247.","journal-title":"Ann Med"},{"issue":"1","key":"427_CR457","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-024-04174-0","volume":"24","author":"SL Wu","year":"2024","unstructured":"Wu SL, Zha GY, Tian KB, Xu J, Cao MG. The metabolic reprogramming of gamma-aminobutyrate in oral squamous cell carcinoma. BMC Oral Health. 2024;24(1):418. https:\/\/doi.org\/10.1186\/s12903-024-04174-0.","journal-title":"BMC Oral Health"},{"key":"427_CR458","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103286","volume":"75","author":"Z Lin","year":"2024","unstructured":"Lin Z, Yang S, Qiu Q, Cui G, Zhang Y, Yao M, et al. Hypoxia-induced cysteine metabolism reprogramming is crucial for the tumorigenesis of colorectal cancer. Redox Biol. 2024;75:103286. https:\/\/doi.org\/10.1016\/j.redox.2024.103286.","journal-title":"Redox Biol"},{"issue":"11","key":"427_CR459","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/14737159.2023.2254884","volume":"23","author":"K Li","year":"2023","unstructured":"Li K, Shi W, Song Y, Qin L, Zang C, Mei T, et al. Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction. Expert Rev Mol Diagn. 2023;23(11):1015\u201326. https:\/\/doi.org\/10.1080\/14737159.2023.2254884.","journal-title":"Expert Rev Mol Diagn"},{"key":"427_CR460","doi-asserted-by":"publisher","DOI":"10.3390\/biom12111700","author":"D Zuo","year":"2022","unstructured":"Zuo D, Xiao J, An H, Chen Y, Li J, Yang X, et al. Screening for lipid-metabolism-related genes and identifying the diagnostic potential of ANGPTL6 for HBV-related early-stage hepatocellular carcinoma. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12111700.","journal-title":"Biomolecules"},{"issue":"1","key":"427_CR461","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.1038\/s41598-018-24676-6","volume":"8","author":"RS O'Connor","year":"2018","unstructured":"O\u2019Connor RS, Guo L, Ghassemi S, Snyder NW, Worth AJ, Weng L, et al. The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations. Sci Rep. 2018;8(1):6289. https:\/\/doi.org\/10.1038\/s41598-018-24676-6.","journal-title":"Sci Rep"},{"key":"427_CR462","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/9993386","volume":"2023","author":"R Singh","year":"2023","unstructured":"Singh R, Gupta V, Kumar A, Singh K. 2-deoxy-D-glucose: a novel pharmacological agent for killing hypoxic tumor cells, oxygen dependence-lowering in Covid-19, and other pharmacological activities. Adv Pharmacol Pharm Sci. 2023;2023:9993386. https:\/\/doi.org\/10.1155\/2023\/9993386.","journal-title":"Adv Pharmacol Pharm Sci"},{"issue":"1","key":"427_CR463","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13046-017-0514-4","volume":"36","author":"D Xu","year":"2017","unstructured":"Xu D, Jin J, Yu H, Zhao Z, Ma D, Zhang C, et al. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2. J Exp Clin Cancer Res. 2017;36(1):44. https:\/\/doi.org\/10.1186\/s13046-017-0514-4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"427_CR464","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12772","volume":"53","author":"B Hu","year":"2020","unstructured":"Hu B, Lin JZ, Yang XB, Sang XT. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: a review. Cell Prolif. 2020;53(3):e12772. https:\/\/doi.org\/10.1111\/cpr.12772.","journal-title":"Cell Prolif"},{"key":"427_CR465","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1166440","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, He J, Feng Y, Xiang M. Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling. Front Immunol. 2023;14:1166440. https:\/\/doi.org\/10.3389\/fimmu.2023.1166440.","journal-title":"Front Immunol"},{"key":"427_CR466","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115584","author":"N Hu","year":"2024","unstructured":"Hu N, Li H, Tao C, Xiao T, Rong W. The role of metabolic reprogramming in the tumor immune microenvironment: mechanisms and opportunities for immunotherapy in hepatocellular carcinoma. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25115584.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"427_CR467","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4251\/wjgo.v15.i4.617","volume":"15","author":"XC Feng","year":"2023","unstructured":"Feng XC, Liu FC, Chen WY, Du J, Liu H. Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy. World J Gastrointest Oncol. 2023;15(4):617\u201331. https:\/\/doi.org\/10.4251\/wjgo.v15.i4.617.","journal-title":"World J Gastrointest Oncol"},{"key":"427_CR468","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179438","author":"M Takaichi","year":"2024","unstructured":"Takaichi M, Tachinami H, Takatsuka D, Yonesi A, Sakurai K, Rasul MI, et al. Targeting CD36-mediated lipid metabolism by selective inhibitor-augmented antitumor immune responses in oral cancer. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25179438.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"427_CR469","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1158\/2159-8290.Cd-24-1409","volume":"15","author":"SF Tzeng","year":"2025","unstructured":"Tzeng SF, Yu YR, Park J, von Renesse J, Hsiao HW, Hsu CH, et al. PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis. Cancer Discov. 2025;15(8):1676\u201396. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-1409.","journal-title":"Cancer Discov"},{"issue":"2","key":"427_CR470","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s43018-020-00160-x","volume":"2","author":"S Wu","year":"2021","unstructured":"Wu S, Fukumoto T, Lin J, Nacarelli T, Wang Y, Ong D, et al. Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. Nat Cancer. 2021;2(2):189\u2013200. https:\/\/doi.org\/10.1038\/s43018-020-00160-x.","journal-title":"Nat Cancer"},{"key":"427_CR471","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007349","author":"N Babl","year":"2023","unstructured":"Babl N, Decking SM, Voll F, Althammer M, Sala-Hojman A, Ferretti R, et al. MCT4 blockade increases the efficacy of immune checkpoint blockade. J Immunother Cancer. 2023. https:\/\/doi.org\/10.1136\/jitc-2023-007349.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"427_CR472","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1158\/1078-0432.Ccr-22-3911","volume":"29","author":"CM Kelly","year":"2023","unstructured":"Kelly CM, Qin LX, Whiting KA, Richards AL, Avutu V, Chan JE, et al. A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma. Clin Cancer Res. 2023;29(11):2043\u201351. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-3911.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"427_CR473","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/hep.0000000000001085","volume":"81","author":"L Fan","year":"2025","unstructured":"Fan L, Tian C, Yang W, Liu X, Dhungana Y, Yang W, et al. HKDC1 promotes liver cancer stemness under hypoxia through stabilizing \u03b2-catenin. Hepatology. 2025;81(6):1685\u201399. https:\/\/doi.org\/10.1097\/hep.0000000000001085.","journal-title":"Hepatology"},{"issue":"4","key":"427_CR474","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1097\/hep.0000000000000962","volume":"81","author":"Q Liu","year":"2025","unstructured":"Liu Q, Zhang X, Qi J, Tian X, Dovjak E, Zhang J, et al. Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC. Hepatology. 2025;81(4):1164\u201380. https:\/\/doi.org\/10.1097\/hep.0000000000000962.","journal-title":"Hepatology"},{"key":"427_CR475","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2147\/jhc.S474343","volume":"11","author":"YJ Liu","year":"2024","unstructured":"Liu YJ, Li JX, Li JP, Hu YD, Ma ZB, Huang W, et al. Endoplasmic Reticulum Membrane Protein Complex Regulates Cancer Stem Cells and is Associated with Sorafenib Resistance in Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2024;11:1519\u201339. https:\/\/doi.org\/10.2147\/jhc.S474343.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"427_CR476","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02208-x","volume":"41","author":"Y Lu","year":"2022","unstructured":"Lu Y, Chan YT, Tan HY, Zhang C, Guo W, Xu Y, et al. Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41(1):3. https:\/\/doi.org\/10.1186\/s13046-021-02208-x.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"427_CR477","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.7150\/thno.92646","volume":"14","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhao H, Ren R, Zhou M, Zhang J, Wu Z, et al. GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma. Theranostics. 2024;14(9):3470\u201385. https:\/\/doi.org\/10.7150\/thno.92646.","journal-title":"Theranostics"},{"issue":"5","key":"427_CR478","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.ijrobp.2022.11.022","volume":"115","author":"S Zhang","year":"2023","unstructured":"Zhang S, Hu Y, Wu Z, Zhou X, Wu T, Li P, et al. Deficiency of carbamoyl phosphate synthetase 1 engenders radioresistance in hepatocellular carcinoma via deubiquitinating c-Myc. Int J Radiat Oncol Biol Phys. 2023;115(5):1244\u201356. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.11.022.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"427_CR479","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70410","volume":"15","author":"JH Law","year":"2025","unstructured":"Law JH, Shao H, DasGupta R, Huang DQ. Developing risk stratification strategies and biomarkers for recurrent hepatocellular carcinoma. Clin Transl Med. 2025;15(8):e70410. https:\/\/doi.org\/10.1002\/ctm2.70410.","journal-title":"Clin Transl Med"},{"issue":"7-8","key":"427_CR480","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10495-024-01967-0","volume":"29","author":"X Liu","year":"2024","unstructured":"Liu X, Gao X, Yang Y, Yang D, Guo Q, Li L, et al. Eva1a reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K\/AKT\/p53 signaling axis. Apoptosis. 2024;29(7\u20138):1161\u201384. https:\/\/doi.org\/10.1007\/s10495-024-01967-0.","journal-title":"Apoptosis"},{"key":"427_CR481","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102396","volume":"56","author":"X Wang","year":"2025","unstructured":"Wang X, Du Q, Mai Q, Zou Q, Wang S, Lin X, et al. Targeting FASN enhances cisplatin sensitivity via SLC7A11-mediated ferroptosis in cervical cancer. Transl Oncol. 2025;56:102396. https:\/\/doi.org\/10.1016\/j.tranon.2025.102396.","journal-title":"Transl Oncol"},{"issue":"1","key":"427_CR482","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-01991-1","volume":"27","author":"AV Ward","year":"2025","unstructured":"Ward AV, Riley D, Cosper KE, Finlay-Schultz J, Brechbuhl HM, Libby AE, et al. Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. Breast Cancer Res. 2025;27(1):32. https:\/\/doi.org\/10.1186\/s13058-025-01991-1.","journal-title":"Breast Cancer Res"},{"issue":"11","key":"427_CR483","doi-asserted-by":"publisher","first-page":"600","DOI":"10.5483\/BMBRep.2023-0029","volume":"56","author":"SM Yang","year":"2023","unstructured":"Yang SM, Kim J, Lee JY, Lee JS, Lee JM. Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma. BMB Rep. 2023;56(11):600\u20135. https:\/\/doi.org\/10.5483\/BMBRep.2023-0029.","journal-title":"BMB Rep"},{"issue":"10","key":"427_CR484","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2024.130675","volume":"1868","author":"N Ochi","year":"2024","unstructured":"Ochi N, Miyake N, Takeyama M, Yamane H, Fukazawa T, Nagasaki Y, et al. The combined inhibition of SLC1A3 and glutaminase in osimertinib-resistant EGFR mutant cells. Biochim Biophys Acta Gen Subj. 2024;1868(10):130675. https:\/\/doi.org\/10.1016\/j.bbagen.2024.130675.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"1","key":"427_CR485","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07434-1","volume":"16","author":"L Scheiblecker","year":"2025","unstructured":"Scheiblecker L, Klampfl T, Doma E, Nebenfuehr S, Torres-Quesada O, Strich S, et al. Cdk6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia. Cell Death Dis. 2025;16(1):107. https:\/\/doi.org\/10.1038\/s41419-025-07434-1.","journal-title":"Cell Death Dis"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00427-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:07:35Z","timestamp":1773115655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00427-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":485,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00427-2","relation":{"references":[{"id-type":"doi","id":"10.1042\/bsr20200219","asserted-by":"subject"}]},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author Bingqiang Zhang is an employee in Qingdao Restore Biotechnology Co., Ltd. The other authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}